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“If you can meet with Triumph and Disaster and treat those two imposters the 
same… you’ll be a man, my son” 
 
(Rudyard Kipling) 
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1.1 Historical introduction 
The group of feline coronaviruses consists of two very similar viruses: feline infectious peritonitis 
virus (FIPV) and feline enteric coronavirus (FECV). FIP was first described in 1963 as a disease 
manifested by vasculitis and the formation of inflammatory granulomatous lesions (Holzworth, 1963). 
During the following years several authors identified the pathogen as a coronavirus (Zook et al., 1968; 
Ward, 1970; Hardy and Hurvitz, 1971; Pedersen, 1976a; Pedersen et al., 1978; Oreilly et al., 1979). 
Since then, the virus has been found to infect several members of the Felidae including domestic cats, 
lions, cheetahs, mountain lions and European wildcats (Paulmurphy et al., 1994; HofmannLehmann et 
al., 1996; Leutenegger et al., 1999; Munson et al., 2004). The first description of FECV was only 
published in 1981 (Pedersen et al., 1981). Its discovery was based on the inconsistency between 
seropositivity and frequency of clinical FIP, which led to the hypothesis that another subclinical 
infection with a similar coronavirus should be present (i.e. FECV) (Pedersen, 1976b). 
1.2 Feline coronavirus pathotypes 
As mentioned above, two pathotypes or biotypes of feline coronaviruses exist: feline enteric 
coronavirus or FECV and feline infectious peritonitis virus or FIPV. The current hypothesis states that 
FIPV emerges most likely through mutation of FECV (Pedersen, 2009). This is supported by the close 
homology between FECVs and FIPVs isolated from the same group of cats while strains of the same 
pathotype isolated from different geographical areas differed significantly more (Poland et al., 1996; 
Vennema et al., 1998). Additionally, there were also cases of FIPV infection in closed cat colonies 
where FECV circulates (Vennema et al., 1995). The aforementioned mutation probably leads to 
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enhanced replication in monocytes/macrophages resulting in a systemic viral spread which in turn 
leads to disease (Dewerchin et al., 2005; Rottier et al., 2005; Kipar et al., 2006a). Several genes have 
been proposed as key mutation sites in literature and with the exception of the S- and M-genes, all of 
them encode members of the accessory protein family (Brown et al., 2009). Studies using field and 
laboratory feline coronavirus (FCoV) strains revealed that loss of the 7b gene correlates with loss of 
virulence, that nearly all naturally occurring FCoVs have an intact 7b gene and that the 7b gene is 
readily lost during in vitro growth (Herrewegh et al., 1995; Kennedy et al., 2008). Additionally, a role 
for the 7a gene has been proposed during a natural FIPV infection, although no conclusion could be 
reached whether or not an intact 7a gene was correlated with disease (Kennedy et al., 2001). The most 
variable expression is found within the 3c protein (Dye and Siddell, 2007; Kennedy et al., 2008; 
Chang et al., 2010). Most authors conclude that all enteric FECVs have an intact 3c gene while a large 
amount of FIPVs have mutated 3c genes encoding non-functional 3c proteins. This favors the idea that 
the expression of the 3c gene is essential for virus survival in the gastrointestinal tract. When leaving 
the intestinal tract, that expression becomes redundant for survival, moreover, loss of 3c expression 
could even be necessary to achieve a higher systemic virulence (Chang et al., 2010). To date, no single 
consistent mutation that could explain the switch from non-virulent enteric viruses to virulent systemic 
ones has been found. 
1.3 Taxonomy 
Feline coronaviruses belong to the Coronaviridae family which, along with the Arteriviridae and 
Roniviridae, belongs to the order of the Nidovirales (King et al., 2012). They are all enveloped, 
positive-strand RNA viruses while Corona- and Roniviridae possess the largest known RNA genome 
(Gorbalenya et al., 2006). Based on comparative analysis of selected sequences, properties, virion 
structure and replication strategy, the Coronaviridae are further divided into the subfamilies 
Coronavirinae and Torovirinae (Gonzalez et al., 2003). The former has three genera: Alpha-, Beta- 
and Gammacoronavirus. The latter has two genera: Torovirus and Bafinivirus. Feline coronaviruses 
are classified in the Alphacoronavirus genus (Table 1.1). 
The two subspecies, feline coronavirus type I and II reflect the two serotypes that can be distinguished 
by neutralization tests with specific antibodies (Fiscus and Teramoto, 1987). Type I is most frequently 
seen under field conditions and depending on the geographical location, its prevalence varies from 
69% to 86% (Hohdatsu et al., 1992; Benetka et al., 2004; Duarte et al., 2009). Type II  has arisen 
through double recombination between type I and canine coronavirus (CCoV) (Herrewegh et al., 
1998). Since serotype II grows better in in vitro cultures, most studies are based on type II strains such 
as 79-1146 (FIPV) and 79-1683 (FECV) (McKeirnan et al., 1981; Pedersen et al., 1984). 
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Table 1.1: List of all species and subspecies in the alphacoronavirus genus (Adapted from King et al., 2012). 
Species Subspecies Prototype 
Isolates 
Abbreviations 
Alphacoronavirus 1 
Canine coronavirus type I Elmo/02 CCoV Elmo/02 
Canine coronavirus type II NTU336/F/2008 CCoV NTU336/F/2008 
Feline coronavirus type I C1Je FCoV C1Je 
Feline coronavirus type II WSU 79-1146 FIPV 79-1146 
Porcine respiratory coronavirus ISU-1 PRCV ISU-1 
Transmissible gastroenteritis virus Virulent Purdue TGEV virulent Purdue 
Human coronavirus 
229E 
N.A. 229E HCoV 229E 
Human coronavirus 
NL63 
N.A. Amsterdam 1 HCoV NL63 
Miniopterus bat 
coronavirus 1 
Miniopterus bat coronavirus 1A AFCD62 Mi-BatCoV 1A 
 Miniopterus bat coronavirus 1B AFCD307 Mi-BatCoV 1A 
AFCD307 
Miniopterus bat 
coronavirus HKU8 
N.A. AFCD77/08/05 
Mm 
Mi-BatCoV HKU8 
AFCD77/08/05 Mm 
Porcine epidemic 
diarrhea virus 
N.A. CV777 PEDV CV777 
Rhinolophus bat 
coronavirus HKU2 
N.A. HK/46/2006 Rh-BatCoV 
HKU2/HK/46/2006 
Scotophilus bat 
coronavirus 512 
N.A. 512/2005 Sc-BatCoV 512/2005 
 
Each of the two serotypes has two pathotypes: FECV and FIPV. Like mentioned earlier, FECV, 
endemic throughout the world, causes at most a mild transient diarrhea. However, up to 12% of the 
cats seropositive for FCoV, proceed to develop FIP, with a near 100% mortality (Barlough et al., 
1982; Pedersen, 1983; Addie and Jarrett, 1992). 
1.4 Structure 
Early research confirmed the viral etiology of feline infectious peritonitis by visualizing virus particles 
by electron microscopy in inflamed tissues of experimentally infected cats (Fig 1.1-A). The detected 
virus was spherical and had an average diameter of 94 nm (Zook et al., 1968). Further research 
confirmed the viral shape and size both in cats infected with FIPV or FECV (Hoshino and Scott, 1980; 
Beesley and Hitchcock, 1982). Additionally, large petal-shaped surface projections (19 nm) were 
detected, which were later found to be the spike proteins (Neuman, 2008). These peplomers created an 
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image reminiscent of the solar corona around the virus particle and inspired the name of the 
coronaviruses (Fig 1.1-B) (subfamiliy Coronavirinae) (King et al., 2012). 
 
Figure 1.1: Electron microscopic image of FIPV particles (adapted from Beesley and Hitchcock, 1982) (A). Schematic 
overview of a coronavirus particle (B) with RNA, envelope (E), spike (S), membrane (M) and nucleocapsid proteins. 
1.5 Viral genome 
As stated earlier, coronaviruses possess an extremely large RNA genome. Feline coronaviruses are no 
exception to this with FIPV and FECV having ~29.000 nucleotides, without their polyA tail (Dye and 
Siddell, 2005, 2007). The genome (Fig 1.2) is capped at the 5’ end and poly adenylated at the 3’ end 
with several open reading frames (ORFs) in between. The replicase gene, occupying two-thirds from 
the 5’ end of the genome consists of two overlapping ORFs 1a and 1b which are connected by a 
slippery sequence. These ORFs encode the polyproteins pp1a and pp1ab. The structural proteins S, E, 
M and N are encoded by the ORFs 2, 4, 5 and 6 respectively while the accessory proteins are encoded 
by ORFs 3 and 7. 
 
Figure 1.2: Schematic overview of the genomic organization of feline coronaviruses with a leader sequence, 8 ORFs 
and a polyadenylated tail. Each of the ORFs encodes one or more proteins depicted below the ORF. 
1.6 Viral proteins 
1.6.1 Replicative proteins 
Both polyproteins pp1a and pp1ab, encoded by ORF1a and ORF1b undergo extensive proteolytic 
processing by three viral encoded proteases. This results in 16 nonstructural proteins (nsp) (Ziebuhr et 
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al., 2000). These nsps have several different functions (e.g. proteases, nucleases , polymerases,…) and 
eventually assemble to generate a multisubunit machinery that synthesizes viral RNA called 
replication-transcription complex (RTC) and that is membrane associated (Gosert et al., 2002). 
1.6.2 Spike protein 
The monomeric large spike protein has a size between 150 and 200 kDa. It is heavily glycosylated and 
forms trimers that incorporate in virions through association with the membrane protein during 
budding in the ER-to-Golgi intermediate compartment (Masters, 2006). Coronavirus S proteins are 
type I membrane proteins with a cleaved signal sequence, a single transmembrane domain and a short 
C-terminal tail inside the virion (Bosch et al., 2005). They are important in determining host tropism 
and in several virus-immunity interactions (Hohdatsu et al., 1991; Dewerchin et al., 2006; Dye et al., 
2007). 
1.6.3 Nucleocapsid protein 
The nucleocapsid or N protein (43-50 kDa) is a small phosphorylated protein that interacts with viral 
RNA and forms the helical structure inside the virion which is atypical for positive-stranded RNA 
viruses (Hogue and Machamer, 2008). The N protein has been implicated during many functions 
including virus assembly, RNA transcription and/or replication and translation (Tahara et al., 1994; 
Yount et al., 2000; Almazan et al., 2004). In addition, N proteins of mouse hepatitis virus A59 have 
been shown to be interferon antagonists which can negatively influence cell-mediated immune 
responses (Ye et al., 2007). 
1.6.4 Envelope protein 
The envelope or E protein is a small non-glycosylated protein (~10 kDa) with two transmembrane 
domains resulting in a loop that is inserted into the cytoplasmatic side of the bilayer and thus with long 
membrane anchor domains (Maeda et al., 2001). Relative to the membrane and spike protein, it is 
present as a minor structural component. Its main function probably lies in virus production and 
release as has been shown by the release of virus-like particles in cells expressing both envelope and 
membrane protein (Maeda et al., 1999). Additionally, it has been found that envelope proteins share 
characteristics with viral viroporins, proteins that alter cellular permeability. Such activity could 
facilitate virus release from infected cells (Madan et al., 2005; Liao et al., 2006). 
1.6.5 M protein 
The membrane or M protein (25-30 kDa), the most abundant viral envelope component, has a short N-
terminal end protruding outside the virion, three membrane spanning domains and a long C -terminal 
end with an amphiphilic region that tightly associates with the membrane which could result in a 
matrix-structure that lines the inside of the virion (Rottier et al., 1986; Spaan et al., 1988). Their main 
function probably lies in retaining S proteins in the Golgi complex in order to ensure the encapsulation 
of both S and M proteins in newly formed virions (Opstelten et al., 1995). The M protein could also be 
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involved in virus infection/entry as was shown by Kida et al. (2000), who succeeded in blocking 
infection of macrophages by FIPV through incubation with anti-M antibodies (Kida et al., 2000). 
1.6.6 Accessory proteins 
In addition to genes that encode structural proteins and replicase proteins, coronaviruses also have 
several genes encoding non-essential or accessory proteins. These proteins are not needed for virus 
growth in vitro and are group-specific (Lai and Cavanagh, 1997). Their function presumably lies in 
virus replication and virulence in the natural host (Narayanan et al., 2008). Specific for feline 
coronaviruses, ORF3 and ORF7 code for the accessory proteins 3a, 3b, 3c, 7a and 7b (Haijema et al., 
2004). The expression and function of proteins derived from ORF3abc are still largely unknown but 
recent research has highlighted an important role for the 3c gene in the pathotype switch from FECV 
to FIPV with a large amount of FIPVs displaying mutated 3c genes while all enteric FECVs have 
intact 3c genes (Pedersen et al., 2009; Chang et al., 2010). Early research also confirmed a similar role 
for products of the 7a and 7b gene, which encode a hydrophobic protein (~11 kDa) and a secretory 
glycoprotein (~26.5 kDa) respectively (Vennema et al., 1992). Viruses isolated from cats diagnosed 
with feline infectious peritonitis were shown to have mutated 7a or 7b genes (Vennema et al., 1998; 
Kennedy et al., 2001; Lin et al., 2009). This indicates that both 7 genes are not essential for virulence.  
However, to date, no single consistent mutation that could explain the switch from non-virulent enteric 
viruses (FECVs) to virulent systemic ones (FIPVs) has been found. 
1.7 Replication cycle 
1.7.1 Entry 
Virus entry into host cells starts with the recognition of receptors on the cell membrane (Fig 1.3-1). 
Early research highlighted the importance of feline aminopeptidase N (fAPN) or CD13, a type II 
metalloprotease in FIPV entry into cell lines (Tresnan et al., 1996; Hohdatsu et al., 1998). However, in 
contrast to serotype II FCoV, fAPN was not the only receptor for serotype I FCoV entry (Hohdatsu et 
al., 1998). Utilisation of different receptors for virus entry was also proposed for type I and II infection 
of monocytes, the in vivo target cells (Van Hamme et al., 2007). It was found that fAPN is not the only 
receptor for type II FCoV infection of monocytes but that another, unknown receptor is involved in 
40% of FCoV entries. During serotype I infection, DC-SIGN was responsible for 65% of virus entry 
while the rest was also mediated by another unknown receptor. These results indicate that care should 
be taken when using cell lines for studying FCoV entry because of clear differences in receptor 
requirement for infection (Van Hamme et al., 2011). Finally, serotype II FCoV internalization, the 
second step in the virus entry process, was shown to be mediated through endocytosis which was 
clathrin- and caveolae-independent, dynamin-dependent and slightly cholesterol depletion sensitive 
(Fig 1.3-2). Genome release from endosomes was not induced by low pH and a possible role for serine 
and/or cysteine protease(s) was proposed (Van Hamme et al., 2008) (Fig 1.3-3). 
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Figure 1.3: Schematic overview of the FCoV replication cycle with binding to the receptor (1), entry through 
endocytosis (2), genome release (3), translation of the proteins that form the RTC complex (4), formation of the RTC 
complex (5), genome and mRNA synthesis (6), translation (7), formation of the ribonucleocapsid (7b), accumulation of 
viral proteins and budding of virus (8), transport through secretory pathway (9) and release of progeny virus (10). 
Adapted from (Dewerchin, 2008). 
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1.7.2 Replication 
Genome replication occurs through minus-strand intermediates (Fig 1.4). After entry into the cell, the 
16 non-structural proteins that get directly translated, assemble to form the earlier mentioned double-
membrane associated replication-transcription complexes (RTC) (Gosert et al., 2002) (Fig 1.3-4 and 
Fig 1.3-5). These complexes mediate the production of minus-strand full-length genomic (replication) 
or subgenomic RNA (transcription) (Fig 1.3-6). After full-length minus-strand production, this 
template is used for full length genome synthesis (Sawicki et al., 2007). 
1.7.3 Transcription 
A hallmark of coronavirus transcription is the production of several nested subgenomic mRNAs, that 
contain sequences from both parts of the genome (Fig 1.4). The joining of these two parts occurs 
through the process of discontinuous RNA synthesis. In this extension model, the RTC complex starts 
transcribing at the 3’ of the virus genomic RNA and continues until a signal motive called 
transcription-regulating sequence (TRS) is encountered. At this point, a fixed amount of RTCs will 
continue to elongate the nascent strand while the rest will stop synthesis and relocate towards the 5’ 
end of the genome where it will copy the leader sequence. This nested subgenomic RNAs will then 
serve as a template for continuous subgenomic mRNA synthesis. 
1.7.4 Translation 
Most FCoV mRNAs are structurally polycistronic, since they contain multiple open reading frames 
(ORFs). However, since they resemble eukaryotic mRNA, having a 5’ cap, leader sequence, start and 
stop codon, most of them are functionally monocistronic. This indicates that during protein synthesis 
by cellular ribosomes, only one product will emerge from the mRNA. Exceptions to this are the 
mRNAs coding for genes 3 and 7. These RNAs are respectively functionally tri- and bicistronic, 
through the mechanism of leaky scanning. This method allows cellular ribosomes to bypass the first 
startcodon and thus initiate protein synthesis at a second or third start codon. The S, M and E proteins 
are co-translationally embedded in the membranes of the RER while the N protein is produced in the 
cytoplasm (Britton and Cavanagh, 2008; King et al., 2012) (Fig 1.3-7). 
1.7.5 Assembly 
The assembly or budding of virus is the process where the viral genomic information gets packed into 
a membranous structure (the viral envelope) embedded with several viral structural proteins to form a 
virion particle (Lim and Liu, 2001). In coronaviruses, the N protein will interact with viral RNA in the 
cytoplasm to form the helical capsid. This complex will then interact in the ERGIC with local patches 
(rafts) consisting of the viral proteins S, M and E to form the characteristic virion particle, surrounded 
by a double membrane in the Golgi complex (Opstelten et al., 1995) (Fig 1.3-8). After few 
modifications (Fig 1.3-9), these vesicle-packed virions will then merge with the plasma membrane to 
release the virions through exocytosis (Fig 1.3-10). 
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Figure 1.4: Schematic representation of viral replication and its subgenomic transcription. TRS = transcription 
regulation sequence, RTC = replication transcription complex. 
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1.8 Pathogenesis 
1.8.1 Feline enteric coronavirus (FECV) 
Although FECV is an endemic intestinal virus, its clinical impact on the infected host is rather limited 
as infection causes at most a transient gastroenteritis and is more likely to be even unapparent 
(Pedersen et al., 2008). Infection typically occurs through the orofecal route with virus infecting the 
columnar epithelial cells of the intestines (Pedersen et al., 1981). Although FECV is mainly restricted 
to the gut, it also has been detected in the blood, lymphoid tissue, bone marrow and thymus (Pedersen 
et al., 1984; Gunn-Moore et al., 1998; Meli et al., 2004) and even organs such as lungs, brain and liver 
(Kipar et al., 2010). After infection, cats start shedding virus after one to three days. Fecal viral 
genomic copies remain high 6 weeks to 10 months post infection, depending on both host and the 
virus strain used (Pedersen et al., 2008; Vogel et al., 2010). After primary infection, three patterns can 
be detected in virus shedding. A first group stops shedding virus (recovery),  a second group has 
periods of shedding interlaced with periods of non-shedding  (recurrent or intermittent shedding) and a 
third group sheds virus continuously (persistent shedding) (Foley et al., 1997; Pedersen et al., 2008). 
These patterns might be explained by the tenuous local gut immunity, which is variable in strength and 
which does not provide substantial stimulation of the adaptive immune system (Brandtzaeg, 2007) as 
well as the indication that virus can persist in healthy cats, mainly in the colon (Kipar et al., 2010).  
The importance of FECV infection mainly lies in the fact that it can mutate into FIPV (vide supra). 
Like all mutations this depends on probability. Higher FECV titers logically have more chance to 
acquire the mutation(s) necessary for FIPV development. Perhaps this can also explain why cats with 
immature or compromised immune systems, who have 10-100 times higher FECV titers, also have 
more chance of developing FIP (Pedersen, 1976b; Poland et al., 1996; Pedersen et al., 2008). In 
addition, genetic predisposition also plays a role in FIP disease susceptibility. For example, within the 
group of non-domestic cats, cheetahs are especially prone to FIPV infection, probably due to their 
population homogeneity and their lack of MHC I polymorphism (Obrien et al., 1985; Briggs et al., 
1986; Munson et al., 2004). Within the domestic species, there are some purebred cats that have a 
higher risk of FIPV infection namely Abyssinians, Bengals, Birmans, Himalayans, Ragdolls and 
Rexes. Like in cheetahs, an increased homozygous genome can be a reason for their higher 
susceptibility (Pesteanu-Somogyi et al., 2006). Also gender could have an influence with male cats 
being more sensitive to FIPV infection (Benetka et al., 2004). However, some controversy exists 
concerning this gender factor (Pedersen, 1976b; Bell et al., 2006). 
1.8.2 Feline infectious peritonitis virus (FIPV) 
Up to 12% of the cats seropositive for FCoV, develop FIP, with a near 100% mortality (Barlough et 
al., 1982; Pedersen, 1983; Addie and Jarrett, 1992). The mutation that transforms FECV to FIPV leads 
to an enhanced monocyte/macrophage tropism (Stoddart and Scott, 1989; Rottier et al., 2005). In vitro 
experiments revealed that FIPV has  10 to 100 times higher virus production in monocytes than FECV 
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and the infection could be sustained 24h post infection with FIPV but not with FECV (Dewerchin et 
al., 2005). In vivo infection experiments showed that infected monocytes migrate and initiate 
inflammation throughout the body (Weiss and Scott, 1981b). Virus can be detected in 
tracheobronchial and mesenteric lymph nodes, lungs, trachea, liver, spleen, mesentery, kidneys, eyes, 
leptomeninges and myocardium (Weiss and Scott, 1981c; Kipar et al., 2005). In the later stages of 
FIPV infection, these affected tissues typically show vasculitis with formation of granulomas. These 
present as both venous and perivenous infiltrates in small veins and focal infiltrates in larger veins. 
These infiltrates are mainly composed out of monocytes/macrophages, a lot of which are FIPV-
infected, and few T cells and neutrophils. Circular granulomas often have a peripheral rim of B  cells 
(Kipar et al., 2005). 
Two forms of the disease have been described in literature. The effusive or wet form is characterized 
by the presence of effusion in one or more body cavities (thoracic, abdominal, pericardiac) due to 
inflammation of visceral serosae and omentum (Wolfe and Grieseme, 1966; Hayashi et al., 1977). In 
contrast, the hallmark of the dry form is the formation of granulomatous lesions on parenchymatous 
organs such as kidneys, intestines, and liver (Montali and Strandberg, 1972; Hayashi et al., 1980). 
Most naturally infected cats however, have pathologic features that are neither exclusively 
granulomatous nor effusive but rather a mixture of both (Wolfe and Grieseme, 1971; Berg et al., 2005; 
Hartmann, 2005). In case of effusion, the median survival time for a FIPV-infected cat is as low as 8 
days post diagnosis (Ritz et al., 2007).  
Cats typically show a general lymphopenia during a FIPV infection. This was first described during 
the discovery of FIPV (Wolfe and Grieseme, 1966; Ward et al., 1974; Weiss and Scott, 1981c, a), and 
it was extensively researched by Haagmans et al. (1996), who showed that this depletion occurs in 
lymphoid organs such as the spleen and mesenterial lymph nodes as well as in the blood lymphocyte 
population. (Haagmans et al., 1996). Later experiments by Kipar et al. (1999) confirmed the depletion 
of T lymphocytes in lymphatic tissues of FIPV-infected cats (Kipar et al., 1999). Further research 
showed that the depletion was caused by programmed cell death or apoptosis, possibly due to a 
bystander mechanism in which soluble molecules, induce apoptosis in activated lymphocytes 
(Haagmans et al., 1996; Takano et al., 2007). When FIPV-associated lesions were examined for the 
presence of different subtypes of lymphocytes, it was found that few lymphocytes were present in the 
lesions and most of them stained positive for CD3, a part of the T cell receptor complex (TCR). Most 
of these CD3+ lymphocytes also stained positive for CD4 while few CD8+ cells were detected, the bulk 
of them being in the periphery of the lesion (Kipar et al., 1998; Paltrinieri et al., 1998a; Paltrinieri et 
al., 1998b; Berg et al., 2005). In addition to the low number of T lymphocytes present in lesions, an 
abundance of B-lymphocytes and plasma cells was found throughout the lesions possibly accounting 
for the immune-driven progress of the disease (Kipar et al., 1998). In a following study, most of the 
previous results were confirmed, and additionally a general B lymphocyte depletion in lymphatic 
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tissues was detected. This group also found hyperplasia in splenic T cell zones in FIPV-infected cats 
that developed no disease (Haagmans et al., 1996; Kipar et al., 2001). More recent histochemic and 
flow cytometric analysis confirmed the general reduction in lymphocytes counts in peripheral blood 
(Knotek et al., 2000; Dean et al., 2003; Paltrinieri et al., 2003). 
Taken into account that several diseases produce lymphopenia in cats, the diagnostic relevance of this 
lymphopenia is low (Paltrinieri et al., 2003). Nevertheless, lymphopenia is indicative of a failing 
immunity, a theory that is supported by most if not all of the authors. 
1.9 Humoral immunity 
1.9.1 FECV 
Although few studies have addressed the humoral immune responses during FECV infections, most of 
them agree that the virus nearly always induces a significant, albeit variable, antibody (Ab) response 
(Poland et al., 1996; Meli et al., 2004; Pedersen et al., 2008; Vogel et al., 2010). The response is 
detectable from 10 days post inoculation and mainly directed against the structural proteins N, M and 
S (Pedersen et al., 2008; Vogel et al., 2010). Antibodies remain highly detectable for several months 
after inoculation and do not offer protection from reinfection with the same or another FECV strain, 
resulting in equivalent amounts of virus shedding (Addie et al., 2003; Pedersen et al., 2008). 
1.9.2 FIPV 
Upon initial infection with FIPV, cats mount an Ab response, which has been proven to be ineffective 
against the FIPV pathogen (Pedersen and Boyle, 1980). Successful experimentally infected cats mount 
a detectable antibody response 10 days post inoculation, which typically increases in strength up until 
euthanization of the cats (Pedersen et al., 1984). The virus has several humoral immune evasive 
properties such as the absence of virus protein expression on the plasma membrane in half of the in 
vitro infected monocytes and internalization of antibodies bound to viral proteins on the cell surface 
(Cornelissen et al., 2007; Dewerchin et al., 2008). These immune evasive characteristics render a 
humoral response (i.e. antibody-dependent cell-mediated cytotoxicity (ADCC) as well as antibody-
dependent complement-mediated lysis (ADCML)) harmless to the infected cell.  Furthermore, caution 
should be taken when developing vaccines that induce neutralizing Abs. Early attempts of immunizing 
cats against the FIPV S protein resulted in an enhanced form of FIP disease (ADE) progressing much 
quicker than natural infections or experimental infections (Weiss and Scott, 1981a; Vennema et al., 
1990). This phenomenon was explained by the reaction of the Fc tail of virus bound anti-S antibody 
with Fc receptors on target cells (e.g. macrophages) (Hohdatsu et al., 1991). Later research however 
stated that this was not a natural event and probably more relevant under laboratory conditions (Addie 
et al., 1995). 
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1.10 Cellular immunity 
Since it was found that the humoral immune response does not protect cats from FIPV infection but 
make them even more susceptible, it was proposed by Pedersen and colleagues that the cellular 
immunity is key to surviving an encounter with FIPV (Pedersen and Boyle, 1980; Pedersen, 1983; 
Pedersen and Black, 1983). They suggested that the magnitude of a cell-mediated immune response 
(CMI) determines the outcome of the disease. A strong CMI would give no disease, a partial CMI 
would lead to the dry disease-form and no CMI would result in the wet form (Pedersen, 1983; 
Pedersen and Black, 1983; Pedersen, 1995). This hypothesis is supported by studies in which delayed-
type hypersensitivity (DTH) responses to intradermal injection of FIPV were evaluated in FIPV-
inoculated cats, both in symptomatic as well as asymptomatic animals. The authors found that 
symptomatic cats showed a weak DTH response or no response at all, while all asymptomatic cats had 
a positive DTH-reaction. On top of that, the strength of the DTH reaction was correlated to the 
outcome of the diseas. A strong positive DTH reaction seemed to prevent illness, while a weaker and 
absent DTH reaction gave the granulomatous and effusive form of disease (Weiss and Cox, 1988, 
1989). Furthermore, it was observed that the clinical incidence of FIP is greatly increased by a 
concurrent infection with feline leukemia virus (FeLV), a potent suppressor of CMI in cats (Rojko and 
Olsen, 1984). Involvement of CMI was also hypothesized in experiments where thymectomized 
kittens showed more severe abdominal lesions than sham-operated kittens. In related experiments, 
athymic mice and mice treated with anti-thymocyte serum had a higher mortality when inoculated 
with a mouse adapted FIPV-strain(Hayashi et al., 1983; Takenouchi et al., 1985).  At present, the 
theory that links FIP disease severity with CMI potency is still valid (Pedersen, 2009). In addition to 
the DTH experiments, several other studies were performed in order to evaluate the efficacy of the 
cellular immune response. 
1.10.1 Lymphocyte proliferation 
When a host is invaded by pathogens, the CMI will react by activating an arsenal of lymphocytes (e.g. 
CD4+, CD8+, natural killer (NK) and regulatory T cells (Tregs)). Some of these activations occur 
through presentation of viral antigens on antigen presenting cells (APC) in the lymphoid tissues 
(Berke and Clark, 2005; Murphy et al., 2008; Smith-Garvin et al., 2009). Following activation, innate 
effector cells (NK cells) will immediately eliminate infected host cells. Other lymphocytes will start 
proliferating (lymphocyte proliferative response (LPR)) for several days and subsequently differentiate 
into effector cells, after which they set out to eliminate cells infected by the viral pathogen (Murphy et 
al., 2008). Throughout the past decades, the technique of in vitro restimulation of T lymphocytes has 
been used to evaluate the immunologic competence in a wide range of hosts, including cats (Cockerell 
et al., 1975; Tham et al., 1982). Up until now, few articles about the LPR and FIPV have been 
published. Pedersen and colleagues found that lymphocytes from cats, recovered from a FIPV 
infection, showed a LPR when stimulated with FIPV-antigen, while lymphocytes from seronegative 
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cats did not (Pedersen and Floyd, 1985). Stoddart and colleagues discovered that FIPV infected cats 
show a profoundly reduced LPR when treated with Concanavalin (ConA), and that the magnitude of 
this blastogenic response to the mitogen is correlated to the survival time of the cats (Stoddart et al., 
1988). Later experiments confirmed these results (Knotek et al., 2000). During the early nineties, 
Gerber et al. (1990) performed LPR tests with cats vaccinated with a temperature-sensitive FIPV and 
non-vaccinated cats. They detected a LPR response to wild type (wt) FIPV in all 10 vaccinated cats, 8 
of which survived a challenge. In contrast, 4 of the 5 non-vaccinated control cats, 3 of which died, 
failed to show any LPR. The fifth cat that did display a LPR response showed some FIP symptoms but 
recovered afterwards. The strongest LPR response was found in the parotid and the mandibular lymph 
nodes as well as in the spleen and in peripheral blood and was still detectable 137 days after 
vaccination, indicating a long lasting immunity (Gerber et al., 1990; Gerber, 1995). More recently, de 
Groot-Mijnes et al. (2004) first constructed a flow cytometric setup in which they identified FIPV 
specific CD4+ and CD8+ T lymphocytes through intracellular staining of TNF-α, a cytokine typically 
produced by Th1-type cells (de Groot-Mijnes et al., 2004). Next, they vaccinated 33 cats using DNA 
vectors and a recombinant vaccinia virus expressing several parts of the FIPV proteome and thus 
covering nearly 100% of it. Following vaccination, the cats were challenged with the virulent 79-1146 
FIPV strain and monitored. The splenocytes of three long-term survivors and two persistently infected 
cats were then used in the flow cytometric setup, previously described (de Groot-Mijnes et al., 2004). 
When using fibroblasts expressing the different parts of the FIPV proteome as APC, a proliferative 
response for CD8+ T cells was observed towards different epitopes in the S-protein, while a 
combination of epitopes in the S-protein and M-protein was recognized by CD4+ T cells (de Groot-
Mijnes et al., 2005). The authors hypothesized in their article a model in which they suggest the viral-
induced T cell depletion and the antiviral T cell response as two opposing forces linking the efficacy 
of the primary T cell response to the further course of the disease. While a strong primary T cell 
response would lead to containment and possibly overcoming a FIPV infection, a weaker response 
would give the virus more power to diminish T cell numbers. This would hamper the cell-mediated 
immunity in counteracting the virus (de Groot-Mijnes et al., 2005). The same group also discovered 
that the T cell depletion and lack of non-specific T cell proliferation can be induced by heat-
inactivated effusion and sera from FIPV-infected cats (Haagmans et al., 1996). 
From all these studies, it can be concluded that the degree of protection by CMI is highly variable. The 
variation depends on both the efficiency of the cats’ immune system and the virulence of the virus 
strain involved. The strong positive reaction from the vaccinated group may be explained by the fact 
that the wt-virus used for proliferation is antigenically almost identical to the one used for vaccination, 
giving a higher probability of cross-recognition between their viral epitopes (Gerber et al., 1990). 
More reliable are experiments executed with the recombinant vaccine viruses (de Groot-Mijnes et al., 
2005). Especially the conclusion where they propose an immunodominance of the S-protein to be part 
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of the complex interaction between the virus and the immune system is fascinating. Such an 
immunodominance could also partially explain the contradicting efficacy of the existing vaccine in the 
field, varying from 0% to 75% (Pedersen, 2009). After all, being a type II strain, the S-protein of the 
vaccine only has about 43% resemblance to the type I strains found in the field (Dye and Siddell, 
2007) and consequently the epitopes found on the protein are also likely to vary between the two 
strains.  
To conclude, more detailed studies are needed to obtain a complete understanding of the role of CMI 
during FIPV infection. As done with other viruses (FIV, FeLV), cytotoxicity assays could be 
performed. By means of detecting  apoptosis in target cells in vitro, the cytotoxicity of virus-specific 
effector CD8+ or CD4+ T cells could be evaluated (Song et al., 1992; Flynn et al., 2000). This would 
reveal if the cellular immunity is able to eliminate virus-infected cells (FECV or FIPV). If no target 
cell apoptosis is detected in these assays, it would be interesting to retrace the steps that lead to the 
cellular targeting: starting with activation and proliferation (which was already seen by several 
authors) followed by migration and finally the homing and adhering to infected cells. In this way, the 
failing step can be determined and the proteins involved can be identified by using the vaccination 
system with recombinant vaccine viruses expressing several parts of the FIPV proteome which has 
been used before (de Groot-Mijnes et al., 2005). 
1.10.2 Cytokines  
During the early stages of an infection with a pathogen, the immune system and more specifically 
macrophages and dendritic cells (DC), start producing inflammatory cytokines such as IL-1β, IL-6, 
and TNF-α. This cytokine production can have several effects on the host and its immune response 
such as pyrogenic reaction, activation of complement opsonisation, initiation of the acute-phase 
reaction, and stimulation of adaptive immune responses. More in detail, during a viral infection, 
several interferons are produced as well (IFN-α, IFN-β and IFN-ɣ) that are believed to act in vivo by 
blocking the spread to uninfected cells. In addition, cytokines such as IL-2, IL-4, IL-10, IL-12, and 
granulocyte-macrophage colony stimulating factor (GM-CSF) are produced by and act on the B,  T 
and NK cell-mediated immunity (Lodish et al., 2008; Murphy et al., 2008). During the past 2 decades 
several of these cytokines have been examined for a possible link with FIPV (Table 1.2).  
Table 1 shows that mRNA expression does not necessarily correlate with protein expression. After all, 
there are several post-transcriptional control mechanisms regulating the expression of genes, in casu 
cytokines. Such mechanisms mostly control stability, localization or translation of mRNA. Stable 
mRNA could for example produce corresponding protein for a longer period than unstable mRNA 
could. Cytokine mRNA is known to be extremely unstable leading to a linear correlation between 
mRNA and protein levels, such as has been shown for feline IL-2 and IL-6 (Rottman et al., 1995; 
Lodish et al., 2008). It should be mentioned that the cytokine research was conducted on samples from 
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different origins and that different treatments were performed on these samples. This makes a 
comparison of results difficult. Even when the same conditions and samples were used, contradictory 
results were obtained. These differences might be contributed to the high individual variability in 
cytokine expression, even when starting with a homogenous group of SPF cats (Foley et al., 2003; 
Gelain et al., 2006; Kipar et al., 2006a; Kipar et al., 2006b).  
Table 1.2: Overview of the differences found in cytokine production associated with FIPV infection. 
Cytokine Form Status References 
TNF-α protein Elevated (Kipar et al., 2005) (Dean et al., 2003) 
mRNA Elevated (Takano et al., 2007) (Dean et al., 2003) (Dean et al., 2003) 
 Not involved (Gunn-Moore et al., 1998) 
IFN-ɣ Protein Elevated  (Giordano and Paltrinieri, 2009)  
mRNA Elevated (Berg et al., 2005) (Foley et al., 2003) 
Reduced (Gelain et al., 2006) (Gelain et al., 2006) (Gunn-Moore et al., 1998) 
 Not involved (Dean et al., 2003) 
IL-1 Protein Elevated (Goitsuka et al., 1987) (Goitsuka et al., 1988) (Kipar et al., 2005) 
mRNA Elevated (Hasegawa and Hasegawa, 1991) (Kipar et al., 2006b) 
 Reduced (Gelain et al., 2006) 
IL-2 mRNA Reduced (Gunn-Moore et al., 1998) 
IL-4 mRNA Reduced (Dean et al., 2003) (Gunn-Moore et al., 1998) 
IL-6 Protein Elevated (Goitsuka et al., 1990) (Kipar et al., 2006b) 
mRNA Elevated (Gunn-Moore et al., 1998) 
IL-10 mRNA Elevated (Kipar et al., 2006b) (Dean et al., 2003) 
Reduced (Kipar et al., 2006b) (Gunn-Moore et al., 1998)  
IL-12 mRNA Elevated (Kiss et al., 2004) 
Reduced (Kipar et al., 2006b) (Dean et al., 2003) (Gunn-Moore et al., 1998) 
 
Despite some contradictory results, three general trends can be observed. First, a high IL-10 : IL-12 
ratio favors illness while a low IL-10 : IL-12 ratio provides protection (Dean et al., 2003; Kipar et al., 
2006b). Even though different results were obtained by Gunn-Moore et al. (Gunn-Moore et al., 1998), 
who found a general suppression of cytokine production by using mitogen-stimulated peripheral blood 
mononuclear cells (PBMCs) as producer cells, this is an attractive theory. After all, IL-10, a notable 
anti-inflammatory cytokine, is a potent suppressor of cellular immunity. When produced, it inhibits the 
TH1 response of T cells and the cytokine release of macrophages. Essentially, it enhances the 
antibody-based B cell response which is typical of a FIPV infection. In contrast, the release of IL-12 
actually supports the cellular immune response by inducing CD4 T cell differentiation to the TH1-type 
and enhancing NK cell / cytotoxic T lymphocyte (CTL) activity (manifested by elevated IFN-ɣ and 
TNF-α production among other things) (Fig 1.5) (Murphy et al., 2008). Although the effect of IL-12 is 
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generally accepted, the opposite was noticed by Glansbeek et al. (2002), who observed a suppression 
of cellular immunity when administering IL-12 during vaccination, possibly linked to an 
overexpression of IL-12 (Glansbeek et al., 2002). 
Second, during FIPV infections an overproduction of TNF-α is observed(Dean et al., 2003; Kiss et al., 
2004; Kipar et al., 2005; Takano et al., 2007; Takano et al., 2009). Although not accepted by 
everyone(Haagmans et al., 1996; Gunn-Moore et al., 1998), such an overexpression could induce 
apoptosis of lymphocytes, as mentioned earlier. A co-expression of TNF-α and lesions together with 
an increased expression of TNFR-I and TNFR-II on CD8+ T cells in FIP cats surely supports this 
hypothesis (Dean et al., 2003; Takano et al., 2007), especially when apoptosis inhibitors such as 
caspase-3, caspase-8, and p38-MAPK inhibitors have been shown to halt apoptosis (Takano et al., 
2007). In addition, TNF-α can upregulate endothelial adhesion molecules such as VCAM-1 which 
could account for the vasculititis, a hallmark for FIPV infection (Fig 1.5) (Kipar et al., 2005).  
A third and final aspect noticed by some of the researchers was an upregulation of IFN-ɣ in lesions 
and tissues from FIPV-infected cats (Dean et al., 2003; Foley et al., 2003; Berg et al., 2005). Some 
other groups reported the opposite in peripheral blood or serum, a down regulation of IFN-ɣ (Gunn-
Moore et al., 1998; Kiss et al., 2004; Gelain et al., 2006; Giordano and Paltrinieri, 2009). These groups 
explained the results by either lymphopenia, causing a reduced number of IFN-ɣ producing cells 
(Gunn-Moore et al., 1998; Gelain et al., 2006; Giordano and Paltrinieri, 2009) or by similarities with 
mouse hepatitis virus (MHV) where IFN-ɣ lacking mouse develop peritonitis when confronted with 
MHV (Kyuwa et al., 1998; Kiss et al., 2004). This differential production of IFN-ɣ in blood and tissue 
is striking, especially when considering that IFN-ɣ is a potent mediator of cellular immunity. As 
Giordano et al. (2009)  proposed, this might indicate that CMI is involved in the pathogenesis of FIP at 
tissue level while high levels of IFN-ɣ in the blood still can protect against infection (Giordano and 
Paltrinieri, 2009). IFN-ɣ can mediate activation of macrophages and an increased macrophage Fc-
receptor-mediated activity (Fig 1.5) (Fertsch and Vogel, 1984; Murphy et al., 2008). These actions 
might then contribute to the antibody-dependent enhancement of disease (ADE) (Pedersen and Boyle, 
1980). 
Although it is tempting to believe some of the arguments above, one must take into account that the 
cytokine network is a complex system with many overlapping pathways (Abbas et al., 2007). 
Although many of the argumentations may be correct, unraveling the whole picture needs more 
complete studies in which many cytokines are followed at both mRNA and protein level. This research 
needs to be done in representative groups (naturally infected cats and appropriate control animals) 
where blood, tissue as well as lesions and effusion fluid are examined.  
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Figure 1.5: Schematic overview of the potential role of several cytokines during infection with feline infectious 
peritonitis virus (FIPV). Beneficial cytokines are depicted in green while malignant cytokines are depicted in red. 
In addition to earlier mentioned aspects of cellular immunity known to be involved and altered during 
an infection with FIPV, there are other cell types whose roles in the pathogenesis of FIP have not yet 
been investigated. It should be mentioned that, although all cell-types mentioned in following 
paragraphs have already been shown to be present in cats, most of the information is based on 
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human/mouse research and that feline-specific immune responses might differ from human/mouse 
models. 
1.10.3 NK cells 
Natural killer cells (NK cells) are a specialized cell-type of the innate immunity known for their 
cytolytic effect against tumors or cells infected with an intracellular pathogen (Fig 1.6-1) (Murphy et 
al., 2008). Besides this property, they also possess the capacity to interact with other cells (e.g. 
dendritic cells, CD4+ and CD8+ T cells) by which they can influence later adaptive responses (Moretta, 
2002; Degli-Esposti and Smyth, 2005). These interactions can occur in inflamed tissues as well as in 
lymph nodes (Moretta, 2002; Fehniger et al., 2003; Ferlazzo et al., 2004). Their interaction with 
dendritic cells can cause these cells to produce a higher amount of IFN-ɣ resulting in a direction 
towards a type 1 adaptive immune response, which is dominated by CTLs. On the other hand, NK-DC 
interaction can also lead to selective killing of immature DC through NKp30 ligation which can lead 
to either amplification or termination of the DC-managed immune response, depending on the DC/NK 
ratio (Ferlazzo et al., 2002; Gerosa et al., 2002; Moretta, 2002; Piccioli et al., 2002; Mailliard et al., 
2003) (Fig 1.6-2).  
 
Figure 1.6: Schematic overview of the natural killer cell modes of action during virus infection. These are categorized 
as direct cytolytic effects (1) and the influence on later adaptive immune responses by (in)direct interaction with DCs 
(2) and CD4+or CD8+ T cells (3)  
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Finally there have been reports that NK cells can exert their influence on both CD4+ and CD8+ T cells 
by direct interaction with co-stimulatory molecules on the surface of these cells (e.g. CD28, 4-1BBL 
and OX40). In that way they can stimulate CD4+ and CD8+ T cells for proliferation and elevated 
cytokine production and also be involved in the differentiation of CD8+ T cells to fully competent 
CTLs (Wilcox et al., 2002; Zingoni et al., 2005). Moreover, ligation of 4-1BB can even induce 
proliferation and elevated cytokine production in NK cells (Fig 1.6-3).  
NK-mediated cytolytic activity is followed by another form of cytotoxicity, namely the one brought 
about by CTLs. These two forms of immunity are linked to each other because the NK cells are 
essential for the complete development of CTLs while the CTLs negatively regulate the NK cells a 
few days post infection (Kos and Engleman, 1995, 1996). Playing an important role in the complex 
interactions and regulations of the immune system, it is of no wonder that NK deficiencies in 
mammals lead to recurrent and life threatening viral and microbial infections. NK cells also play a role 
in the severity of illness during infection with viruses such as herpes virus, hepatitis B virus, and HIV 
(Moretta, 2002; Robbins et al., 2007). Even immunological memory cannot develop completely 
without the help of NK cells (Kos and Engleman, 1996; Berke and Clark, 2005). 
More specifically, in cats, infection with feline immunodeficiency virus (FIV) leads to strongly 
reduced NK cell activity and frequency (Hanlon et al., 1993; Zaccaro et al., 1995; Howard et al., 2010; 
Simoes et al., 2012). Still, there is very limited information concerning the general distribution and 
phenotype of NK cells in cats.  
Up until now no research has been done on the role of NK cells in the pathogenesis of a FIPV 
infection. The NK cells could be important because they also possess Fc receptors by which they 
could eliminate a cell through antibody-dependent cell-mediated cytotoxicity (ADCC). This requires 
viral proteins to be expressed in the membrane of infected cells which are recognized by the mounting 
humoral immune response (Cornelissen et al., 2007). Furthermore it is described that α1-acid 
glycoprotein, a protein with an anti-inflammatory and immunomodulatory character, is found in higher 
concentrations in the blood of cats infected with FIPV (Giordano et al., 2004). This protein gives rise 
to a lowered amount of neutrophils and complement in blood in addition to a down-regulation of NK 
cell activity which might play a role in the pathogenesis of FIP (Addie, 2004). Finally, the low IL-12 
and IL-18 levels associated with FIP (Table 1) in combination with the involvement of transforming 
growth factor β (TGF-β) in the FIPV-induced lymphopenia can be linked to decreased NK cell activity 
since IL-12 and IL-18 are both enhancers of NK cell responses in contrast to TGF-β that is a typical 
suppressor of NK cell activity (Haagmans et al., 1996; Foley et al., 2003; Lanier, 2008). Recent 
advancements in amplifying NK cell responses by increasing NK cell number and activity could give 
the innate as well as the adaptive CMI the chance to fight an infection with FIPV. These advancements 
include the addition of cytokines such as IL-2, IL-12, IL-15, IL-18 and IL-21, the administration of 
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drugs and antibody therapeutics such as thalidomide, imatinib mesylate, rituximab and daclizumab, 
and a NK cell-based adoptive immunotherapy (Terme et al., 2008). 
1.10.4 Regulatory T cells 
Tregs were first discovered more than forty years ago. Thymic lymphocytes were found to be crucial 
in restraining autoimmunity and mediating suppression of immunity (Nishizuka and Sakakura, 1969; 
Sakaguchi et al., 1995). Later on, Tregs were shown to be CD4+CD25+, while more recently the 
transcription factor forkhead box P3 (Foxp3) was found to be crucial to Treg development and 
function (Sakaguchi et al., 1995; Bennett et al., 2001). Since these discoveries, these enigmatic cells 
have been shown to be involved in processes like autoimmunity, the rejection of transplanted organs 
and the down regulation of a specific immune response after destruction of the pathogen to keep the 
immunity at bay (Simpson, 2008; Tang and Bluestone, 2008). 
Table 1.3: Overview of several virus infections that have been shown to be correlated with changes in Treg numbers, 
phenotype or function. 
 Virus Altered property Reference 
C 
 
H 
 
R 
 
O 
 
N 
 
I 
 
C 
Friend virus Tregs inhibit anti-viral CD8 response and IFN-γ 
production 
(Mills, 2004; Li et al., 
2008) 
Murine leukemia virus Depletion of Tregs prevents disease progression 
and spleen pathology 
(Mills, 2004) 
Hepatitis B virus Carriers show higher Treg frequencies in blood 
and liver compared to healthy or recovered 
hosts 
(Li et al., 2008) 
Hepatitis C virus Chronic infection is correlated with higher 
peripheral Treg frequencies 
(Mills, 2004; Keynan 
et al., 2008; Li et al., 
2008) 
Epstein Barr virus Infectious mononucleosis is correlated with 
lower amounts of Tregs in comparison with 
seropositive hosts. 
(Wingate et al., 2009) 
Herpes simplex virus Infection is correlated with Treg-induced 
diminishment of CD4 and CD8 T cell 
responses. 
(Mills, 2004; Keynan 
et al., 2008; Li et al., 
2008) 
Human immunodeficiency 
virus 
Complex, Treg-induced diminishment of T cell 
responses against virus-infected cells 
(Mills, 2004; Keynan 
et al., 2008; Li et al., 
2008) 
Feline immunodeficiency  
virus 
Infection correlates with higher activated Tregs, 
leading to immune suppression and loss of anti-
FIV response 
 
(Tompkins et al., 
2008) 
A 
C 
U 
T 
E 
Dengue virus Disease is associated with insufficient 
peripheral Treg frequencies 
(Luhn et al., 2007) 
Herpes simplex virus HSV infection induces enhanced Treg function 
that suppresses CD8+ T cell responses 
(Suvas et al., 2003) 
 
During several chronic viral infections (e.g. human and feline immunodeficiency virus (HIV and FIV), 
hepatitis B and C virus (HBV and HCV) and cytomegalovirus (CMV)) (Table 1.3) they have been 
shown to modulate and attenuate the immune response to facilitate the persistence of virus and to 
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minimize immunopathology in the infected host (Lankford et al., 2008; Li et al., 2008; Smithberg et 
al., 2008). Here, virus-Treg interaction is almost always associated with either increases in Treg 
frequency or function (Li et al., 2008). In contrast, little is known about the role of Tregs during acute 
viral infections. Studies on Tregs during dengue virus and herpes simplex virus infections indicate that 
Tregs mainly serve to limit damaging virus-induced immunopathology (Suvas et al., 2003; Luhn et al., 
2007). 
Several studies also highlight the importance of trafficking and compartmentalization in Treg function 
and analysis. Both trafficking to inflamed tissues and sites of viral replication as well as to lymphoid 
tissues have been described during viral diseases (Wei et al., 2006; Sather et al., 2007; Belkaid and 
Tarbell, 2009; Campbell and Koch, 2011) and have been shown to be vital to proper Treg regulation 
of immune responses. 
Little information is available on Tregs in cats. However, it is known that cats possess Tregs in blood, 
spleen and lymphoid compartments and they can be characterized by the expression of CD4, CD25 
and Foxp3 (Vahlenkamp et al., 2004; Lankford et al., 2008). A more recent study also investigated the 
feasibility of Treg depletion for the treatment of FIV (Smithberg et al., 2008). 
During the past years, several in vitro and in vivo models of immunosuppression have been 
established, making it very plausible that Tregs suppress immune responses by several distinct 
mechanisms (von Boehmer, 2005). The basic suppressive mechanisms used by Tregs can be divided 
into four models: production of inhibitory cytokines, induction of cytolysis, inducing metabolic 
disruption and modulation of APC maturation or function (Vignali et al., 2008). In the first 
mechanism, three inhibitory cytokines, IL-10, IL-35 and TGF-β stand central as mediators of Treg 
function (Fig 1.7-A). However, their relative importance differs depending on distinct immunological 
settings. IL-10, a known immune regulatory cytokine, has potent anti-inflammatory capacities and is 
known to down modulate Th1 responses. However, its contribution to Treg function is not fully 
understood and probably depends on the target organism and/or disease and the experimental setup 
(Vignali et al., 2008; Schmetterer et al., 2012). Similarly, the role of TGF-β in Treg function is only 
evident in in vivo settings, and less clear in vitro (Vignali et al., 2008). Its function primarily lies in 
inducing Foxp3 expression, Treg maintenance and inhibition of T cell activation. Additionally, IL-35, 
a relative novel cytokine has also been found to be important in Treg function and homeostasis 
(Schmetterer et al., 2012). 
During the past few years it has been shown that Tregs can regulate T cell responses at least partially 
by inducing apoptosis in these effector cells. Major contributing molecules are perforin together with 
granzyme A and B, although recent work also suggests roles for tumor-necrosis‑factor-related 
apoptosis-inducing ligand (TRAIL) and FasL-Fas (Vignali et al., 2008; Schmetterer et al., 2012) (Fig 
1.7-B). 
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A third group of suppressive functions encompass metabolic disruptions (Fig 1.7-C). As a first 
mechanism here, Tregs can function as an IL-2 sink because they constitutively express the high 
affinity IL-2 receptor part CD25. This leads to IL-2 deprivation which induces apoptosis in effector T 
cells who depend on this cytokine for survival and proliferation (Schmetterer et al., 2012). Secondly, a 
more recent mechanism is the pericellular release of adenosine. This inhibits T effector function, 
inhibits DC maturation and enhances the generation of Tregs (Vignali et al., 2008; Schmetterer et al., 
2012). Lastly, the interaction of CTLA4 on Tregs and CD86 on DCs induces activation of indoleamine 
2,3-dioxygenase (IDO), which is important for the tryptophan metabolism. This in turn, leads to 
reduced amounts of free tryptophan and increased amounts of pro apoptotic metabolites of tryptophan 
which both lead to an increased apoptosis in effector T cells (von Boehmer, 2005). 
 
Figure 1.7: Schematic overview of the Treg basic mechanisms of action: cytokine mediated interaction leading to 
inhibition of T effector cells (A), apoptosis-inducing mechanisms by the release of granzyme A and B (B), metabolic 
disruption mechanism based on the IL-2 sink properties of Tregs, the alternation of the tryptophan metabolism of DC 
and the inhibition of T effector and DCs by adenosine production(C) and the interaction with DCs through ligation of 
CTLA4, CD225, neuropilin I and TCR (D). 
Finally a last group of mechanisms represents an interaction and modulation of DCs (Fig 1.7-D). In a 
first model here, down regulation of CD80/CD86 on DCs can lead to lower T cell activating capacity. 
In a second model, binding of Treg CD227 (a CD4 homologue) with MHC II (on DCs) induces 
suppression of DC maturation and their immunostimulatory capacity (Vignali et al., 2008). Finally, the 
differential expression of neuropilin-1 on Tregs can lead to prolonged interactions with DCs, giving 
them an advantage over effector T cells in modulating DC responses (Vignali et al., 2008).  
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As stated earlier, disfunctionality of Tregs has been correlated with many pathogen induced diseases, 
autoimmune diseases and allergies. Obviously, a lot of focus has been placed on the manipulation of 
Tregs to enhance or suppress their function to ameliorate disease. An overview of current strategies is 
given in Table 1.4. It should be noted that most of the Treg-immunotherapeutic strategies are 
developed for either cancer or autoimmunity (Sakaguchi et al., 2010; Sehrawat and Rouse, 2011). 
Table 1.4: Overview of several therapeutic products that aim to either enhance or dampen Treg functionality (Based 
on (Sakaguchi et al., 2010; Sehrawat and Rouse, 2011).  
Strategies to enhance Treg activity  
Evaluated products Effect 
IL-7 & IL-15 Promotes Treg survival 
TGF-β & Retinoic acid Induces Treg generation from stimulated CD4+ Tcells 
IFN-γ, TNF-α, IL-2 Induction and enhancement  regulatory mechanisms  
TSP-1 Promotes generation Tregs 
Rapamycin Increases Treg purity during Treg expansion 
FTY720 Enhances induction of Foxp3 
COP-1 / glatiramer acetate Induction of Foxp3 expression in CD4+ T cells 
Azacytidine Stably induces Foxp3 expression 
Vorinostat Enhances Foxp3 stability 
Trichostatin A / Valproic acid Promote Foxp3 expression - enhance functionality TGF-β converted 
Tregs 
Strategies to inhibit Treg activity  
Evaluated products Effect 
IL-6, IL-12 & IL-21 Induction of Th17 cells 
STAT-3 neutralizing antibody Decreased generation of Tregs 
Ipilimumab Suppresses Treg function 
TIM-1 antibody Inhibit Treg generation-deprogram Tregs 
Calcineurin inhibitor Reduces number of peripheral Tregs 
Cyclophosphamide Specifically depletes Tregs (low dosis) 
 
1.11 Treatment 
The virus does not respond to conventional antivirals and therapeutics. A contemporary review by 
Hartmann et al. (2008) has listed all the therapeutic products that have been tested on FIPV-infected 
cats (Hartmann and Ritz, 2008). Neither antivirals such as ribavirin nor immune-modulators such as 
prednisolone or interferon could be proven to be effective. At the moment, treatment of FIP is mainly 
symptomatic. Additionally, the lack of early diagnosis also contributes to the ineffectiveness of 
therapeutics (Hartmann and Ritz, 2008). Early diagnosis ante-mortem is extremely difficult during 
FIPV-infections. At present, many cats are diagnosed having FIP by determining anti-FCoV serum 
antibody titers, although it is common knowledge that this test is not diagnostic for FIP (Weiss and 
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Scott, 1980). Currently, there are only two ways of definitely diagnosing FIP in living cats, taking 
biopsies or obtaining effusion and subsequently performing an immunocytochemical staining for 
FCoV antigens (Parodi et al., 1993; Paltrinieri et al., 1999). While effusion is only present in the wet 
form, biopsies can be taken in both the wet and the dry form. However, both these techniques are 
invasive and not without risk in terminal patients and they have a low specificity. If neither of these 
two techniques can be used, a diagnostic approach as suggested by Addie et al. (2009) could be useful. 
They propose a step-wise approach, combining several diagnostic criteria.  
1.12 Prevention 
Currently, one commercial vaccine against FIPV is available (Primucell FIP, Pfizer animal health). 
This vaccine is a temperature-sensitive attenuated FIPV strain (DF2), that has to be administered 
intranasally (Gerber et al., 1990). However, the results of several field and experimental studies were 
inconsistent (Fehr et al., 1995; Hoskins et al., 1995a; Hoskins et al., 1995b; Mcardle et al., 1995; Scott 
et al., 1995; Fehr et al., 1997). This led to the conclusion that although the vaccine can be considered 
to be safe to use, the efficacy is variable. This was attributed to the fact that vaccination needs to be 
done on FCoV negative cats and that the vaccine was based on a serotype II strain, while most 
circulating strains are serotype I (Addie et al., 2009). In 2004, another approach was devised to 
develop a vaccine. Deletion mutants void of the accessory genes 3abc and/or 7ab were used to 
vaccinate cats. The results were promising with protection against inoculation with lethal amounts of 
homogenous virus (Haijema et al., 2004).  
Pro-active management seems to be the best way to fight a FIPV infection. Proper prevention should 
therefore aim to avoid exposure to FECV (Addie and Jarrett, 1995). After all, FIPV arises from FECV 
through mutation. Precautions that can be taken are mainly focused on hygiene to minimize FCoV 
spread. A sufficient amount of litter trays, which are frequently cleaned, has to be available. They 
should be placed in rooms at a long distance from the food and water bowls. In addition, stress 
reduction and early weaning can also prevent or minimize the spread of FCoV (Addie and Jarrett, 
1995; Addie et al., 2009). 
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1 Aims 
Feline enteric coronavirus (FECV), one of the most wide-spread viruses in cats around the world is 
considered harmless to cats. Its main importance lies in an occasional mutation that leads to feline 
infectious peritonitis virus (FIPV), which has nearly always a fatal outcome. The current hypothesis 
states that humoral immunity cannot offer protection and that cellular immunity stands central in the 
proper functioning of anti-coronavirus immunity. However, despite nearly 50 years of research, still 
not much is known about the cell-mediated immune response during coronavirus infection and no 
efficient vaccines have been discovered. 
Cellular immunity consists of several, partially redundant lymphocyte subsets that communicate 
tightly with each other. Central effector cells are CD4+, CD8+ and natural killer (NK) cells. However, 
different regulatory systems also exist to keep unwanted harmful immune reactions at bay. Crucial 
players here are regulatory T cells (Tregs). Both these effector and regulatory cells are understudied 
and have been shown to be manipulated by a plethora of viruses to their benefit. This incited us to 
gather more information on the role of these lymphocytes during both FECV and FIPV infection, since 
this can provide the basis for the development of cell-specific therapeutics that target FECV and/or 
FIPV. 
Research on feline cellular immune responses against viruses is somewhat scarce and contradicting. 
Therefore, in a first part a sensitive assay will be developed to evaluate cell-mediated immune 
responses. For this purpose, a 5-bromo-2’-deoxyuridine (BrdU) labeling method will be optimized, 
using monocyte-derived dendritic cells as antigen presenting cells with autologous N2-stored 
lymphocytes as responder cells to detect virus-specific T cell proliferative responses. This assay will 
then be used to assess coronavirus-specific responses (Chapters 4.1 and 4.2). 
In chapter 3.2, both absolute and relative NK cell frequencies will be determined in blood, mesenteric 
lymph node, spleen, mesentery and kidney of healthy cats. Additionally, several surface markers will 
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beused to assess NK cell phenotype in terms of cytotoxicity, trafficking and activation. Finally, a 
feline cell line will be proposed to evaluate the functionality of feline NK cells because the standard 
cell line (K562) is not sensitive to feline NK cell mediated lysis. These results will provide us with 
reference values needed to further explore the role of NK cells in coronavirus immunity. 
In Chapter 4.1, the previously optimized assay from chapter 3.1 will be used to evaluate proliferative 
responses in three cats experimentally infected with FECV. Further, with the knowledge of NK cell 
properties in healthy cats, NK cells and Tregs as well as several other major cell components of the 
immune system (i.e. T cells, B cells, monocytes, granulocytes) will be quantified and phenotyped in 
peripheral blood during the entire FECV infection course. Additional focus will be placed on virus 
titer kinetics (both genomic and infectious), antibody response and several clinical parameters. 
In a final part (Chapter 4.2), the role of T cells, B cells, NK cells and Tregs will be investigated in 
naturally FIPV infected cats. Similar to chapter 4.1, quantification, phenotyping and functionality tests 
will be performed in blood, mesenteric lymph node, spleen, mesentery and spleen.
42 
Chapter 
3 The feline cell-mediated immune response in cats: 
development of an assay to study lymphocyte 
proliferation against several feline viruses and 
establishing reference values for NK cell numbers, 
phenotype and function 
Summary 
In order to study the feline cell-mediated immune response, several methods had to be optimized to 
allow analysis of feline immunity. Therefore, in chapter 3.11 an in vitro assay was optimized to detect 
feline proliferating lymphocytes in response to viral antigens as an assessment for the cell-mediated 
immune response. This method could then be applied to analyze FCoV responses in chapters 4.1 and 
4.2. In the second part, chapter 3.22, reference values were determined for NK cells in healthy cats in 
addition to the optimization of a new assay to evaluate feline natural killer cell cytotoxicity. 
1 Adapted from: Vermeulen, B.L., Gleich, S.E., Dedeurwaerder, A., Olyslaegers, D.A., Desmarets, L.M., 
Dewerchin, H.L., Nauwynck, H.J., 2012b. In vitro assessment of the feline cell-mediated immune response 
against feline panleukopeniavirus, calicivirus and felid herpesvirus 1 using 5-bromo-2'-deoxyuridine labeling. 
Vet. Immunol. Immunopathol. 146, 177-184. 
2 Adapted from: Vermeulen, B.L., Devriendt, B., Olyslaegers, D.A., Dedeurwaerder, A., Desmarets, L.M., 
Grauwet, K.L., Favoreel, H.W., Dewerchin, H.L., Nauwynck, H.J., 2012a. Natural killer cells: Frequency, 
phenotype and function in healthy cats. Vet. Immunol. Immunopathol. 150, 69-78. 
43 
Chapter 3 
 
3.1 In vitro assessment of the feline cell-mediated immune response against 
several feline viruses using 5-bromo-2’-deoxyuridine labeling 
3.1.1 Summary 
In this study an in vitro assay was optimized to detect feline proliferating lymphocytes as an 
assessment for the cell-mediated immune response. For this purpose, 5-bromo-2’-deoxyuridine 
labeling (BrdU) labeling was chosen because of its sensitivity and the possibility of further 
characterization of proliferating cells. The assay was optimized by selecting the best batch and 
concentration of fetal bovine serum, β-mercaptoethanol concentration, cell density, BrdU incubation 
time and antigen presenting cell type. Cats were vaccinated with the attenuated Nobivac vaccine Tricat 
and the peripheral blood lymphocyte proliferation responses were quantified upon in vitro 
restimulation with inactivated and infectious feline panleukopenia virus (FPV), feline calicivirus 
(FCV) and felid herpesvirus 1 (FeHV-1). Proliferation signals were detected with inactivated FeHV-1 
in the CD8+ but not in the CD8- T lymphocyte population, with inactivated FCV and FPV in both 
CD8- and CD8+ T lymphocyte populations. Restimulation with infectious FCV caused significant 
proliferation in the CD8- T lymphocyte population only while infectious FPV and FeHV-1 seemed to 
suppress lymphocyte proliferation in both T cell populations. Additional IFN-γ quantification in the 
culture supernatant revealed a large correlation between the proliferation signals and IFN-γ 
production, indicating that BrdU labeling is a very reliable technique to assess and characterize feline 
lymphoproliferative responses to viral antigens in vitro.  
3.1.2 Introduction 
The most reliable and accurate way to evaluate the proliferation of T cells in response to either 
mitogens or antigens is to quantify DNA-synthesis (Hughes and Mehmet, 2003). Currently two 
methods are generally used, the DNA incorporation of either radioactive tritiated thymidine ([3H] 
TdR) or the fluorescently labeled thymidine analogue 5-bromo-2’-deoxyuridine (BrdU). BrdU 
labeling has been proven to be advantageous over [3H] thymidine labeling in many aspects. While 
equally sensitive, there is no need for specialized equipment and special care during handling with the 
fluorescent compounds. The fluorescent cells are not destroyed during the process allowing additional 
staining for membrane molecules (e.g. CD3 and CD8) and final analysis is done by flow cytometry 
(Huong et al., 1991; Motobu et al., 2002). At present, mainly [3H] TdR labeling is used for in vitro 
restimulation assays in cats. Therefore, FITC BrdU labeling would be an interesting alternative.  
A notable problem with in vitro proliferation assays in general is the need for repeated blood 
collection for the generation of APC and effector cells (lymphocytes). This can be a serious drawback, 
especially if severely weakened infected animals are involved or if only a single blood sample can be 
taken. Working with frozen PBMC would present a solution to these problems. 
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In the present study, the proliferative responses of feline T lymphocytes, originating from vaccinated 
cats were determined by FITC BrdU labeling upon restimulation with both infectious and inactivated 
feline panleukopenia virus, feline calicivirus, and felid herpesvirus 1. A double staining for feline CD3 
and CD8 was performed, to allow identification of proliferating CTL (CD8+) or CD8- T lymphocytes. 
All cells, both APC and lymphocytes, originated from PBMC stored in liquid nitrogen, thus bypassing 
the problem of repeated blood sampling. Subsequent flow cytometrical analysis allowed the specific 
identification of the subset of proliferating T cells. Both monocytes and monocyte-derived dendritic 
cells (mDC) were used as APC. Additionally, the production of IFN-γ, the signature molecule of Th1, 
was evaluated in the cell culture supernatant and compared with the degree of proliferation. To the 
author’s knowledge, this is the first time that FITC BrdU labeling was used to evaluate in vitro 
proliferative responses of feline T lymphocytes to viral antigens.  
3.1.3 Materials and methods 
3.1.3.1 Viruses and antibodies 
Third passages of the belgian feline panleukopenia virus (FPV) isolate 09K444, the feline calicivirus 
(FCV) reference strain F9 and the belgian felid herpesvirus 1 (FeHV-1) isolate 95K270 in Crandell 
feline Kidney cells were used. A monoclonal antibody NZM1 against the epsilon chain of feline CD3 
was kindly provided by Dr. Yorihiro Nishimura (Tokyo University, Japan). Monoclonal antibodies 
recognizing feline CD1a (FE1.5F4) and CD1c (FE5.5C1) were kindly provided by Dr. Peter F. Moore 
(University of California, USA). Monoclonal antibody DH59B, recognizing CD172a and monoclonal 
antibody CAT82A, reacting with feline MHC class II, were purchased from Veterinary Medical 
Research and Development (VMRD, Pullman, USA). Monoclonal antibody FE5.4D2, recognizing 
feline CD8β and monoclonal antibody TÜK4 against CD14 were purchased from AbD serotec 
(Dusseldorf, Germany). Conjugated secondary antibodies [Molecular Probes (Invitrogen, Carlsbad, 
USA)] were goat anti-mouse IgG-R-Phycoerythrin and goat anti-mouse IgG1-Alexa Fluor 647. 
3.1.3.2 Immunization of cats 
Three feline coronavirus-, feline leukemia virus- and feline immunodeficiency virus-negative cats 
were used as blood donors. All cats were vaccinated with the attenuated Nobivac Tricat vaccine (FPV, 
FCV and FeHV-1) according to the manufacturer’s manual (Intervet Ltd, Boxmeer, The Netherlands). 
Briefly, the vaccine was resuspended in 1 mL of the accompanying diluens at room temperature and 
administered subcutaneously. Cats were vaccinated three times, twice at arrival with a 3-week interval 
and a third time, 4 weeks before the first blood sampling. 
3.1.3.3 Isolating, freezing and storing PBMC 
Blood (10ml) was collected from the vena jugularis in heparin (15 U ml-1) (Leo, Zaventem, Belgium) 
and mononuclear cells were separated on Ficoll-Paque. The blood was first diluted with 10 ml of cold 
phosphorus buffered salt solution (PBS), the 20 ml suspension was then brought onto 20 ml of Ficoll-
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Paque solution (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom) at room 
temperature. After centrifugation at room temperature, the buffy coat layer, containing the PBMC, was 
extracted and a lysis step was implemented to remove any unwanted red blood cells. Cell counts 
typically showed  2 - 4 * 106 monocytes and 6 – 14 * 106 lymphocytes. Immediately after purification, 
cells were frozen and stored in liquid nitrogen (N2). Briefly, maximum 2 x 107 cells ml-1 were 
resuspended in RPMI supplemented with 30 % FBS, 100 U ml-1 penicillin, 0.1 mg ml-1 streptomycin, 
and 10 % DMSO. The cells were then frozen by lowering the temperature slowly with 1°C min-1 untill 
-30°C, followed by a 15 min incubation period at -30°C and finally lowering the temperature to -
150°C at a rate of 1°C s-1 (PTLPD81, Orthodyne, Alleur, Belgium). After freezing, cells were stored at 
-196°C in liquid nitrogen. 
3.1.3.4 Generation of monocytes, monocyte-derived dendritic cell and macrophages 
In order to generate monocytes, stored cells were thawed and seeded at a concentration of 2 x 105 ml-1 
monocytes in a 24-well dish or 96-well dish (Thermo Fisher Scientific, Waltham, Massachussets, 
USA), in complete RPMI 1640 medium (Invitrogen) containing 10 % FBS (Greiner Bio-
one, Kremsmuenster, Germany), 100 U ml-1 penicillin, 0.1 mg ml-1streptomycin, 0.1 mg ml-1 
gentamycin, 1 mM sodium pyruvate and 1 % non-essential amino-acids (100x) (Invitrogen). After 
overnight incubation, non-adherent cells (typically 0.6 - 1.4 * 106 cells) were removed by washing the 
dishes with RPMI 1640. The non-adherent cells consisted of 59±15 % of T lymphocytes (as assessed 
by fluorescent staining with the lymphocyte marker NZM1). The adherent cells consisted of 86±7 % 
of monocytes (as assessed by fluorescent staining with the monocyte marker DH59B). 
For the generation of monocyte-derived dendritic cells (mDCs), 2 x 105 ml-1 monocytes were 
incubated during 7 days in complete medium supplemented with 10 ng ml-1 recombinant feline IL-4 
and 50 ng ml-1 recombinant feline granulocyte macrophage colony-stimulating factor (GM-CSF) 
(R&D systems, Minneaoplis, Minnesota, USA) in order to obtain). Cells were refed on day 3 and 5 
before application in experiments.  
For the generation of monocyte-derived MΦ, 2 x 105 ml-1 monocytes were incubated in complete 
medium without IL-4 and GM-CSF. Final flow cytometrical characterization occurred on day 7. 
Briefly, cells were detached by incubation with accutase (Sigma-Aldrich, St. Louis, Missouri, USA), 
for 10 minutes at 37°C after which they were washed with icecold medium. Staining was performed 
on living cells at 4°C using monoclonal antibodies targeting CD14, MHC II, CD1a and CD1c, 
followed by either R-Phycoerythrin (CD14) or Alexa Fluor 647 (MHC II, CD1a and CD1c). Isotype-
matched irrelevant monoclonal antibodies were included as controls in each experiment 
3.1.3.5 In vitro restimulation assay 
Monocytes and generated mDC served as APC and were incubated for 1 hour with several infectious 
viruses at a multiplicity of infection (m.o.i.) of 1: feline panleukopeniavirus (FPV), feline calicivirus 
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(FCV), and felid herpesvirus 1 (FeHV-1). Simultaneously, the APC were incubated for 3 hours with 
equivalent UV-inactivated amounts of each virus (180 mJ cm-2). After antigen pulsing, cells were 
washed and further incubated with 5 x 105 ml-1 homologous non-adherent cells stored in liquid 
nitrogen (N2) for 4 days at 37°C, 5 % CO2 in complete RPMI 1640 medium containing 5 % FBS 
(Invitrogen 16000) instead of 10 % and 0.05 mM 2-mercaptoethanol (ME) (Invitrogen). Cells were 
then stained for proliferation with the FITC BrdU flow kit according to manufacturer’s instructions 
(Becton, Dickinson and Company, New Yersey, USA). Additionally, cells were stained with surface 
markers against CD3 and CD8 to identify the proliferating cell population. Analysis was done by flow 
cytometry (FACSCanto, Becton, Dickinson and Company). Data were analyzed using FACSDiva 
software. 
3.1.3.6 Analysis of culture supernatant 
IFN-γ concentrations in cell culture supernatant were determined using a ELISA specific for feline 
IFN-γ according to manufacturer’s instructions (R&D Systems). 
3.1.3.7 Statistical analysis 
Statistical analyses were performed with SPSS 17.0 (SPSS Inc., Chicago, Illinois, USA). For all data, 
differences between medians were assessed by the Mann-whitney U test, while correlation was 
assessed by the Spearman correlation test. Significant differences were considered when P ≤ 0.05. 
3.1.4 Results 
3.1.4.1 Optimization of assay parameters 
The restimulation assay setup was optimized to obtain maximal proliferation responses while 
minimizing the background proliferation. In all tests, monocytes were used as APC. To assess 
maximum responses, the mitogen ConA (Sigma-Aldrich), which induces aspecific lymphocyte 
proliferation was added after which cells were incubated for 3 days. To evaluate background 
proliferation mock cultures were incubated during 5 days. Tested parameters were: responder cell 
concentration [0.5 - 1 - 5 (x 106 cells ml-1)], FBS concentration [0 - 1 - 2.5 - 5 - 10 – 20 (%)], 2-
mercaptoethanol concentration [0 - 0.05 - 0.25 (mM)],  and BrdU incubation time [1 - 2 - 4 - 8 (h)]. 
The tested FBS batches can be found in Table 3.1. Additionally, the serum free medium X-vivo 15 
was also included (Lonza, Basel, Switzerland). The best results were obtained when 0.5 x 106 cells ml-
1 were incubated in RPMI medium with 5 % of FBS batch 16000 of Invitrogen and 0.05 mM 2-
mercaptoethanol and when cells were incubated with BrdU for 4 hours before staining and flow 
cytometric analysis. Because the need of repeated blood collection for the generation of APC and 
effector cells (lymphocytes) forms a well-known problem with in vitro proliferation assays, all cells 
used in the experiments originated from PBMC stored in liquid nitrogen. 
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Table 3.1: Overview of different FBS batches that were tested for the in vitro restimulation assays. 
Fetal Bovine Serum   
Manufacturer Catalog number Batch 
Greiner Bio-one 758093 6845093 
Greiner Bio-one  758093 (Antibody depleted) 6845093 
Sigma  F7524 030M3396 
Sigma  F6178 129K0361 
Sigma  F2442 128K8423 
Invitrogen 16000 941273 
Gentaur FB-1001/50 batch .8460 
Gentaur FB-1090/50 batch .8026 
Gentaur FB-1090/50 batch .8033 
 
3.1.4.2 Generation of monocytes, monocyte-derived dendritic cells and macrophages 
In order to generate stronger responses, dendritic cells were generated from monocytes by culturing 
them with 10 ng ml-1 recombinant feline IL-4 and 50 ng ml-1 recombinant feline GM-CSF. 
Characterization of mDC was done by using several available monoclonal antibodies to assess four 
phenotypic markers on feline monocytes, MΦ and mDC: TÜK4 (CD14), CAT82A (MHCII), FE1.5F4 
(CD1a), and FE5.5C1 (CD1c). 
 
Fig 3.1 shows the comparison of mean fluorescence intensities of several stained cell surface antigens 
on feline monocytes, mDCs and MΦ. There were marked differences between monocytes, mDCs and 
MΦ concerning the expression of all markers. mDC stained consistently stronger than monocytes and 
MΦ for all markers [MFI: 16070±1717 (CD14), 4384±202 (MHCII), 2427±1070 (CD1a) and 
3134±1131 (CD1c)], while monocytes did not stain [MFI: 34±6 (CD1a) and 114±30 (CD1c)] or were 
stained 8 to 14 times less bright [MFI: 929±178 (CD14) and 303±13 (MHCII)] than MΦ [MFI: 
12791±1013 (CD14), 2550±300 (MHCII), 766±707 (CD1a) and 7987±515 (CD1c)]. Finally, Figure 
Figure 3.1: Mean fluorescence 
intensities (MFI) of different 
phenotypic markers on monocyte 
derived dendritic cells (mDC), MФ 
and monocytes). The MFI of 
different phenotypic markers on 
MФ and monocytes were 
compared with the markers on 
mDC. Results are shown as mean ± 
SD (n=3). Significant differences (p 
≤ 0.05) are indicated with an 
asterix (*). 
 
48 
 
Development of immunity assays and establishment of NK reference values 
3.2 shows that the size and granularity, assessed by forward and side scatter respectively (FSC-A and 
SSC-A), were found to be significantly higher for mDC [Linear value parameter: 115±2 (FSC-A) and 
37±1 (SSC-A)] when compared with MФ [Linear value parameter: 103±3 (FSC-A) and 23±3 (SSC-
A)]. 
Figure 3.3: Phase contrast pictures of 7-day old macrophages (a) and monocyte-derived dendritic cells (b). 
Magnification was 400x. 
Fig 3.3 shows the morphological analysis of MΦ (a) and mDC (b) on a phase contrast microscope. 
MΦ were generally tightly adherent cells characterized by a highly variable morphology and size and 
the presence of pseudopodia. mDC were generally non-adherent or loosely adherent cells with a round 
shape and had numerous fine cytoplasmic protrusions (dendrites) that are typical for dendritic cells. 
Figure 3.2: Linear values of the area of forward scatter 
(FSC-A) and side scatter (SSC-A) from monocyte derived 
dendritic cells (mDC) and MФ populations. Results are 
shown as mean ± SD (n=6). Significant differences (p ≤ 
0.05) between mDC and MФ, with regard to FSC-A and 
SSC-A are indicated with an asterix (*). 
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3.1.4.3 Proliferation response upon in vitro restimulation with monocytes as APC 
First, the proliferation response was evaluated using monocytes as APC. This method is the least 
labor-intensive method. Figure 3.4-A shows the detection of proliferating CD3+/CD8+ and CD3+/CD8- 
lymphocytes. In the CD8+ population, only when inactivated FeHV-1 was presented to monocytes, 
marginally significant proliferation compared to mock infection (P<0.05) was observed. In the CD8- T 
lymphocyte population, a proliferative response could be detected only when inactivated FCV was 
presented.  
 
Figure 3.4: Percentage proliferating T lymphocytes in response to both infectious and inactivated  feline 
panleukopenia virus (FPV), feline calicivirus (FCV), and felid herpes virus 1 (FeHV-1), using monocytes (A) and 
monocyte derived dendritic cells  (B) as APC. Results are shown as mean ± SD (n=3). Significant differences between 
mock-treated and virus-treated conditions (p ≤ 0.05) are indicated with an asterix (*). 
Additional IFN-γ levels were determined in cell culture supernatant; all samples fell under the 
detection limit. These results indicate that even weak responses induced by monocytes, known to be 
poor antigen presenters, can be detected in cats using the BrdU assay. 
3.1.4.4 Proliferation response upon in vitro restimulation with mDC as APC 
Using the mDC as more potent APC, the restimulation experiment was repeated. Fig 3.4-B shows the 
detection of proliferating CD3+/CD8+ and CD3+/CD8- lymphocytes that were in co-culture with 
antigen-pulsed mDC. When inactivated viruses were used as antigen stimuli, all viruses induced 
significant proliferation (P≤0.05) in the CD8+ T lymphocyte population while only inactivated FPV 
and FCV induced proliferation (P≤0.05) in the CD8- T lymphocyte population. Although not 
significant, inactivated FeHV-1 did induce some proliferation in the CD8- T lymphocyte population. 
When infectious virus was used, a totally different pattern was detected. Infectious FPV and FeHV-1 
caused severe suppression of proliferation (P≤0.05) in both the CD8+ and CD8- population while 
infectious FCV strongly induced proliferation in the CD8- T lymphocyte proliferation. Additionally, 
IFN-γ levels were determined in the cell culture supernatant (Fig 3.5). Significant production was seen 
in the presence of both infectious and inactivated FCV while significantly reduced production was 
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seen with infectious FPV and FeHV-1. Although the production was not significant, some IFN-γ was 
detected in the presence of inactivated FPV and FHC. The concentration of IFN-γ was positively 
correlated with the proliferation response for all the tested viruses in the CD8- (r = 0.964 ; p = 0.003) 
as well as in the CD8+ population (r = 0.679 ; p = 0.11). 
 
3.1.5 Discussion 
Currently, four immune parameters can be monitored by flow cytometry in order to evaluate the cell-
mediated immune response (CMI): activation-proliferation, cytokine-production, cytotoxicity and 
receptor-detection (Sandbulte and Roth, 2004; Thiel et al., 2004). Although all parameters play a 
crucial role in the development of an immune response, the proliferation of antigen-specific T 
lymphocytes is one of the first things to occur during a CMI (Berke and Clark, 2005). It is therefore 
not surprising that many studies to this day use the proliferative response to assess the T cell 
immunological function in response to virus infections.  
To our knowledge, this is the first time the BrdU staining method in combination with membrane 
antigen labeling has been used to evaluate the feline lymphoproliferative response to viral antigens. 
The first aspect in the development of the assay was to minimize the background proliferation. This 
phenomenon is also know in other species but felids seem to be especially prone to this (Brenchley 
and Douek, 2004; Raulf-Heimsoth, 2008) (personal communication, Rochelle Mikkelsen). Optimal 
results were obtained when 0.5 x 106 cells ml-1 were incubated in medium containing 5 % FBS 
(Invitrogen 16000) and 0.05 mM ME and when cells were incubated with BrdU for 4 hours before 
flow cytometric analysis. It should be noted that the ratio of lymphocytes/monocytes during the assay 
did not play a major role until monocyte amounts were extremely low (results not shown). This is in 
stark contrast to what has been discovered for bovine proliferation assays, where 
lymphocyte/monocyte ratios smaller than 10/1 have an inhibitory effect on the proliferation 
(Goddeeris et al., 1987). The assay was further simplified for practical use by freezing the cells from 1 
blood sample in liquid nitrogen. This allowed the generation of APC and effector cells from the same 
sample, reducing the stress that accompanies repeated blood sampling or allowing analysis when only 
Figure 3.5: Interferon-γ (IFN-γ) concentration in 
culture supernatant of the in vitro restimulation 
assay that analyzes proliferation responses to 
infectious and inactivated and feline panleukopenia 
virus (FPV), feline calicivirus (FCV), and felid 
herpes virus 1 (FeHV-1) when monocyte derived 
dendritic cells (mDC) were used as APC. Results are 
shown as mean ± SEM (n=3). Significant differences, 
when comparing each condition with the mock, (p ≤ 
0.05) are indicated with an asterix (*). 
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one blood sample is available. Like in human immunology, several precautions were taken into 
account in order to preserve the immunophenotypic characteristics (such as proliferation and IFN-γ 
production) (Bull et al., 2002; Disis et al., 2006). Cells were frozen immediately after isolation, they 
were kept at -196°C for the entire storage period and viability of thawed cells was routinely 80-90%. 
Proliferation assays using both infectious and inactivated virus as antigen stimuli were set up in order 
to evaluate if BrdU staining is applicable in cats. Additionally, CD3 and CD8 molecules, both co-
receptors for the T cell receptor (TCR), were stained in the membrane of responding lymphocytes in 
order to characterize the proliferative response more in detail. Some viruses were selected for 
restimulation: feline calicivirus (FCV), feline panleukopenia virus (FPV) and felid herpesvirus 1 
(FeHV-1). Infectious panleukopenia virus, typically causes severe enteritis, diarrhea and vomiting and 
is characterized by high mortality rates (Parrish, 1995; Lamm and Rezabek, 2008). Feline calicivirus 
induces mainly moderate and self-limiting acute oral and upper respiratory tract disease, is rarely fatal 
and resolves quickly after infection (Radford et al., 2007). Finally, felid herpesvirus 1 causes moderate 
to severe respiratory disease (Gaskell et al., 2007). These viruses were chosen because well-
performing combined vaccines exist for these viruses and are recommended to be administered to cats 
(Poulet et al., 2009).  
BrdU analysis of lymphocyte proliferation, using monocytes as APC revealed overall little response to 
any virus, with the exception of a strong reaction to inactivated FCV in the CD8- T lymphocyte 
population. This correlates well with earlier research where proliferation signals were detected in 
whole and washed feline blood cultures that were stimulated with inactivated FCV (Tham and 
Studdert, 1987a). However, the same research group also found proliferation signals when stimulation 
occurred with inactivated FPV and FeHV-1, which could not be detected in our study (Tham and 
Studdert, 1987b, c). This might be due to the different virus inactivation methods that were used to 
produce virus antigens for restimulation. Tham and Studdert (1987a, b, c) used β-propiolactone, a 
chemical disinfectant that preserves most of the immunogenic properties of viral proteins but is very 
hazardous to work with. It is nowadays mostly replaced by other chemical compounds such as binary 
ethyleneimine (Larghi and Nebel, 1980). In our study, UV irradiation was applied to inactivate the 
viruses. Although this is a promising inactivation method that has been used frequently because it 
mainly targets the genome, there have been reports of structural modifications of viral proteins which 
can have an influence on the immunogenic capacities of the inactivated virus (Miller and Plageman, 
1974). Another group found significant proliferation signals in response to FeHV-1 antigens, however, 
their method of vaccination and restimulation, using immune stimulating complexes and purified virus 
protein differed significantly from our method (Martina et al., 2001). In addition, their in vitro 
restimulation assay involved adding exogenous IL-2 to the incubation medium which could modify 
the response, especially since, in a normal response, activated lymphocytes produce their own IL-2 
and thus stimulate their own proliferation. Furthermore, IL-2 addition has been shown to increase non-
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stimulated background proliferation (Chain et al., 1987; von Baehr et al., 2001). Overall, there is little 
data concerning in vitro restimulation techniques in cats and there is a large diversity in used 
protocols. This makes a comparison of results difficult. 
There are a couple of possible explanations for the lack of proliferation when adding inactivated FPV 
and FeHV-1. There is an inherent difference in antigenic capacity depending on the virus inactivation 
method, as has been found for feline parvoviruses (Churchill, 1982). Inactivated herpes viruses (e.g. 
Epstein-barr virus and bovine herpes virus 1) have been found to be able to induce apoptosis in 
monocytes and regulate DC development (Li et al., 2002). Furthermore, when comparing proliferation 
responses to infectious and inactivated bovine herpes virus 1, using DC and monocytes, the same 
absence of proliferation was noted when monocytes were used as APC (Renjifo et al., 1999). The 
authors reported that this was mainly due to a lower viability of monocytes and due to the inhibitory 
effects of the virion glycoprotein gD, which is also present in FeHV-1. All these facts might contribute 
to the absence of proliferation when adding inactivated FPV and FeHV-1. Early research in humans 
has shown that dendritic cells are much more capable of stimulating T lymphocytes in comparison to 
monocytes or macrophages (Steinman, 1991; Sallusto and Lanzavecchia, 1994). In order to better 
detect proliferation signals to virus antigens, monocyte-derived dendritic cells (mDC) were generated 
by adding IL-4 and GM-CSF to the culture medium and used as APC in further experiments. Surface 
phenotyping of feline mDC was performed through labeling, quantifying and comparing surface 
molecules on monocytes, macrophages and mDCs. Generally, mDC stained brightest for CD14, 
MHCII, CD1a, and CD1b, followed by MФ while monocytes were not or weakly stained for these 
surface markers. The same pattern was detected by other authors using feline mDC (Bienzle et al., 
2003; Freer et al., 2005; Sprague et al., 2005) and is characteristic for the high antigen presenting 
capacity of mDC (Zhou and Tedder, 1996). In human immunology, mDC generally lose CD14 
expression after differentiation in vitro (Sallusto and Lanzavecchia, 1994). This seems to differ from 
feline mDC since they stained very brightly for this glycosylphosphatidylinositol receptor. This had 
already been noted in earlier studies using feline mDC (Bienzle et al., 2003; Freer et al., 2005; 
Sprague et al., 2005) as well as porcine mDC (Carrasco et al., 2001) and mDC obtained from rhesus 
macaques (O'Doherty et al., 1997). These differences in CD14 expression might be attributed to the 
use of certain monoclonal antibodies recognizing CD14 on monocytes but not on DC or MФ, a fact 
that has also been found for porcine cells. In addition, even when CD14 expression is detected, there 
could still be a cell type-dependent functional difference of the CD14 receptor (e.g. on porcine 
monocytes CD14 is a functional LPS receptor while this is not the case for CD14 on porcine mDC) 
(Carrasco et al., 2001). Similar to the work from Freer et al. (2005), size and granularity, assessed by 
forward and side scatter respectively (FSC-A and SSC-A), were found to be significantly higher for 
mDC when compared with MФ. Finally, the morphological analysis of both mDC (non-adherent, 
round shaped and presence of dendrites) and MФ (tightly adherent, irregular shape and presence of 
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pseudopodia) revealed characteristics similar to those reported in other studies on feline mDC 
generation (Bienzle et al., 2003; Freer et al., 2005; Sprague et al., 2005). BrdU analysis of lymphocyte 
proliferation, using mDCs as APC revealed proliferation signals for inactivated FeHV-1 in the CD8+ T 
lymphocyte population and for inactivated FCV and FPV in both the CD8- and CD8+ T lymphocytes 
population while infectious FCV caused significant proliferation only in the CD8- T lymphocyte 
population and infectious FPV and FeHV-1 seemed to suppress lymphocyte proliferation in both T 
cell populations. The highly pathogenic panleukopenia virus and the immune evasive felid herpesvirus 
both caused a severe suppression of proliferation during in vitro restimulation. This suppression of 
proliferation might be caused by certain immunosuppressive mechanisms of the viruses (e.g. down 
regulation of MHC-I expression with FeHV-1 (Montagnaro et al., 2009), suppression of proliferation 
after in vivo infection with FPV (Schultz et al., 1976)) or the death of infected cells (80 % cell death 
after FeHV-1 infection in monocytes, results not shown). The fact that inactivated FeHV-1 and FPV 
do not seem to suppress proliferation indicates that none of the structural proteins are involved but that 
active infection needs to be present to elicit the immunosuppressive mechanisms.  
Another aspect frequently investigated in veterinary immunology is the cytokine production  in 
antigen-stimulated cell cultures (Sandbulte and Roth, 2004). In the complex realm of cytokines, 
interferons and especially IFN-γ are key molecules in the protection against viruses. IFN-γ is the 
signature molecule of the Th1 response, has antiviral capacities and is in the adaptive CMI response 
mainly produced by CD4+ T helper cell (Th1) and CD8+ CTL (Sen, 2001; Katze et al., 2002; Schroder 
et al., 2004). In order to verify the signals detected by the BrdU labeling method, IFN-γ was detected 
in the supernatant of the proliferation assay using a sandwich ELISA specific for the detection of 
feline IFN-γ. IFN-γ-levels were below the detection limit when monocytes were used as APC (results 
not shown). This absence of production together with the proliferation signal detected with infectious 
FCV might indicate that a Th2 response rather than a Th1 response is mounted. This hypothesis 
however, would need to be verified through the detection of typical Th2 cytokines such as IL-4 and 
IL-13. Another interpretation might be the higher sensitivity of the BrdU labeling in comparison with 
the IFN-γ ELISA for the detection of Th1 biased CMI. If mDC were used however, there was a large 
similarity between detected proliferation signals and detected IFN-γ levels, indicating that, when using 
mDC as APC, the BrdU method is suitable for the in vitro evaluation of CMI responses to viruses. 
3.1.6 Conclusion 
In conclusion, this study demonstrates the suitability of the BrdU labeling technique to detect and 
characterize specific T lymphocyte proliferative responses to both infectious and inactivated viruses 
using N2-stored cells from vaccinated cats for the first time. The use of mDC as APC is recommended 
since only low responses were detected when monocytes were used as APC. The obtained results were 
verified via the detection of IFN-γ in culture supernatant. In this study, the BrdU labeling method was 
used to evaluate and describe proliferative responses to FPV, FCV and FeHV-1, some of the most 
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common viral infections in cats. In the future this will be extended to CMI-studies in cats infected with 
other major feline pathogens such as infectious peritonitis virus (FIPV) and feline enteric coronavirus 
(FECV). Further, this method could be implemented in a bioassay-tool to evaluate CMI responses to 
other vaccines or to analyze the effect of drugs and other health-promoting products on CMI 
responses. 
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3.2 Natural killer cells: frequency, phenotype and function in healthy cats 
3.2.1 Summary 
Natural killer (NK) cells play a central role in innate immunity and have been shown to influence 
adaptive immune responses as well. This study aimed to provide a general NK cell quantification and 
phenotyping in several compartments of healthy cats and assess their functional properties. The results 
indicated that NK numbers, both absolute and relative, and phenotype mostly correspond with those 
found in bovine, ovine, human and murine immunology. However, there were also distinct 
differences, especially with regard to the expression of the integrin CD11b and the selectin CD62L 
(between 10 and 30% of feline NK cells stain positive for these markers) and the relative frequencies 
in lymph nodes (6.7%), which stand central in NK cell development. Caution should be taken when 
extrapolating findings on NK cell properties over species, notwithstanding the generally accepted 
evolutionary conservation of NK cells and their subtypes. It was also shown that K562 cells, the 
‘golden’ target cell line for NK functionality tests did not work for feline cells. The feline kidney cell 
line CRFK proved to be very responsive to NK- and NKT- mediated lysis and therefore, represents an 
ideal alternative target. This study is a good reference for NK cell numbers, both absolute and relative, 
phenotype and function in several anatomical compartments of healthy cats and for cat-specific 
cytotoxic assays involving both NK and NKT cells. 
3.2.2 Introduction 
Since their description by Govaerts et al (1960), NK cells have been found to be major players in 
tumor, anti-viral and host-graft immunology (Yu et al., 1992; Diefenbach and Raulet, 2002; 
Brandstadter and Yang, 2011). NK cells fight infection by directly lysing the infected cells. In addition 
they can modulate the immune response through the secretion of pro-inflammatory cytokines and 
interaction with antigen-presenting cells (Jonjic et al., 2008). NK cells have been found in blood, 
lymphoid tissues, several organs and inflammatory sites (Cooper et al., 2001; Fehniger et al., 2003; 
Dalbeth et al., 2004). In human immunology, NK cells are characterized by the expression of CD56, 
CD16 and the absence of CD3. Early research confirmed the existence of feline NK cells but was 
somewhat hindered by the lack of monoclonal antibodies against specific NK markers. Feline NK 
cells were found in blood and lymphoid tissue and were determined to be non-adherent, to bear Fc 
receptors, to possess cytoplasmatic granules and to be activated by IL-2 (Mccarty and Grant, 1983; 
Tompkins et al., 1983; Tompkins et al., 1989). Crucial roles for NK cells have been described for 
human viruses such as human immunodeficiency virus, cytomegalovirus and herpesvirus 
(Brandstadter and Yang, 2011). Indeed, NK cell deficiencies cause severe recurrent viral diseases 
(Wood et al., 2011).  
NK cells play, without a doubt, a major role in innate defences against pathogens. Some viruses 
however, have evolved immune evasive mechanisms by disrupting NK function. In cats for example, 
infection with feline immunodeficiency virus (FIV) leads to strongly reduced NK cell activity and 
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frequency (Hanlon et al., 1993; Zaccaro et al., 1995; Howard et al., 2010). Still, there is very limited 
information concerning the general distribution and phenotype of NK cells in cats. Recent findings in 
human NK biology showing major differences in NK cell distribution, phenotype and function 
between blood, lymphoid organs and tissue, incited us to deepen our knowledge of NK cell biology in 
cats. This could contribute to a better understanding of cellular immunity towards feline pathogens and 
shed light on how pathogens may escape from NK-mediated lysis of infected cells. 
In this study, general frequency, phenotype and functionality of feline NK cells were investigated. In a 
first part, NK cell quantification, both absolute and relative was performed in blood, mesenteric lymph 
node (LN), spleen, mesentery and kidney. In a second part, general NK cell phenotyping was done on 
mononuclear cells derived from blood, LN and spleen from of healthy cats. To this end, several 
surface markers (CD56, CD3, CD8, CD11b, CD16, CD25 and CD62L) and appropriate isotype 
controls were used. In the last part, a functionality assay was optimized and used for feline NK and 
NKT cells originating from blood, LN and spleen, since the ‘golden’ NK target cell line K562 was 
unresponsive to feline NK cell-induced lysis. 
3.2.3 Materials and methods 
3.2.3.1 Antibodies 
Monoclonal antibodies against the epsilon chain of feline CD3 (IgG3) (NZM1) and against feline 
CD56 (IgG1) (SZK1) were kindly provided by Dr. Yorihiro Nishimura (Tokyo University, Japan) 
(Shimojima et al., 2003). Monoclonal antibodies recognizing feline CD25 (IgG2a) were produced by 
the cell line 9F23.3, which was purchased from North Carolina State University (Raleigh, North 
Carolina, USA). Monoclonal antibodies FE5.4D2, CA16.3E10, YFC120.5 and CA2.1D6 recognizing 
feline CD8β (IgG1), canine CD11b (IgG1), human CD16 (rat IgG2b) and canine CD21 (IgG1) 
respectively, were purchased from AbD Serotec (Dusseldorf, Germany). A monoclonal antibody 
DREG56, cross reactive with feline CD62L (IgG1) (Kaname et al., 2002), was purchased from Acris 
antibodies (Hereford, Germany). Conjugated secondary antibodies [Molecular Probes (Invitrogen, 
Carlsbad, USA)] were goat anti-rat Alexa Fluor 488, goat anti-mouse IgG2a Alexa Fluor 488, goat 
anti-mouse IgG1 Alexa Fluor 647 and goat anti-mouse IgG3 fluorescein isothiocyanate (FITC). When 
primary antibodies from the same IgG1 isotype were used, one primary antibody was labeled with 
Zenon Alexa Fluor 488 Mouse IgG1 (Invitrogen, Carlsbad, USA). 
3.2.3.2 Target cell lines 
Crandell feline kidney cells were cultured in Minimal Esential Media (GlutaMAX) supplemented with 
5% fetal calf serum (FCS) (Greiner Bio-one, Kremsmuenster, Germany), 100 U ml-1 penicillin, 0.1 mg 
ml-1 streptomycin, 0.1 mg ml-1 kanamycin and 2% lactalbumin (Invitrogen). After two days of culture, 
CRFK cells were detached through incubation with Accutase (Sigma-aldrich) for 5 minutes at 37°C. 
The human K562 cell line was cultured in Iscove's Modified Dulbecco's medium (GlutaMAX) 
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(Invitrogen) supplemented with 10% FCS, 100 U ml-1 penicillin, 0.1 mg ml-1 streptomycin and 0.1 mg 
ml-1 gentamycin (Invitrogen). Before being used as target cells, cells in suspension (1 x 106 ml-1) were 
stained with 2 µM carboxyfluorescein succinimidyl ester (CFSE) (Invitrogen) for 10 minutes at 37°C, 
followed by several washing steps. 
3.2.3.3 Cell-isolation from blood and tissue 
Six healthy, conventionally housed, feline leukemia virus- and feline immunodeficiency virus-
negative cats were used in this study, all originating from private owners (Table 3.2). Blood from all 
cats was collected from the vena jugularis in heparin (15 U ml-1) (Leo, Zaventem, Belgium) and 
mononuclear cells were separated on Ficoll-Paque (GE Healthcare, Little 
Chalfont, Buckinghamshire, United Kingdom). Cells in tissue were isolated by grinding small pieces 
of tissues through a tissue grinder (250 µM mesh) (Sigma-aldrich, St. Louis, Missouri, USA) and 
subsequently through a smaller cell strainer (70 µM mesh) (Becton, Dickinson and Company, New 
Yersey, USA). After isolation, cells were counted and frozen. Briefly, a maximum 2 x 107 cells ml-1 
were resuspended in RPMI supplemented with 30% fetal bovine serum (FBS), 100 U penicillin ml-1, 
0.1 mg streptomycin ml-1, and 10% dimethyl sulfoxide (DMSO). Subsequently, cells were frozen by 
lowering the temperature with 1°C min-1 until -30°C, followed by a 15 min incubation period at -30°C 
and finally lowering the temperature to -150°C at a rate of 1°C s-1 (PTLPD81, Orthodyne, Alleur, 
Belgium). After freezing, cells were stored in liquid nitrogen. 
Table 3.2: Detailed overview of the characteristics of cats used in this study. 
Cat Age Gender Breed 
11GK5 8 years ♀  European shorthair 
11GK12 11 years ♀ European shorthair 
11GK13 2 years ♂ European shorthair 
11GK18 9 years ♂ European shorthair 
11GK24 5 years ♂ European shorthair 
11GK25 7 years ♀ Persian 
3.2.3.4 NK cell phenotyping 
Phenotyping of cells from all compartments was performed simultaneously. All analyzed cells were 
first stored in liquid nitrogen, facilitating analysis workflow. Several precautions were taken in order 
to preserve immunophenotypic properties as was done in previous research (Vermeulen et al., 2012). 
Briefly, cells were frozen directly after isolation, they were stored at -196°C for the entire storage 
period and viability of thawed cells was routinely 80-90%. A minimum of 1 × 106 of frozen cells were 
stained for phenotypic analysis in RPMI supplemented with 1 mM Ethylenediaminetetraacetic acid 
(EDTA). Cells were incubated for 20 min at 4°C while gently shaking, both with the primary and dye-
conjugated secondary antibodies. Cells were washed with cold RPMI containing EDTA and 
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centrifuged at 300g for 10 min at 4°C. Stainings of several surface molecules in combination with 
CD56 and CD3 were performed: CD8 / CD11b / CD16 / CD25 / CD62L. Analysis was done on a 
FACSCanto flow cytometer using FACSDiva software (BD Biosciences, Mountain View, California, 
USA). After singlet gating, a minimum of 1 × 105 viable cells was analyzed. Additional confocal 
microscopical analysis was performed on CD56+CD16+ LN cells (DM B fluorescence microscope, 
Leica Microsystems GmbH, Heidelberg, Germany). 
3.2.3.5 NK(T) cell purification 
Frozen PBMC, LN and spleen cells from three healthy cats were stained with anti-CD56 and anti-CD3 
followed by incubation with IgG3 isotype-specific FITC, IgG1 isotype-specific AF647 secondary 
antibody and Sytox blue dead cell stain (5 nM) (Invitrogen). These stainings allowed the identification 
of viable NK cells (CD3-CD56+) and NKT cells (CD3+CD56+), similar to Howard et al (2010). 
Viability was always >80%. Cells were then sorted on a FACSARIA III flow cytometer (BD 
Biosciences). Typical NK cell yield varied between 5 x 103 and 2 x 104 cells per ml blood or mg 
tissue, while NKT cell counts varied  between  3 x 102  and 2 x 103 per ml blood or mg tissue. Purity 
of the sorted cell populations was routinely >97%.  
3.2.3.6 Functionality assay 
Both CFSE-stained CRFK and K562 cells were used as target cells in the functionality assay. Briefly, 
5 x 104 target cells were brought in a well of V-bottomed 96-well plates (Nunc, Langenselbold, 
Germany). Target cells were then cocultured with a varying amount of non-purified effector cells. 
Evaluated effector/target cell ratios were: 0, 1, 2, 5, 10, 25 and 50 (the latter only with non-activated 
PBMC). Effector cells were feline cells originating from the blood (PBMC), mesenteric LN and 
spleen, both untreated and activated with rHu IL-2 (100U ml-1) for 18h (Invitrogen). When FACS-
purified feline and porcine NK cells were used, tested effector/target ratios were: 0, 1, 5 and 10. Cells 
were first centrifuged for 3 minutes at 200g to promote conjugate forming. After 60 minutes, cells 
were gently resuspended and further incubated at 37°C for a total time of 4 hours after which dead 
cells were stained with propidium iodide (PI) and analyzed on a FACSCANTO flow cytometer (BD 
Biosciences). The cytotoxic effect of different effector cells was then evaluated by the amount of dead 
target cells (CFSE and PI labeled). 
3.2.3.7 Statistical analysis 
Statistical analyzes were performed by Mann-whitney U tests with SPSS 19.0 (SPSS Inc., Chicago, 
Illinois, USA). Significant differences were considered if P ≤ 0.05. 
3.2.3.8 Animal welfare 
This study was performed according to animal welfare guidelines. Under the application EC2012/043, 
this research was evaluated positive by the ethical committee of the faculty of veterinary medicine, 
Ghent university 
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3.2.4 Results 
3.2.4.1 NK cell quantification 
In order to evaluate NK cell frequencies in cats, cells extracted from blood, mesenteric LN, spleen, 
mesentery and kidney were stained with a Mab against CD56 and CD3. Fig 3.7-A shows absolute 
numbers of NK cells (CD3-CD56+) in each compartment. For blood an average of 227 NK cells µl-1 
[56-593] was found while in LN, spleen, mesentery and kidney the averages were 3372 [1249-5729], 
2231 [904-4896], 11 [2-30] and 127 [21-421] NK cells mg-1. 
Figure 3.7: (A) Absolute number of NK cells in all analyzed compartments. (B) Percentage of NK cells relative to the 
total amount of lymphocytes (T, B and NK cells). Values are depicted as box-and-whisker plots where the whiskers 
refer to the minimum and maximum values (n=6). 
In order to be able to compare with other species, NK cell numbers were also plotted relatively to the 
total amount of lymphocytes (T-, B-lymphocytes and NK cells, identified through staining with CD3, 
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CD21 and CD56/CD3 respectively). For blood, LN, spleen, mesentery and kidney, the percentages 
were 5.2±2.5%,  3.4±1.7%, 6.7±3.4%, 12.6±5.0% and 21.8±9.3% respectively (Fig 3.7-B). 
3.2.4.2 NK cell phenotype and morphology 
Phenotype analysis was performed on cells extracted from blood, LN and spleen. Cells from 
mesentery and kidney were too few in numbers to make this analysis possible. Surface molecules that 
were evaluated on NK cells were CD8, CD11b, CD16, CD25 and CD62L (Fig 3.8 –A&B). 
Diminished CD56 intensity can be seen when co-staining for CD8, CD11b and CD62L. This is the 
result of fixation. Since these antibodies are all the same isotype as CD56, AF488-zenon labeling was 
performed on these markers, which requires fixation after staining. These different intensities were 
noted in all tissues and for all animals but did not influence total % CD56 positive cells. 
 
Figure 3.8: (A) Phenotypic analysis of feline NK cells, CD3 positivity (%) was determined on CD56+ cells (first 
column) ; CD8, CD11b, CD16, CD25 and CD62L positivity (%) was determined on CD3-CD56+ cells. Values are 
mean ± SD (n=6). (B) Representative phenotypic analysis on lymph node cells from one animal. Percentages indicate 
the positivity for each marker in the CD56+ population (CD3) or in the CD3-CD56+ population (CD8 – CD11b – 
CD16 – CD25 and CD62L). 
In order to analyze cell size and granularity, FSC-A and SSC-A respectively were determined on both 
NK (CD3-CD56+) and T cells (CD3+CD56-). NK cells were significantly larger and more granulated 
when compared to T cells (Fig 3.9-A). Confocal microscopical analysis of LN cells stained for CD16 
(AF488), CD56 (AF647) and Hoechst revealed small (~10 µm) double surface-stained cells with little 
cytoplasm and a large nucleus (Fig 3.9-B). 
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Figure 3.9: (A) Analysis of size (FSC-A) and granuluratiy (SSC-A) on both T (CD3+CD56-) and NK cells (CD3-
CD56+). Presented values are mean ± SD (n=4). Significant differences (p≤0.05) between T cells and NK cells in terms 
of FSC-A and SSC-A are indicated with an asterisk. (B) Confocal microscopical analysis of lymph node cells stained 
with CD16 (green) and CD56 (red).  Nuclei were counterstained with Hoechst (blue). 
3.2.4.3 NK and NKT cell functionality 
Initially, the cytotoxic capacities of different feline cell populations were to be determined on the 
human erythroleukemia cell line (K562), since this is the most frequently used target line cross-
species. However, no cytotoxicity was found using feline PBMC (Fig 3.10-A), not even with IL-2 
activated PBMC at an effector/target cell ratio of 50:1 (Fig 3.10-B). Finally, even FACS-purified 
feline NK cells failed to show any cytotoxicity towards K562 cells (Fig 3.10-C). To verify the assay-
setup, FACS purified porcine NK cells, purified similar to Gerner et al (2009), were assessed. They 
showed a cell concentration-dependent, cytotoxicity with a maximum of 37±6% for an effector/target 
cell ratio of 10:1 (Fig 3.10-D). This proves that the assay is valid for general NK function analysis but 
that feline cells lack cytolytic activity towards K562 cells. 
Further testing revealed that the Crandell feline kidney cell line (CRFK) was susceptible to cell lysis 
when incubated with IL-2 activated PBMC with a maximum of 27±8% at a E/T ratio of 50:1 (Fig 
3.11-A). When cells from LN and spleen were analyzed, much higher cytotoxicity levels were 
detected. For LN, 11±1%, 18±5%, 41±9% and 73±6% dead cells were detected for E/T ratios of 
respectively 1, 5, 10 and 50 while for the spleen, 9±2%, 22±3%, 44±11% and 64±3% dead cells were 
detected for the same E/T ratios. These results illustrate a cytotoxicity that is cell concentration-
dependent for cells from each compartment. Cells from LN and spleen seem to have comparable 
cytolytic capacities, much higher than PBMC (Fig 3.11-A). 
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Figure 3.11: Analysis of cytotoxic activity on the 
Crandell feline kidney cell line (CRFK). 
Analyzed effector cell populations were 
unpurified total cells (A), NK cells (B) and NKT 
cells (C) from blood (PBMC), mesenteric lymph 
node and spleen. All effector cells were IL-2 
stimulated (100 U ml-1). Values are represented 
as mean  (n=3). 
Figure 3.10: Analysis of 
cytotoxic activity on the 
erythroleukemia cell line K562. 
Analyzed cell populations were 
non activated PBMC (A), IL-2 
activated PBMC (B), IL-2 
activated purified feline NK 
cells (C) and IL-2 activated 
purified porcine NK cells (D). 
Values are represented as 
mean ± SD (n=3). 
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In order to verify if these cytolytic cells are NK cells and not another lymphocyte population, FACS 
purified CD3-CD56+ cells were used to repeat the experiment. For blood, the percentage of dead cells 
was 8±3%, 16±6%  and 28±9% for E/T ratios of 1, 5 and 10, while the LN had values of 24±6%, 
42±7% and 61±6% and the spleen values of 11±3%, 23±2% and 41±4% for the same E/T ratios (Fig 
3.11-B). Without regard to their origin, the cells also seemed to have the concentration-dependent 
cytotoxicity, but at much lower E/T ratios. 
Since NKT cells can also lyse NK-sensitive cells (Kuylenstierna et al., 2011), their cytotoxicity was 
also evaluated similar as for NK cells. The maximum E/T that could be obtained was only 5:1. 
Nevertheless, cytotoxicity was seen for both blood (9±4% and 15±5% for E/T 1:1 and 5:1) and LN 
(27±5% and 43±4% for E/T 1:1 and 5:1) NKT cells (Fig 3.11-C). No cytotoxicity could be detected 
with spleen NKT cells. 
3.2.5 Discussion 
Although feline natural killer cells have been described in literature almost thirty years ago (Mccarty 
and Grant, 1983), the lack of feline specific monoclonal antibodies has hampered further phenotyping. 
With the availability of antibodies against feline epitopes or cross reacting with feline epitopes, this 
study first aimed to quantify NK cells, both absolute and relative, in blood, mesenteric lymph node 
(LN), spleen (all three important immunological compartments), mesentery and kidney (tissues with a 
large sensitivity for disease (e.g. feline infectious peritonitis). 
The absolute number of feline natural killer cells (CD3-CD56+) in blood is comparable, but a little 
lower, to that in human,monkey, and cattle (Alter et al., 2007; Ishizaki and Kariya, 2010; Reeves et al., 
2010). NK numbers were much higher in feline LN and spleen, when compared to feline blood, but 
this was expected since lymphoid organs contain the vast majority of most immune cells (Blum and 
Pabst, 2007). When interpreting immune cell frequencies, absolute numbers are always preferable, 
since relative numbers are easily influenced by expansion or contraction of other immune cell 
populations. Nevertheless, nearly all data in other species are presented relatively. Thus relative values 
were also assessed to enable a direct comparison of our data with those from other species. Relative 
frequencies in the different compartments showed large similarities between feline, bovine, porcine 
and ovine blood, LN and spleen (Boysen et al., 2008; Gerner et al., 2009; Elhmouzi-Younes et al., 
2010). Compared to murine and human LN and murine spleen, feline NK cell percentages were 
notably higher, while in human blood and spleen the opposite was true (Ferlazzo et al., 2004; Tessmer 
et al., 2011). Not much is known about NK cell numbers in non-lymphoid tissues, but just like in 
human and rat liver and lungs, high percentages were found in feline mesentery and kidney (Reynolds 
et al., 1981; Westermann and Pabst, 1992; Norris et al., 1998). Recent results by Howard et al. (2010), 
who found 1-5% NK cells in feline PBMC and spleen cells and 0.1-1% in feline LN, show the same 
trend in percentages, although generally lower. This discrepancy might be caused by the use of 
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different monoclonal antibodies (clone C5.9 against human CD56 versus clone SKZ1 against feline 
CD56) or by the use of SPF animals versus conventionally housed animals which can influence the 
properties of feline NK cells (Tompkins and Tompkins, 1985). Finally, their relative NK cell 
percentage was based on total cell count, which encompasses also other cell populations found in 
blood, LN and spleen (e.g. APC). Lower NK cell numbers were also described by Shimojima et al. 
(2003) who found 1.1-1.7% NK cells in peripheral blood monocytes. Similar to the study of Howard 
et al. (2010), these differences could be attributed to the use of SPF animals or gating technique 
(forward-side scatter was used for lymphocyte determination). Additionally, SPF cats that were used 
were all >10 years old which could influence CD56 membrane density and thus lead to an 
underestimation of CD56+ cells, especially when combined with a generally less bright secondary 
detection antibody (FITC) (personal communication Dr. M Shimojima) (Tarazona et al., 2009). 
CD16 and CD56 staining revealed a double membrane staining of cells with a large nucleus to 
cytoplasm ratio and an average size of ~10 µm, which is comparable with human NK cells (Babcock 
and Phillips, 1983). Analysis of cell size and granularity, revealed that feline NK cells were 
significantly larger and more granulated than feline T lymphocytes, similar to human NK cells 
(Timonen et al., 1981).  
Natural killer T cells (NKT cells) have characteristics of both T and NK cells and can be defined by 
the co-expression of both CD3 and CD56. This enigmatic subset recognizes mainly CD1d-presented 
lipids and glycolipids and has recently gained a lot of interest because of its potential as biomarker 
and/or therapeutic target (Berzins et al., 2011). When CD56+ cells were costained for CD3, a part of 
the T cell receptor complex (TCR), ~20% of the PBMC and spleen cells stained positive, while 33% 
of the LN cells stained positive. The same ratio was found in human blood, while in bovine blood and 
both bovine and human LN remarkably lower amounts of NKT cells were found (Fehniger et al., 
2003; Lee et al., 2010). A recent study on feline cells revealed ~30% of CD56+ cells to be NKT cells 
in PBMC while more than half of the CD56+ spleen cells were NKT cells (Howard et al., 2010). The 
use of different monoclonal antibodies and cats with a different immunological status could again be 
responsible for these differences. 
Besides differences in NK frequency between species, phenotypical analysis also revealed some 
feline-specific flavors in NK cell phenotype with regard to CD8, CD11b, CD16, CD25 and CD62L 
expression. 
It has been stated that there is large population within the human NK population that stains positive for 
CD8, a co-receptor of the TCR. There are indications that these CD8+ NK cells have a higher 
cytotoxicity and are more resistant to activation-induced apoptosis (Addison et al., 2005). Staining for 
CD8 on feline NK cells from the peripheral blood, LN and spleen cells revealed that respectively 10%, 
20% and 20% stained positive for this marker. This is lower than in human, bovine and rat blood, 
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where 30-50%, 29% and 100% of the NK cells are CD8+, respectively, but higher than murine cells, 
where CD8 is absent on NK cells (Trinchieri, 1989; Boysen et al., 2008). In human and bovine LN, 
respectively 2% and 70% of the NK cells were positive for CD8 while in human and bovine spleen, 
respectively 25% and 58% stained positive (Ferlazzo et al., 2004; Boysen et al., 2008). 
In murine immunology, CD11b or integrin alpha M (ITGAM) can be used in conjuction with CD27 to 
differentiate between several developmental stages of NK cells, which can also be done for human NK 
cells where CD11b is mostly expressed on mature NK cells (Freud et al., 2006; Chiossone et al., 
2009). Typically, in human and murine blood, nearly all cells stain positive for CD11b, whereas in 
murine LN and spleen, CD11b expression on NK cells is ~25% and ~50%, respectively (Chiossone et 
al., 2009; Fu et al., 2011). In cats, between 10% and 30% of the NKs are positive for CD11b. Since 
CD11b expression is closely correlated with CD56 expression in humans (Fu et al., 2011) and taken 
into account that nearly all human blood NK cells express CD56, we conclude that CD11b expression 
and developmental stages are not as closely correlated as they are in human and murine immunology. 
However, CD11b could play other unidentified roles in cats. 
CD16, a low affinity Fc receptor (FcγRIII), is mainly used in human immunology to differentiate 
between the cytotoxic NK cell subset (CD56dimCD16+) that is mainly present in the blood and spleen 
(80-95% of NK cells) and the immunoregulatory NK cell subset (CD56hiCD16-) that accounts for 
75% of the LN NK cells (Ferlazzo and Munz, 2004; Ferlazzo et al., 2004). Both ovine and bovine 
blood and spleen NK cells also are characterized by high percentages of CD16 (~95% positive for 
CD16). In feline blood and spleen, on average 76% and 82%, respectively, of the NK cells were 
CD16+, indicating large cross-species similarities (Boysen et al., 2008; Elhmouzi-Younes et al., 
2010). Like bovine LN NK cells (~85%), but in stark contrast to the human situation (1-2%), feline 
LN NK cells were also highly positive for CD16 (~70%) (Ferlazzo et al., 2004). These results indicate 
that feline CD16+ NK cells could use antibody-dependent cell-mediated cytotoxicity (ADCC) as a 
mechanism to lyse target cells. Indeed, while human CD16- LN NK cells lack a cytolytic capacity, 
bovine LN and murine spleen NK cells efficiently lyse target cells and express CD16 or CD27 and 
other activation markers (Hayakawa and Smyth, 2006; Boysen et al., 2008). 
CD25 (α-chain of the IL-2 receptor) is expressed on 10% and 22% of human and bovine blood NK 
cells, respectively while in cats 43% of the blood NK cells stained positive for this activation marker 
(Cooper et al., 2001; Boysen et al., 2008). In feline LN, 60% of the NK cells were CD25+, which is 
comparable with bovine LN NK cells. This is different from the situation in the spleen, where cats 
have 48% CD25 positive NK cells versus 28% for bovine NK cells (Boysen et al., 2008). This could 
indicate that for blood and spleen NK cells, cats have a higher activation status in comparison with 
humans and cattle. The higher activation status of LN NK cells versus blood and spleen NK cells is 
also reflected by the significantly higher cytolytic activity of LN NK cells on CRFK cells (61±6% for 
LN NK cells versus 28±9% and 41+4% for blood and spleen NK cells). 
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CD62L or L-selectin, an adhesion molecule important for homing to lymphoid organs is expressed on 
about 10% of the human blood NK cells (all CD56hi), a proportion which is also found in feline blood 
NK cells (~13%) (Cooper et al., 2001). This contrasts with the high amounts of CD62L+ NK cells 
found in bovine (63%) and murine blood (Bajenoff et al., 2006; Boysen et al., 2008). In the LN, 14% 
of the feline NK cells were CD62L+, which is substantially lower than bovine (87%), but higher than 
human LN NK cells, who lack CD62L expression (Ferlazzo et al., 2004). The low amount of CD62L 
on feline LN NK cells can be explained by the fact that mesenteric lymph nodes are mucosa-
associated lymph nodes who use the α4β7-MADCAM pathway for leukocyte homing, which is 
CD62L-independent. Like the human and murine situation, feline spleens might lack high endothelial 
venules (HEV), structures that express the ligand for CD62L. Finally, cells can also access lymph 
nodes through the afferent lymph in the subcapsular sinus, which is also HEV-independent (von 
Andrian and Mempel, 2003). To conclude, CD62L expression on feline NK cells and feline leukocytes 
in general is low (~10-30%). This could indicate that cats use other pathways for leukocyte homing 
such as the α4β7-MADCAM pathway or through afferent lymph. 
To summarize, analysis of feline NK cells in blood, LN and spleen revealed that both the morphology 
and absolute number of NK cells is comparable with other species including man. Relative numbers 
were also similar between cats, cattle, sheep and monkey. Some differences, however, were present 
between cats, mice and humans, especially with regard to LN and spleen. 
To analyze NK cell functionality several cell lines have been assessed in the past as targets for NK 
cell-mediated cytotoxicity in both human and veterinary immunology. Up until now, in most species, 
the K562 cell line has been most frequently used (Jondal and Pross, 1975; Evans and Jasofriedmann, 
1993). In feline NK biology, information about susceptible target cell lines is scarce and contradicting 
with groups finding no NK activity (Hu et al., 1982; Kooistra and Splitter, 1985) or activity that is 
dependent on breed and immunological history of the cats used (Mccarty and Grant, 1983; Tompkins 
et al., 1983). In order to assess NK cytotoxicity, experiments were first conducted with the K562 cell 
line. Here, no NK cytolytic activity could be demonstrated on the K562 line. In fact, neither PBMC, 
IL-2 activated PBMC nor IL-2 activated purified feline NK cells could lyse the K562 line in 4h or 16h 
assays, which contradicts earlier work from Zaccaro et al. (1995). Some differences in assay setup 
might explain this discrepancy. In their experiments, they used autofluorescence and scatter plot 
properties to detect target cells, whereas in this research, target cells were specifically identified with a 
CFSE-labeling. They also worked with SPF cats, for which aberrant NK functionality has already been 
found earlier (Tompkins and Tompkins, 1985). Since NKp30 and NKp46 have been reported to 
contribute substantially to K562 lysis by human NK cells (Sivori et al., 2002), monoclonal antibodies 
against human NKp30 and NKp46 were evaluated for reaction with feline cells. However, no 
crossreactiviy could be detected for any of the clones tested (data not shown). In addition, all NK cells 
originated from genetically unrelated cats, excluding a common genetic defect in expression of 
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activating natural killer cell receptors. Porcine purified NK cells on the other hand, lysed the cell line 
effectively with up to 45% lysed cells for an E/T ratio of 10:1. This shows the assay-setup is valid for 
assessing NK functionality. 
Crandell feline Kidney cells (CRFK) on the other hand, were susceptible to lysis by activated feline 
NK cells that originated from the blood, LN and spleen. A typical pattern of increasing cytotoxicity 
with increasing E/T ratios was noted in all three assessed populations. LN and spleen NK cells were 
more cytotoxic (~70% dead cells at E/T ratio of 50:1) than NK cells originating from blood (~30% for 
an E/T ratio 50:1). This difference might be caused by a higher activation status of the initial cells 
(evaluated by CD25), whereas it is know that human LN NK cells are non-cytotoxic and need 
prolonged stimulation (72h) with IL-2 in order to become activated and cytotoxic (Fehniger et al., 
2003). The same pattern was detected in calves: LN>spleen>blood with regard to cytolytic activity. 
Similar to our results, the activation status of these bovine NK cells, as assessed by CD25 and CD44 
expression, was the highest in LN NK cells, followed by NK cells isolated from spleen and blood 
(Boysen et al., 2008).   
Since other cells (e.g. effector T cells) can also have cytotoxic properties, NK cells (CD3-CD56+) 
were sorted from blood, LN and spleen. Cytotoxicity tests using the CRFK line revealed cytotoxicity 
patterns similar to unsorted cells albeit at lower E/T ratios. This is to be expected since only three to 
seven percent of the lymphocytes in PBMC, LN and spleen are NK cells. In fact, in theory lower 
percentages of dead cells were expected with the evaluated E/T ratios of unsorted cells, indicating that 
other ‘contaminating’ cells, such as effector T cells and monocytes, that have cytotoxic capacities 
(West et al., 1977), are still present in the unsorted cell suspensions. In addition to NK cells, the 
function of NKT cells (CD3+CD56+) was also investigated in a similar manner. NKT cells originating 
from blood and LN had a cytolytic activity that was comparable with NK cells. Only NKT cells 
originating from the spleen failed to induce any cytotoxicity. Recent developments in immunotherapy 
suggest possibilities to enhance NKT function in order to suppress autoimmune and cancerous 
diseases in humans and mice (Van Kaer, 2007). Earlier research showed very low cell concentration 
dependent cytotoxicity of lymphokine-activated killer cells (LAK) (~5% with the highest E/T ratio) on 
CRFK cells (Zhao et al., 1995). These different results could be attributed to some differences in assay 
setup. LAK cells originate from Concanavalin A / IL-2 stimulated PBMC, which contain ~5% NK 
cells while in our studies FACS-purified NK cells were used. This makes comparison of used E/T 
ratios challenging, especially considering that there are other lytic populations present in PBMC (e.g. 
monocytes, T cells). Additionally, the method used to detect cell lysis was 51Cr labeling, which differs 
considerably from our fluorescent approach in terms of sensitivity and the labeling of subsets of 
effector cells (Jedema et al., 2004). 
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In short, the CRFK cell line can be used to evaluate cytolytic functions of NK and NKT cells, but it is 
advised to use FACS or MACS-purified cells in order to avoid the effect from any unwanted cell 
populations, such as monocytes and T cells. 
Conclusion 
This study represents the first detailed quantification and phenotyping of feline NK cells. Results show 
a correlation of many NK properties between several species, another proof of their evolutionary 
conservation, but caution in comparing and extrapolating results over species is still advised since 
there exist also species-specific differences. Nevertheless, this work is a good reference for NK cell 
parameters in healthy cats which can be used to evaluate pathogen-, environment- or disease-induced  
changes in NK cell frequency and phenotype. This could lead to the development of biomarkers or 
therapeutic avenues that target specific diseases. Additionally it was found that the golden target cell 
line for NK functionality assays, the K562 cell line, was resistant to feline NK cell-mediated lysis. 
Instead, the feline cell line CRFK should be used to evaluate the cytotoxic activity of feline NK and 
NKT cells, to assess their functionality in healthy and diseased cats or to appreciate the effect of 
immunotherapeutic strategies on both NK and NKT cells. 
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Chapter 
4 Feline cell-mediated immune responses against the 
feline coronaviruses FECV and FIPV with emphasis on 
natural killer cells and regulatory T cells 
Summary 
Cellular immunity is typically divided into innate and adaptive branch. Where in the adaptive part, the 
main players are CD4+ and CD8+ T lymphocytes, NK cells form a crucial component of the innate 
defenses. Additionally, regulatory cell types exist to exert control over all immune responses, both 
cellular and humoral. Regulatory T cells are most famous in this part, although it has been amply 
shown that certain NK cells and NKT cells can also perform regulatory roles. Most of these cell types 
have been shown to exert influence on each other; analysis of several types simultaneously would 
logically yield the most valuable information. 
In order to obtain data in both FECV- and FIPV-infected cats, two large experiments were devised. In 
the first experiment (Chapter 4.11), three SPF cats were experimentally inoculated with the infectious 
field strain FECV-UCD. The animals were monitored daily and samples were taken at frequent, 
predetermined time points. For the second experiment (Chapter 4.22), both healthy cats that had to be 
euthanized for diverse reasons and naturally FIPV-infected cats were sampled and euthanized over a 
two-year period. Several extensive stainings and functionality assays were performed on samples from 
different body compartments in order to obtain information on different immune cell types. 
1 Manuscript in preparation, in co-authorship with Desmarets L.M. 
2 Adapted from: Vermeulen, B.L., Devriendt, B., Olyslaegers, D.A., Dedeurwaerder, A., Desmarets, L.M., 
Favoreel, H.W., Dewerchin, H.L., Nauwynck, H.J., (2013). Suppression of NK cells and regulatory T 
lymphocytes in cats naturally infected with feline infectious peritonitis virus. Vet. Microbiol. 164, 46-59. 
79 
Chapter 4 
4.1 Clinical, virological and immunological parameters during infection with 
feline enteric coronavirus 
4.1.1 Summary 
Feline enteric coronavirus (FECV), ubiquitously present in felids, causes at most a mild enteritis 
which is quickly resolved. However, occasionally, a mutation occurs that transforms FECV into the 
deadly feline infectious peritonitis virus (FIPV). Infection with FIPV nearly always results in death. In 
the present study, the FECV pathogenesis and both the humoral and cell-mediated immune response to 
FECV was investigated, in order to better understand feline anti-coronavirus immunity. Virus was 
quantified, both by real time RT-PCR and virus titration, in feces and oral fluids during the entire 
infection course of three cats, experimentally infected with the field strain FECV UCD. 
Simultaneously, both neutralizing antibodies and different subsets of leukocytes were quantified in 
blood. In addition, the phenotype of natural killer (NK) cells was evaluated and the cell-mediated 
immunity was evaluated through the detection of proliferating T cells in response to viral antigens. 
After inoculation, FECV was shed in the oral cavity infrequently during the first three weeks, with the 
highest amounts during the first 2 days after inoculation. FECV was detected in the feces from 2 days 
post inoculation (p.i.) in cats 1 and 3 and remained detectable for 2 months p.i. while cat 2 started 
secreting virus in feces starting from 14 days p.i. and continued shedding until the end of the 
experiment. Infectious virus was detected from 4 days till 28 days p.i. in feces from cats 1 and 3 but 
not from cat 2 by titration on feline enterocyte cultures. The infectious virus titers were 107-108 times 
lower than the virus RNA levels. Neutralizing antibodies (Nabs) were detected from 9 days p.i. for the 
2 cats that showed early fecal secretion. The cat with delayed fecal secretion also showed a delayed 
generation of Nabs, which started at 14 days p.i.. High Nab levels in all cats did not eliminate viral 
infection. An FECV infection resulted in a progressing minor to moderate reduction of all 
lymphocytes, albeit with different starting points for each subset, which started to resolve at 21 days 
p.i.. Blood NK cells showed an activated status (elevated CD16 and CD25 expression) and were more
prone to migration (elevated CD11b and CD62L). No differences could be seen in leukocyte numbers 
that could explain the difference in shedding patterns, with the exception of CD8+ regulatory T cells 
(Tregs), who were shown to be considerably increased in the blood of the delayed shedder. This 
relatively unknown subset has been frequently associated with gut immunity as they suppress immune 
responses during gut parasite infections and rectal retrovirus infections. Proliferation assays verified 
that cats mounted a cell-mediated response to FECV antigens, probably Th2 oriented. In conclusion, 
this research provides more in depth knowledge on the complex interaction of the feline immune 
system in response to an FECV infection. 
4.1.2 Introduction 
Feline coronaviruses (FCoVs) circulate as two pathotypes associated with either enteric or systemic 
disease in cats. Feline enteric coronavirus (FECV) is an enteropathogenic virus that is ubiquitously 
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present throughout the cat population worldwide (Pedersen et al., 1981). Intestinal FECV infection can 
be manifested by mild diarrhea but is mostly unapparent (Pedersen et al., 1981). Feline infectious 
peritonitis virus (FIPV) arises most likely by mutation from FECV in individually infected cats 
(Herrewegh et al., 1995; Poland et al., 1996; Vennema et al., 1998; Pedersen et al., 2009; Chang et al., 
2010a; Chang et al., 2011; Pedersen et al., 2012). These yet unknown mutations provide the virus with 
tools to productively replicate in monocytes/macrophages causing a highly fatal systemic disease (FIP) 
characterized by a diffuse vasculitis, polyserositis and severe lymphopenia (Horzinek and Osterhaus, 
1979; Kipar et al., 1998; Addie et al., 2009).  
FCoVs are divided in 2 serotypes and both serotypes contain both pathotypes. Serotype II viruses have 
arisen by double recombination events between serotype I FCoVs and canine coronavirus but 
represent only a minority of all strains worldwide (Hohdatsu et al., 1992; Herrewegh et al., 1998; 
Vennema, 1999; Addie et al., 2003; Benetka et al., 2004; Kummrow et al., 2005; Lin et al., 2009). 
Nevertheless, they have been most extensively studied since growth of serotype I strains have been 
hampered by the lack of cell lines expressing the yet unknown receptor for these strains. This implies 
that in vivo experiments are indispensable to study serotype I pathogenesis and that viral loads can 
only be estimated by means of quantitative RT-PCR, giving only a rough approach of viral infectivity.  
Due to its pathogenicity, most studies have been done with FIPV in order to investigate its complex 
epidemiology, pathogenesis and its interplay with host’s immune system. Although FECV is the 
source of every FIPV and an important target in the control of FIP, experimental studies with FECV 
are rather scarce (Pedersen et al., 1981; Poland et al., 1996; Meli et al., 2004; Pedersen et al., 2008; 
Vogel et al., 2010). Recently, some comprehensive infection studies have been performed that focused 
mainly on disease causing potential, fecal excretion patterns (as determined by real time RT-PCR) and 
humoral immune responses during FECV infection (Pedersen et al., 2008; Vogel et al., 2010). 
However, up until now, very little is known about oral shedding of the virus, the viral infectivity in 
oral and fecal secretions, the presence of neutralizing serum antibodies and the dynamics of the several 
immune cell subsets during FECV infections. More details on host immunity during an FECV 
infection may help to better understand coronavirus pathogenesis. This is especially important as 
initial control of FECV infection is imperative to keep virus titers low, and thus lowering the odds of 
the generation of a FIPV by mutation (Vijgen et al., 2007). To this end, three cats were experimentally 
inoculated perorally with the FECV UCD strain and viral shedding was followed together with the 
kinetics of neutralizing antibodies, T cells, B cells, monocytes, granulocytes, regulatory T cells and 
NK cells in blood during the entire infection course. Additionally, the NK phenotype was investigated. 
As mentioned before, most in vitro research focused on the detection of viral copies in feces to detect 
and quantify infection. The relationship between PCR results and infectivity have been investigated 
once, by infecting SPF cats with either PCR-negative, weak-positive or strong-positive fecal samples 
(Foley et al., 1997). However, quantification of infectious virus and its correlation to real-time RT 
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PCR results have never been investigated. Here, using a recently developed intestinal epithelial cell 
line sustaining the growth of the serotype I strain FECV UCD, viral titration of secretions and 
excretions in in vivo experiments could be determined.  
4.1.3 Materials and methods 
4.1.3.1 Virus 
FECV UCD was originally isolated by UC Davis (Pedersen et al., 1981). A fecal suspension 
containing the FECV UCD was kindly provided by Prof. P. Rottier (Utrecht University, The 
Netherlands) (Vogel et al., 2010). This suspension was diluted 1/10 in phosphate buffered saline and 
stored at -70 °C until use. The RNA content was determined using a real-time RT-PCR based on 
SYBR Green detection (vide infra). The suspension was centrifuged at 16200 x g for 10 minutes to 
remove bacterial or host cells and animals were infected with the suspension supernatant.  
4.1.3.2 Inoculation and monitoring 
Three specific pathogen free (SPF) cats (Harlan laboratories, Indianapolis, IN, USA) were orally 
inoculated with 800 µl of fecal suspension supernatant, containing 1011.3 viral RNA copies, while 
stimulating the swallowing reflex. Cats were kept in isolation. Additionally, precautions were taken to 
prevent exposure to any source of contaminating coronavirus. Briefly, with each handling, sterile 
clothing and footwear was ensured while litter trays, food trays and water bowls were cleaned and 
decontaminated daily. To ensure no contamination could arise from the litter being used, fine sand was 
washed extensively and autoclaved to serve as litter. The cats were monitored each day during the first 
week after inoculation and subsequently on 9, 14, 21, 28, 56 and 84 dpi. Each time, the rectal 
temperature was measured, lymph nodes were palpated, an oral swab was taken and feces were 
collected. If feces were not available, feces was collected by inserting cotton tipped swabs into the 
rectum. Swabs were suspended in 1ml DMEM supplemented with 1000 U/ml penicillin (Continental 
Pharma Inc., Puurs, Belgium), 0.4 mg/ml gentamycin (Gibco BRL, Merelbeke, Belgium) and 10% 
fetal bovine serum (FBS, Gibco BRL). Feces were diluted 1:5 (w:v) in the same medium. Suspensions 
were centrifuged at 4000 x g for 10 minutes and supernatant was frozen (-70°C) until determination of 
the viral load. Additionally, on -1, 0, 3, 5, 7, 9, 14, 21, 28, 56 and 84 dpi, cats were weighed and 5ml 
blood was taken from the vena jugularis in heparin (15 U ml-1) (Leo, Zaventem, Belgium). 
4.1.3.3 Determination of neutralizing serum antibody titers 
Sera were incubated at 56°C for 30 minutes to inactivate complement. Two-fold serial dilutions of the 
sera were mixed with an equal volume of a virus suspension containing 100 TCID50 FECV UCD and 
incubated for 1h (37°C, 5% CO2). Then, colonocytes were added and further incubated with the virus-
serum suspensions for 3 days. Infection was visualized by means of an immunoperoxidase monolayer 
assay (IPMA) as described for the assessment of the infectious titer. The VN titers were expressed as 
the reciprocal of the serum dilution that neutralized infection in 50% of the monolayers. 
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4.1.3.4 One-step real time RT-PCR for the detection of the viral load 
RNA was extracted from the fecal suspension using the QIAamp Viral RNA Mini Kit (Qiagen, 
Benelux BV, Belgium). A one step real-time RT-PCR based on SYBR Green detection was performed 
with primers described by Gut et al. (1999), targeting a 102bp fragment at the 3’ end of the genome 
(Gut et al., 1999). A 15 µl PCR mixture was used per reaction and contained 0.3 µl Superscript™ III 
RT/ Platinum® Taq Mix, 7.5 µl 2x SYBR® Green Reaction Mix with ROX (Superscript™ III 
Platinum® SYBR® Green One-Step qRT-PCR Kit with ROX, Invitrogen), 0.5 µM forward primer 
FCoV1128f, 0.5 µM reverse primer FCoV1229r and 3 µl FECV UCD RNA or diluted standard RNA 
(vide infra). A reverse transcription step of 20 min at 50°C and a denaturation step at 95°C for 5 min 
were followed by 45 cycles each 15 s at 95°C and 30 s at 60°C. A first-derivative melting curve 
analysis was performed by heating the mixture to 95°C for 15 s and then cooling to 60°C for 1 min 
and heating back to 95°C at 0.3°C increments. Reverse transcription, amplification, monitoring and 
melting curve analysis were carried out in a Step One Plus™ real-time PCR system (Applied 
Biosystems, Life Technologies Corporation, Carlsbad, CA, USA). 
4.1.3.5 Synthetic RNA standards for absolute quantification 
RNA was extracted from FECV 79-1683 using the QIAamp Viral RNA Mini Kit (Qiagen). The RNA 
was reverse-transcribed into cDNA using the SuperScript™ III First-Strand Synthesis System for RT-
PCR (Invitrogen). Briefly, 250 ng RNA was incubated for 5 min at 65°C with 2 µM reverse primer 
FCoV1229r and 10 mM dNTP mix. Afterwards, an equal volume of cDNA synthesis mix, containing 
10x RT buffer, 25 mM MgCl2, 0.1 M DTT, 40 U/µl RNase OUT and 200 U/µl Superscript III RT was 
added and incubated for 50 min at 50°C. The reaction was terminated at 85°C for 5 min. RNA was 
removed by incubation with RNase H for 20 min at 37°C. The 50 µl PCR mixture for the 
amplification of the cDNA contained 5x Herculase II reaction buffer, 25 mM dNTP mix, 200 ng DNA 
template, 0.25 µM forward primer FCoV1128f modified with a T7 promotor sequence at its 5’ end, 
0.25 µM reverse primer FCoV1229r and 0.5 µl Herculase II fusion DNA polymerase (Agilent 
Technologies Inc., Santa Clara, CA, USA). After a denaturation step for 1 min at 95°C, 30 cycli of 
amplification, each 20 s at 95°C, 30 s at 60°C and 1 min at 68°C, were followed by a terminal 
elongation of 4 min at 68°C. cRNA standards were transcribed by inbubation for 1 h at 37°C with 10x 
transcription buffer, 500 µM rNTPs and 20 U T7 RNA polymerase-Plus Enzyme Mix (Applied 
Biosystems). Transcription reactions were DNase treated and the amount of RNA was determined 
using the Nanodrop 200 system. Ten-fold serial dilutions were made over a range of 6 log units (1010-
105) for the generation of the standard curve. 
4.1.3.6 Determination of the infectious titer of FECV UCD 
Monolayers of colonocytes, seeded in collagen I coated 96-well plates, were inoculated with 50 µl of 
serial dilutions (1/10) of the fecal suspensions (ranging from 100 to 10-7). After 1h (37°C, 5% CO2), 
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medium was added and the cells were further incubated for 72 h. To avoid cell loss due to fecal 
toxicity, undiluted suspensions were removed from the wells 1h p.i., the cells were washed 2 times and 
further incubated in medium for 72 h. Then, plates were washed with PBS, air-dried (1h 37°C) and 
frozen (-20°C). The 50% tissue culture infection dose was determined after an immunoperoxidase 
staining.  Therefore, cells were fixed by incubation with PF 4% (10 minutes, RT), followed by 
incubation with methanol containing 1% H2O2 (5 minutes, RT). Then, cells were incubated with PBS 
containing 10% negative goat serum and 0.1% Tween 80 for 30 minutes at 37°C. Subsequently, cells 
were incubated with monoclonal antibodies against the N-protein (produced and characterized in the 
lab), followed by goat anti-mouse HRP-labelled antibodies. Infected cells were visualized by adding 
sodium-acetate buffer containing AEC and H2O2 for 10 minutes at RT. The 50% end-point was 
calculated according to the method of Reed and Muench. 
4.1.3.7 Leukocyte isolation 
Blood mononuclear cells were separated on Ficoll-Paque (GE Healthcare, Little Chalfont, 
Buckinghamshire, United Kingdom). After isolation, cells were counted and frozen. Briefly, 
maximum 2 x 107 cells ml-1 were resuspended in RPMI supplemented with 30% fetal bovine serum 
(FBS), 100 U penicillin ml-1, 0.1 mg streptomycin ml-1, and 10% dimethyl sulfoxide (DMSO). 
Subsequently, cells were frozen by lowering the temperature with 1°C min-1 until -30°C, followed by a 
15 min incubation period at -30°C and finally lowering the temperature to -150°C at a rate of 1°C s-1 
(PTLPD81, Orthodyne, Alleur, Belgium). After freezing, cells were stored in liquid nitrogen. 
4.1.3.8 Antibodies used for leukocyte staining 
Monoclonal antibodies against the epsilon chain of feline CD3 (NZM1) and against feline CD56 
(SZK1) were kindly provided by Dr. Yorihiro Nishimura (Tokyo University, Japan) (Shimojima et al., 
2003). Monoclonal antibodies recognizing feline CD25 were produced by the hybridoma 9F23.3, 
which was purchased from North Carolina State University (Raleigh, North Carolina, USA). 
Monoclonal antibodies FE5.4D2, CA16.3E10, YFC120.5 and CA2.1D6 recognizing feline CD8β, 
canine CD11b, human CD16 and canine CD21 respectively, were purchased from AbD Serotec 
(Dusseldorf, Germany). A monoclonal antibody DREG56, cross reactive with feline CD62L, was 
purchased from Acris antibodies (Hereford, Germany). A monoclonal antibody (FJK-16s), directly 
conjugated with Alexa fluor 647 (AF647) and crossreacting with feline Foxp3 was purchased from 
eBioscience (San Diego, USA). Monoclonal antibody CAT30A against feline CD4 was purchased 
from Veterinary Medical Research and Development (VMRD, Pullman, USA). Conjugated secondary 
antibodies [Molecular Probes (Invitrogen, Carlsbad, USA)] were goat anti-rat Alexa Fluor 488, goat 
anti-mouse IgG R-Phycoerythrin (R-PE), goat anti-mouse IgG2a Alexa Fluor 488, goat anti-mouse 
IgG1 Alexa Fluor 647 and goat anti-mouse IgG3 fluorescein isothiocyanate (FITC). When primary 
antibodies from the same IgG1 isotype were used, one primary antibody was labeled with Zenon 
Alexa Fluor 488 Mouse IgG1 (Invitrogen, Carlsbad, USA). 
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4.1.3.9 Leukocyte staining 
Phenotyping of cells from all compartments was performed simultaneously. All analyzed cells were 
first stored in liquid nitrogen, facilitating analysis workflow. Several precautions were taken in order 
to preserve immunophenotypic properties as was done in previous research (Vermeulen et al., 2012b). 
Briefly, cells were frozen directly after isolation, they were stored at -196°C for the entire storage 
period and viability of thawed cells was routinely 80-90%. A minimum of 1 × 106 of frozen cells were 
stained for phenotypic analysis in RPMI supplemented with 1 mM Ethylenediaminetetraacetic acid 
(EDTA). Cells were incubated for 20 min at 4°C while gently shaking, both with the primary and dye-
conjugated secondary antibodies. Cells were washed with cold RPMI containing EDTA and 
centrifuged at 300g for 10 min at 4°C. Staining the surface molecules CD8, CD11b, CD16, CD25 and 
CD62L was performed in combination with CD56 and CD3. During T  regulatory cell staining, 
surface molecules were first stained (CD3, CD4, CD8 and CD25) after which cells were fixed with the 
fixation/permeabilization kit optimized for staining of intracellular Foxp3 (eBioscience, San Diego, 
USA). Cells were then stained with anti-Foxp3 antibody, directly conjugated with AF647. Analysis 
was done on a FACSCanto flow cytometer using FACSDiva software (BD Biosciences, Mountain 
View, California, USA). After singlet gating, a minimum of 2 × 105 events was analyzed.  
4.1.3.10 In vitro restimulation assay 
An in vitro restimulation assay, optimized by Vermeulen et al. (2012b) (Chapter 3.1), was used to 
evaluate lymphocyte proliferation responses against both infectious and inactivated FECV and FIPV 
(Vermeulen et al., 2012b). Some modifications were made to make this analysis possible. The source 
for both antigen presenting cells (mDCs) and effector cells (lymphocytes) was blood taken at 28 days 
p.i.. This time point was selected to allow detection of proliferating FECV-specific memory effector
cells and to burden the cats not too heavy early in the experiment. Briefly, mDCs were generated by 
incubating 2 x 105 ml-1 monocytes in complete RPMI 1640 medium (Invitrogen) containing 10 % FBS 
(Greiner Bio-one, Kremsmuenster, Germany), 100 U ml-1 penicillin, 0.1 mg ml-1streptomycin, 0.1 mg 
ml-1 gentamycin, 1 mM sodium pyruvate and 1 % non-essential amino-acids (100x), supplemented 
with 10 ng ml-1 recombinant feline IL-4 and 50 ng ml-1 recombinant feline granulocyte macrophage 
colony-stimulating factor (GM-CSF) (R|D systems, Minneaoplis, Minnesota, USA) during 7 days. For 
antigen presentation, mDCs were incubated for 1 hour with infectious FECV or for 3 hours with 
equivalent UV-inactivated amounts FECV (180 mJ cm-2). FECV that was used to stimulate the cells 
was the same UCD-1 strain that was used to inoculate the cats. However, since the inoculum was a 
centrifuged fecal suspension, virus was first passaged two times on the newly developed colonocyte 
cell line. Culture supernatant was then ultracentrifuged (32.000 rpm, 2 h at 4°C) to obtain pure virus in 
PBS. The pelleted virus was then subsequently quantified with RT-PCR. The amount of virus that was 
brought on mDC was then adjusted to 1 x 1010 FECV RNA copies/ml. The same strategy was 
followed to obtain pure FIPV, only starting from collected ascites from a cat naturally infected with a 
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serotype I FIPV. This ascites was ultracentrifuged, quantified and brought onto the cells at the same 
concentration (1 x 1010 FIPV RNA copies/ml). After antigen pulsing, mDCs were further incubated for 
4 days at 37°C, 5 % CO2 in complete medium with 0.05 mM 2-mercaptoethanol (ME) (Invitrogen) 
together with 5 x 105 ml-1 homologous non-adherent cells (effector cells). Cells were then stained for 
proliferation with the FITC BrdU flow kit according to manufacturer’s instructions (Becton, 
Dickinson and Company, New Yersey, USA). Additionally, cells were stained with surface markers 
against CD3 and CD8 to identify the proliferating cell population. Analysis was done by flow 
cytometry (FACSCanto, Becton, Dickinson and Company). Data were analyzed using FACSDiva 
software. 
4.1.3.11 Statistical analysis 
Statistical comparison of means was performed by Mann-whitney U tests while correlation was 
assessed by the Spearman correlation test in SPSS 20.0 (SPSS Inc., Chicago, Illinois, USA). 
Significant differences were considered if P ≤ 0.05. 
4.1.3.12 Animal welfare 
This study was performed according to animal welfare guidelines. Under the application EC2012/043, 
this research was positively evaluated by the Ethical Committee of the Faculty of Veterinary 
Medicine, Ghent University. 
4.1.4 Results 
4.1.4.1 Course of FECV infection after oral inoculation: clinical symptoms, viral shedding and 
viremia 
Clinical symptoms were only visible during the first week p.i. Two cats (cat 1 and 3) showed a 
diminished appetite, resulting in weight loss (up to 84% of the original weight) (Fig 4.1-B). From 9 
days p.i., these cats started to recover and reached their normal weight at 21 days p.i. Cat 2 showed no 
symptoms in that period. However, response to infection was noticed in this cat since enlarged 
submandibular lymph nodes were present 3 days p.i. This cat developed a short fever at day 7 p.i.. 
Concerning the other 2 cats, one cat displayed several peaks of fever (day 4, 6 and 9) (Fig 4.1-A) and 
the other one did not develop fever at all over the entire experiment. Consistency of the feces remained 
normal in all cats during the entire experiment. 
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Directly after oral inoculation, only a fraction (106.55 - 107.47 copies) of the viral inoculum was found in 
the mouth, indicating that all cats had swallowed most of the inoculum (Fig 4.2). In 1 cat, oral viral 
RNA could not be detected the next day, whereas in the 2 other cats, oral viral load remained at 
relatively high levels for 2 additional days. Thereafter, oral viral load and days of detection varied 
considerably between cats (Fig 4.2-A). 
At 2-4 days post inoculation, viral RNA was first detected in the feces of cats 1 and 3(Fig 4.2-B), 
peaked at 5 days p.i. and remained at detectable levels for another 2 months. In cat 2, viral RNA 
appeared 2 days p.i., but disappeared afterwards and was not detected anymore until 14 days p.i., from 
which fecal shedding remained positive for the remainder of the experiment. This suggests that there 
was no productive intestinal viral replication the first week p.i..  
 
Figure 4.1: Clinical parameters 
during the entire FECV infection 
course. Analyzed parameters were 
rectal temperature (A) and weight 
(B). The line in A represents the 
cutoff value for the determination 
of fever (39.1°C).  
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The development of a new colonocyte line (Desmarets et al., 2013) allowed to quantify infectious 
virus in feces. Results revealed infectious virus titers of up to 1 x 103 mg-1 feces for cats 1 and 3 
starting from 4 days p.i. until 28 days p.i. In cat 2 with the delayed shedding pattern, infectious virus 
could not be isolated at any of the time points (Fig 4.3).  
Figure 4.2: Virus quantification in the 
oral fluid (A) and feces (B) as 
analyzed by real time RT-PCR and 
shown as viral RNA copies from 
respectively 1 oral swab or 1 mg of 
feces. The horizontal lines represent 
the detection limit. 
Figure 4.3: Shedding of infectious 
virus in feces as determined by 
virus titration on a newly 
developed colonocyte line. The 
missing points represent moments 
where no feces could be collected 
(only swabs) and thus sufficient 
material was absent to allow 
analysis. The horizontal line 
represents the detection limit. 
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4.1.4.2 Immunological parameters 
4.1.4.2.1 Neutralizing antibody responses 
Quantification of coronavirus-specific neutralizing antibodies (Nab) revealed that cat 1 and 3, which 
both displayed an active intestinal replication during the first week p.i., had detectable antibody levels 
starting from 9 days p.i. (Fig 4.4). Similarly, seroconversion of cat 2 occurred 21 days p.i., which is 
after the first signs of virus replication (14 days p.i.). Nab titers peaked 1-4 weeks after seroconversion 
and slowly decreased but remained detectable afterwards. 
 
4.1.4.2.2 General haematological parameters 
Analysis of general leukocyte subsets (Fig 4.5) revealed that T cells (CD3+) showed a high (± 50% 
increase) and a low (± 40% decrease) in cats 1 and 2 at respectively 3 and 5 days p.i. At 14 days p.i., 
cat 1 had the lowest amount of peripheral T cells (770 T cells µl-1 blood) and at 21 days p.i., all cats 
had low peripheral T cell numbers (cat 1: 1308 cells µl-1; cat 2: 1526 cells µl-1; cat 3: 1363 cells µl-1) 
which slowly resolved and resulted in high numbers at  56 days p.i.. Staining for B cells (CD21+) 
revealed more or less the same fluctuation as was shown for T cells. When monocytes and 
granulocytes were analyzed, more fluctuation in numbers was noted, however this was cat dependent. 
As for monocytes, cat 1 shows progressively declining numbers until day 14 p.i. (7 cells µl-1 blood) 
after which numbers rose again to pre-infection levels. Cat 2 showed the same trend until 7 days p.i. 
(24 cells µl-1 blood) returning to pre-infection levels afterwards with another low point at 21 days p.i. 
(42 cells µl-1 blood). Finally, cat 3 shows progressively increasing levels until 7 days p.i., thereafter 
points with pre-infection levels (9, 21 and 84 days p.i.) and points with highs were seen (at 14, 28 and 
56 days p.i. respectively 1310, 539 and 938 cells µl-1 blood). Staining for granulocytes revealed a 
severe decrease in numbers for cat 1, starting from 3 days p.i., with the lowest point at 9 days p.i. (211 
cells µl-1 blood) and returning to normal levels at 28 days p.i.(~4500 cells µl-1 blood). 
Figure 4.4: Neutralizing 
antibody response during 
the entire FECV infection 
course. 
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Figure 4.5: Quantification of several leukocytes µl-1 blood during the entire FECV infection course. Analyzed cells were T 
cells (A), B cells (B), monocytes (C) and granulocytes (D). Two horizontal dashed lines represent reference ranges in 
healthy animals for each subset (A | B (Vermeulen et al., 2012a), C | B (Latimer, 2011)). 
Cat 2 and 3 showed trends similar to each other, with an increase in numbers at 3 days p.i. (± 100% 
increase), after which numbers stayed constant around pre-infection levels with the exception of 
another peak at 56 days p.i. (± 120% increase). Both T and B cell numbers were significantly 
correlated with viral RNA load (Fig 4.7-A | Fig 4.7-B) while both monocyte and granulocyte numbers 
were uncorrelated with viral RNA load (Fig 4.7-E | Fig 4.7-F).  
4.1.4.2.3 NK cells and regulatory T cells 
Fig 4.6 shows the NK cell frequencies during the infection course of FECV. All cats started with ~300 
CD3-CD56+ cells µl-1 blood which slowly declined with the lowest point at 14-21 days p.i. at ~50 
CD3-CD56+ cells µl-1 blood, after which NK cell count rose again to pre-infection levels. NK cell 
numbers were shown to be significant negatively correlated with viral RNA load (Fig 4.7-C).  
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Figure 4.7: Linear correlation of 
both the mean amount of several 
cell types (T cells (A), B cells (B), 
NK cells (C), Tregs (D), monocytes 
(E) and granulocytes (F)) and the 
mean percentage of NK cells 
expressing CD16 (G) with the 
mean amount of virus (quantified 
as number of viral RNA copies mg-
1 feces). Correlation was analyzed 
through the spearman correlation 
test as indicated by r. The level of 
significance is indicated by p 
(significant if ≤ 0.05) (n = 3). 
Figure 4.6: Quantification of regulatory 
leukocytes µl-1 blood during the entire 
FECV infection course. Analyzed cells were 
NK cells (CD3-CD56+) (A) and classical 
regulatory T cells (CD4+CD25+Foxp3) (B) 
and CD8+ regulatory T cells 
(CD3+CD8+Foxp3+) (C). Two horizontal 
dashed lines represent reference ranges in 
healthy animals for NK cells and Tregs 
(Vermeulen et al., 2012a). 
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Some clear trends in surface phenotype were seen (Fig 4.8). CD16 was expressed on 10-20% more 
cells starting from 3-7 days p.i. and lasting until the end of the experiment. Curiously, the CD16 
expression was significantly positive correlated with viral RNA copies (Fig 4.7-G). Similarly, CD25 
was also expressed on 10-20% more cells. Expression peaked at 5-7 days p.i. after which it returned to 
normal at 14 and 21 days p.i.. For cats 2 and 3, expression rose again towards the end of the 
experiment. CD62L expression only showed one peak at 7 days p.i. with a 50 to 150% increase in 
expressing cells. For CD3, CD11b and CD8, less distinct and uniform trends were seen. Only in cat 3, 
CD3 expressing cells rose in numbers at 5 to 9 days p.i. while in cat 2 the opposite was noted and in 
cat 1 no differences were seen in this time frame. As for CD8 expressing cells, all cats show a rising 
trend during the first days (3, 5 and 7 days p.i.), after which they return to normal at 9 – 14 days p.i. 
with another rise in expressing cells at 21 or 28 days p.i.. CD11b expression showed a peak with 50 to 
100% more expressing cells at  7 days p.i. for cats 1 and 3 while cat 2 showed a low at that time point. 
Figure 4.8: The amount of CD56+ cells expressing CD3 (A) and the amount of NK cells (CD56+CD3-) expressing CD8 (B), 
CD11b (C), CD16 (D), CD25 (E) and CD62L (F).  
Staining for Tregs (Foxp3+CD4+CD25+) revealed a progressive reduction in absolute numbers (Fig 
4.6-B) (pre-infection levels were ~100 Tregs µl-1 blood) starting from day 9 until day 28 p.i. with low 
numbers of 15 Tregs µl-1 blood. Additional staining for CD8+ revealed that CD8+ Treg numbers (% 
Foxp3+ cells positive for CD3 and CD8) were elevated until day 7 p.i. for cat 2 (± 200% increase) 
while cats 1 and 3 showed rather decreases in CD8+ Treg numbers of up to 50%. At day 14 p.i. CD8+ 
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Treg numbers were lowered for all cats, reaching their pre-infection levels back at day 84 p.i.. Treg 
numbers were uncorrelated with viral RNA load (Fig 4.7-D). 
4.1.4.2.4 Proliferation response upon in vitro restimulation with FECV and FIPV using mDC as 
APC 
Analysis of specific lymphoproliferative responses revealed significant higher proliferative responses 
in the CD8- T cell population (19.0 ± 9.3 %) compared to the mock infected control (4.0 ± 4.3 %) 
when mDCs were primed with infectious FECV (Fig  4.9). When inactivated FECV was presented, a 
significant higher proliferation was only detected in the CD8+ T cell population (2.1 ± 1.2 %) when 
compared to the mock treated control (0.4 ± 0.4 %). No response could be detected when either 
infectious or inactivated FIPV was presented to mDCs. All three cats showed similar patterns, so 
results are given as the mean of the three cats. Quantification of IFN-γ in culture supernatant revealed 
no detectable IFN-γ in any of the culture supernatant analyzed (results not shown). 
4.1.5 Discussion 
Clinical, virological and immunologic responses against FIPV have been frequently studied. During 
infection with FECV however, little to no information is available, especially on the presence of 
infectious virus, neutralizing antibodies (Nabs) and cell-mediated immune responses (CMI). 
Therefore, this study aimed to evaluate clinical responses, to quantify virus (virus RNA copies and 
infectious virus in both oral fluids and feces), to perform neutralizing serology, to quantify general cell 
subsets (T and B cells, monocytes, granulocytes), regulatory T cells and natural killer cells and to 
assess T cell proliferation in response to FCoV antigens during experimental infection with a serotype 
I FECV strain. 
Clinical signs were moderate to unapparent, depending on the cat evaluated. Diarrhea was never 
observed. Cat 1 showed some low fever (< 40°C) up till the ninth day p.i. while cat 2 showed fever on 
one occasion (7 days p.i.). Cat 3 did not develop fever during the whole experiment. During the first 2 
Figure 4.9: Percentage proliferating T 
lymphocytes in response to both infectious and 
inactivated FECV and FIPV in FECV-inoculated 
cats using monocyte derived dendritic cells as 
antigen-presenting cells. Results are shown as 
mean ± SD (n=3). Significant differences 
between mock-treated and virus-treated 
conditions (p ≤ 0.05) are indicated with an 
asterix (*). 
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weeks p.i., cat 1 showed some moderate weight loss (<5% of pre-infection weight) while cat 3 lost up 
to 13% of its pre-infection weight. Cat 2 did not lose weight during the experimental period. Only in 
cat 2, submandibular lymph nodes were clearly swollen at 7 days p.i.. These findings are in 
accordance with other studies and corroborate the low pathogenicity of FECV (Pedersen et al., 2008; 
Vogel et al., 2010). 
Virus was detected in oral swabs of two cats until 2 days after inoculation. This brief period was 
followed by inconsistent oral shedding over 21 days that was uncorrelated with fecal shedding. Oral 
shedding has been described earlier, both with oral FECV and FIPV infections (Stoddart et al., 1988b; 
Addie and Jarrett, 2001). Like proposed by Stoddart et al. (1988), the early detected virus in the naso-
oropharyngeal cavity is most probably the consequence of virus replication in tonsils. In these oral 
lymphoid tissues, lots of monocytic cells are present, which could be the target cell as they have been 
shown to be susceptible for FECV (Dewerchin et al., 2005; Arzi et al., 2011). These findings propose 
a route of infection through naso-oropharyngeal mucosal tissues much like has been found in equine 
herpes virus 1, equine arteritis virus, Epstein-Barr virus and human/feline immunodeficiency virus 
(HIV and FIV) infections (Perry and Whyte, 1998; Obert and Hoover, 2002; Gryspeerdt et al., 2010; 
Vandekerckhove et al., 2011; Vairo et al., 2012).  
Viral RNA quantification in feces showed two distinct patterns. In cats 1 and 3, virus could be 
detected from 2-4 days p.i., peaking at 5 days p.i. and then showing a plateau until 28 days p.i., 
diminishing at 56 days p.i. and becoming undetectable 84 days p.i. This pattern is reminiscent of most 
literature with experimental FECV infections to this point (Pedersen et al., 2008; Vogel et al., 2010). 
The second pattern showed a delayed fecal shedding from cat 2 as demonstrated by viral RNA 
quantification. It is unlikely that this was the result of a failed primary infection since virus was 
detected in oral fluids during the first days post inoculation. Infectious virus could only be detected 
(on a newly developed ileocyte and colonocyte cell line) in fecally shed virus from cat 1 and 3 
between 4 and 28 days p.i.. This finding, together with the different courses of virus RNA copies 
between cats 1 and 3 on the one hand and cat 2 on the other hand and the earlier described virus 
replication in the naso-oropharyngeal cavity (vide supra), encourage the idea of a new route of 
infection, based on the tropism of FECV for cells of the monocytic lineage.  
The kinetics of the antibody response to an experimental FECV infection (9 days p.i.) are in 
accordance with earlier reports (Pedersen, 1995). However, it is the first time that neutralizing 
antibodies were evaluated because an appropriate cell line to perform the neutralizing assay was 
lacking up til now. From our results it became clear that neutralizing antibodies against FECV do not 
block virus replication in vivo. How FECV escapes from neutralization by antibodies is not clear. 
When analyzing general peripheral leukocyte subsets, no major changes were noted. Some smaller 
trends, could be detected such as high T and B cell counts (for cat 1 and 2) at 3 days p.i. and low cell 
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counts for T and B cells between 5 and 21 days p.i.. The drop in monocytes in cats 1 and 2 and the 
drop in granulocytes in cat 1 can be explained by homing to sites of infection/inflammation (i.e. the 
gut) (Muller, 2001) where they form one of the first barriers of the innate immune system and acquire 
antigens for later presentation. Earlier research also showed higher leukocyte counts at 2 days p.i. and 
lower counts at 5 days p.i. and attributed this to an absolute neutropenia. Although in our research, 
neutropenia (neutrophils are the main granulocyte subset) could only be seen in cat 1, the leukocyte 
increase and decrease at respectively 3 and 5 days p.i., are the result of a combined increase or 
decrease of T, B and granulocyte cells (Pedersen et al., 1981). These deviating results might be the 
consequence of differences in the studied animals (with regard to immunity maturation, kittens versus 
adults) and different detection techniques (manual cell counts versus flow cytometry). More recently, 
Vogel et al. (2010) did not detect any change in lymphocyte numbers. However, the authors did not 
perform absolute numbering nor specific staining for any subsets, making comparison of results 
difficult (personal communication Prof. P. Rottier) (Vogel et al., 2010). 
Given the prolonged virus shedding and the absence of major changes in cell frequencies, a role for 
regulatory cells might be proposed. Therefore, focus was placed on Tregs and NK cells. Both these 
cell types haven been shown to be crucial in several virus infections where they can influence both 
adaptive and innate immune responses (Andoniou et al., 2006; Zhang et al., 2006; Li et al., 2008).  
When NK cell frequencies were followed during the first three months after infection with FECV, a 
progressing reduction in NK cell numbers was revealed, which slowly resolved starting from 21 days 
post infection (p.i.). This could be caused by peripheral NK cell homing to places of infection, i.e. 
enterocytes or to lymphoid tissues (e.g. mesenteric lymph node that directly drains the gut), where 
they can stimulate a developing adaptive immune response or directly lyse viral infected cells (Martin-
Fontecha et al., 2004; Kipar et al., 2010). The number of cells was negatively correlated with the fecal 
virus RNA copies, proposing a crucial role for NK cells in the anti-FECV immune response.  
Besides cell frequency, the phenotype can also play an important role in the functional status of a cell 
type (Morishima et al., 2006). In a second part, the phenotype of NK cells originating from blood was 
evaluated according to Vermeulen et al. (2012a) during the entire FECV infection. This revealed rising 
CD16+ NK cell percentages starting from day 5 which stay high until the end of the experiment (day 
84 p.i.). CD16 is a low affinity Fc receptor (FcγRIII) which has only recently been shown to be 
present on feline cells and is involved in antibody-dependent cell mediated cytotoxicity (ADCC) and 
production of cytokines such as IFN-γ and TNF-α when cross linked (Marquez et al., 2010; 
Vermeulen et al., 2012a). Curiously, CD16 expression on NK cells was significantly positively 
correlated with the amount of fecal virus RNA copies. This could indicate that NK cells respond to 
virus presence with a higher cytotoxic phenotype in addition to the higher numbers seen earlier. 
Alternatively, CD16- NK cells could preferentially migrate to sites of virus replication (i.e. gut 
mucosa) (Reeves et al., 2010). Similarly, CD25+ (α-chain of the IL-2 receptor) NK cell percentages 
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also show a rising trend starting at day 3-5, peaking at day 7-9 and returning to pre-infection levels at 
day 14 p.i. CD25 is generally considered to be an activation marker and more specifically for NK cells 
a marker for their proliferative potential (Clausen et al., 2003). This could reflect the important role 
that NK cells play in early innate responses against viral infections. Surprisingly, at day 28 p.i., all cats 
showed an additional peak in NK CD25 expression. This could be the result of the homeostatic 
proliferation of NK cells that typically follows virus-induced lymphopenia (Sun et al., 2011) which is 
also supported by the rise in NK cell numbers starting from day 28 p.i. Additional CD62L (L-selectin) 
staining showed a peak at day 7 p.i.. This adhesion molecule is of key importance for trafficking to 
lymphoid organs, inflamed tissues and during certain cell-cell interactions (Rosen, 2004). The peak 
increase might reflect a NK migration pattern to lymphoid tissue to aid in the developing cellular 
immune response, similar to human immunology (Martin-Fontecha et al., 2004). 
Staining feline NK cells for CD8 and CD11b revealed no distinct patterns, making it difficult to assess 
the role of these markers during FECV pathogenesis. The same conclusion can be drawn for NKT 
(CD3+CD56+) cells since different patterns were seen for each cat. 
FECV infection is thus characterized by a transient NK cell reduction in peripheral blood which is 
probably the result of migration of NK cells to infected tissue (i.e. gut epithelial cells) and lymphoid 
tissue (as was demonstrated by elevated CD11b and CD62L expression). Furthermore, NK cells 
showed an activated phenotype with elevated CD25 and CD16 expression, in addition to higher 
amounts of CD8+ NK cells, a highly cytotoxic subset of NK cells.  
When Tregs were quantified in the peripheral blood, FECV infection appeared to be characterized by a 
transient lowered amount of peripheral Tregs which can be explained by specific trafficking to sites of 
infection/inflammation (i.e. the gut) or lymphoid tissue similar to infection with dengue virus, another 
RNA virus which shares some clinical findings with FIPV infection (Luhn et al., 2007). In turn, this 
can lead to a decreased capacity to completely eradicate FECV from the gut. Analogous results were 
seen in HIV/SIV infection, two viruses that use the gastrointestinal tract as major replication sites and 
which are correlated with higher Treg numbers in gut mucosa (Allers et al., 2010).  In contrast to our 
results, several chronic and acute virus infections are nearly always correlated with either an increase 
in peripheral Treg frequency or function (Li et al., 2008). However, gut immunology seems to differ 
quite a lot from systemic immunity, especially given the fact that the gut has regulatory systems in 
place to induce tolerance against commensal bacteria and food antigens, systems where Tregs play a 
vital role. Manipulation of Tregs through accumulation or activation at sites of infection could cause 
immune tolerance against pathogenic micro-organisms as is exemplified by protozoan (Leishmania 
Major), nematodic (Heligmosomoides polygyrus) and bacterial (Heliobacter pylori) infections  
(Belkaid, 2007; Bilate and Lafaille, 2012).  
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Additionally, a role for CD8+ Tregs is suggested by the correlation of CD8+ Treg numbers and virus 
shedding. Although this small subset has recently gained a lot of interest in the context of gut 
immunity to colorectal cancer, graft-to-host disease and rectal HIV/SIV infections where they are 
associated with suppressed immunity, not much is known about their in vivo development (Chaput et 
al., 2009; Nigam et al., 2010; Beres et al., 2012).  
As pointed out by Pedersen and Floyd (1985), it was notoriously difficult in the past to detect feline 
cellular immune responses against feline coronaviruses. However, with little adaptation of an earlier 
developed technique, it became possible to detect these (Vermeulen et al., 2012b). To evaluate 
lymphoproliferative responses to both inactivated and infectious FECV and FIPV, the assay had to be 
adjusted a little since no well-performing vaccine exists against either FECV or FIPV. Frozen PBMC 
(originating from blood taken at 28 days p.i.) were seeded to generate the monocyte-derived dendritic 
cells (mDCs) necessary for antigen-presentation, the same frozen PBMC also served as a source for 
effector cells (lymphocytes). Virus-stimulant was FECV UCD grown on a newly developed enterocyte 
cell line. Results indicated that cats infected with FECV mount a cellular immune response, as 
indicated by the lymphoproliferative response. Curiously, CD8- lymphocytes only seem to proliferate 
in response to infectious FECV. This contrasts with earlier results obtained with FCV, FPV and 
FeHV-1, where all inactivated viruses elicited strong CD8- proliferation responses. However, all cats 
were vaccinated three times with an attenuated vaccine, while here an actual infection occurred, which 
may have additional immune evasive consequences (such as lymphocyte depletion) and which may 
not be as strong as repeated exposure to antigen. As a result, the immune system might require 
relatively more antigen to be stimulated again, explaining the need for infectious virus that can 
multiply and intensify the antigen load. Additionally, although it can be detected throughout the body, 
FECV infection is mainly constricted to the gut, which differs significantly in terms of immunity from 
systemic immunity (Kipar et al., 2010). These differences mainly lie in the migration of 
memory/effector cells to effector sites and in a self-limiting response protecting the gut inductive 
lymphoid tissue which can mask generated immunological memory (Brandtzaeg, 2007). Further, no 
proliferation could be detected with either inactivated or infectious FIPV. This indicates there may be 
no cross immunogenicity which may partially explain why FECV recovered cats can still develop FIP 
(Kiss et al., 2004). Remarkably, IFN-γ could not be detected in any of the culture supernatants. This 
suggests that a Th2 response is initiated rather than a Th1 response. Further analysis of supernatant, 
detecting Th2 cytokines such as IL-4, IL-5 and IL-6 would further consolidate this hypothesis. 
Possibly, the addition of infectious or inactivated whole feline coronavirus can (re)direct the immune 
response to a Th2 response, which is arguably less effective against intracellular viral pathogens. This 
has been found for hepatitis B virus infections, where different peptides can generate either a Th1 or 
Th2 response (Huang et al., 2006). The latter consisted of a non-protective humoral response which 
was mainly directed at minimizing damaging immunopathology (Milich et al., 1997). A Th2 response 
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is correlated with a strong humoral immunity, however feline coronaviruses seem to be especially 
equipped to evade humoral responses (Cornelissen et al., 2007; Dewerchin et al., 2008).  
Finally, with the recent development of a feline colonocyte line in our group, it became possible for 
the first time to titrate infectious FECV virus without the need to infect naïve cats. Results revealed a 
large discrepancy between infectious and genomic titers. This difference can be partially explained by 
the fecal nature of the inoculum that negatively influences in vitro titration. Another factor is the 
targeted 3’ genome fragment by the generally used QPCR primers. This might lead to a strong 
overestimation of the genomic titer since free RNA can also be targeted by these primers. 
To conclude, this study determined for the first time, simultaneously, the role of several lymphocytes 
during the entire infection course of FECV in three cats. Results indicate that the immune system 
functions properly, as shown by the functionality assay of T cells, the activated and migratory NK cell 
phenotype and the production of neutralizing antibodies. However, the antibodies were only functional 
in vitro, as they provide no protection from infection in vivo. Remarkably, an aberrant, delayed fecal 
virus shedding pattern was detected in one cat, and detected virus was shown to be non-infectious. 
This cat proceeded to a persistent shedding status. The generation of neutralizing antibodies was also 
delayed in this cat. This divergent shedding could not be explained by any of the assessed immune 
parameters with the exception of CD8+ Tregs, which showed a drastic increase in the aberrant shedder 
during the first week after inoculation. The data generated here will hopefully contribute to unraveling 
the complex interaction of the immune system and feline coronaviruses and could lead to 
immunotherapies targeting specific cell populations to stimulate FECV-immunity and prevent 
mutation towards the highly pathogenic FIPV. 
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4.2 Suppression of NK cells and regulatory T lymphocytes in cats naturally 
infected with feline infectious peritonitis virus 
4.2.1 Summary 
A strong cell-mediated immunity (CMI) is thought to be indispensable for protection against infection 
with feline infectious peritonitis virus (FIPV) in cats. In this study, the role of natural killer (NK) cells, 
T lymphocytes and regulatory T cells (Tregs), central players in the innate, adaptive and regulatory 
immunity respectively, was examined during natural FIPV infection. When quantified, NK cells, T 
cells and Tregs were drastically depleted from the peripheral blood, mesenteric lymph node (LN) and 
spleen in FIP cats. In contrast, mesentery and kidney from FIP cats did not show any difference when 
compared to healthy non-infected control animals. In addition, other regulatory lymphocytes 
(CD4+CD25-Foxp3+ and CD3+CD8+Foxp3+) were found to be depleted from blood and LN as well. 
Phenotypic analysis of blood-derived NK cells in FIP cats revealed an upregulation of activation 
markers (CD16 and CD25) and migration markers (CD11b and CD62L) while LN-derived NK cells 
showed upregulation of only CD16 and CD62L. LN-derived NK cells from FIPV-infected cats were 
also significantly less cytotoxic when compared with healthy cats. Although T cells were depleted 
from blood and lymphoid tissue, they still proliferated when stimulated with inactived FIPV but not 
with infectious FIPV. This study reveals for the first time that FIPV infection is associated with severe 
suppression of NK cells and Tregs, which is reflected by cell depletion and lowered cell functionality 
(only NK cells). This will un-doubtfully lead to a reduced capacity of the innate immune system (NK 
cells) to battle FIPV infection and a decreased capacity (Tregs) to suppress the immunopathology 
typical for FIP. However, these results will also open possibilities for new therapies targeting 
specifically NK cells and Tregs to enhance their numbers and/or functionality during FIPV infection. 
4.2.2 Introduction 
Feline infectious peritonitis virus (FIPV) is a coronavirus causing FIP that is characterized by 
polyserositis, vasculitis and severe lymphopenia (Addie et al., 2009). This disease has fascinated cat 
researchers for already half a century (Holzworth, 1963) but up until now, it cannot be 
treated/controlled in an efficient way. None of the conventional antivirals and therapeutics have been 
found effective against FIPV infection (Hartmann and Ritz, 2008). At present, it is the most important 
viral cause of death in cats. The current hypothesis states that FIPV arises through mutation from the 
avirulent coronavirus feline enteric coronavirus (FECV) (Chang et al., 2010b). Additionally, FIPV is 
very immune evasive, especially towards the humoral branch of immunity (Pedersen and Boyle, 1980; 
Cornelissen et al., 2007; Dewerchin et al., 2008). About 30 years ago, Pedersen and Black (1983) 
already stated that a strong cell-mediated immune response (CMI) is key to surviving a FIPV 
infection. Cats with a strong CMI would survive, while cats with weaker CMI would develop disease 
(Pedersen and Black, 1983). 
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Natural killer cells (NK) are part of the innate branch of CMI and play major roles in anti-viral control 
(Brandstadter and Yang, 2011). They can lyse virus-infected cells directly, secrete pro-inflammatory 
cytokines or modulate ensuing innate and adaptive immune responses (Jonjic et al., 2008). Regulatory 
T cells (Tregs) on the other hand are central players in the adaptive branch of CMI. They are 
characterized by the expression of CD4, CD25 and Foxp3 and function to maintain an immunological 
balance that allows resolving pathogen infection while minimizing immunopathology. Virus-induced 
enhancement of Treg function and frequencies may lead to persistent infection and possibly pathogen 
induced pathology while subversion of Tregs (virus or host induced) may cause damaging 
immunopathology (Belkaid and Rouse, 2005; Li et al., 2008). Foxp3 can also be expressed in other 
cells than classical Tregs, such as CD4+CD25- cells, CD8+ T cells and CD21+ B cells. These cells 
have been shown to be implicated in tumor immunology and autoimmunity, where they have a 
immunosuppressive role (Han et al., 2009; Leavy, 2010; Mauri and Bosma, 2012). T lymphocytes are 
central effector cells in the adaptive cell-mediated immune response, both for cytotoxicity and 
cytokine production. They have been shown to be at least partially responsible for recovery of FIP 
disease and to be affected by lymphopenia (de Groot-Mijnes et al., 2005). 
Since NK cells, T cells and Tregs represent important players in CMI and given their crucial role in 
the development of adaptive immune responses (Kos and Engleman, 1996; Robbins et al., 2007), it is 
worth to dissect their roles during a natural FIPV infection. A strong innate NK cell-mediated immune 
response is often responsible for an acute viral control, exemplified during FIV and cytomegalovirus 
infections (Zingoni et al., 2005; Howard et al., 2010), while Treg enhancement suppresses anti-viral 
responses (Li et al., 2008). NK cell deficiencies regularly lead to severe recurrent viral diseases (Wood 
et al., 2011) and Treg deficiencies lead to damaging pathology (Luhn et al., 2007).  
In order to investigate the role of NK cells, T cells and Tregs during a FIPV infection, NK cells, 
classical Tregs and other Foxp3+ T cell subsets were quantified in immunological compartments 
(blood, mesenteric lymph node (LN), spleen) and infection sites (mesentery and spleen) of both 
healthy and FIPV-infected cats. Subsequently, NK cell phenotype and both NK cell and T cell 
functionality was determined and compared between FIPV-infected cats and healthy cats.  
4.2.3 Materials and methods 
4.2.3.1 Antibodies 
Monoclonal antibodies against feline CD3ε (NZM1) and against feline CD56 (SZK1) were kindly 
provided by Dr. Yorihiro Nishimura (Tokyo University, Japan) (Shimojima et al., 2003; Nishimura et 
al., 2004). Monoclonal antibodies recognizing feline CD25 were produced by the hybridoma 9F23.3 
(North Carolina State University, Raleigh, North Carolina, USA). Monoclonal antibodies FE5.4D2, 
CA16.3E10, YFC120.5 and CA2.1D6 recognizing feline CD8β, canine CD11b, human CD16 and 
canine CD21 respectively, were acquired from AbD serotec (Dusseldorf, Germany). Monoclonal 
antibodies CAT30A and 3-4F4 against feline CD4 were purchased from Veterinary Medical Research 
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and Development (VMRD, Pullman, USA) and SouthernBiotech (Birmingham, USA), respectively. A 
monoclonal antibody DREG56, cross reactive with feline CD62L, was purchased from Acris 
antibodies (Hereford, Germany). A monoclonal antibody (10A12) against the N-protein was generated 
earlier (Dewerchin et al., 2006). During each staining, appropriate isotype-matched controls were 
used. Conjugated secondary antibodies [Molecular Probes (Invitrogen, Carlsbad, USA)] were goat 
anti-mouse IgG1 Alexa Fluor 647, goat anti-rat Alexa Fluor 488, goat anti-mouse IgG2a Alexa Fluor 
488 and goat anti-mouse IgG3 fluorescein isothiocyanate (FITC). When primary antibodies from the 
same IgG1 isotype were used, the second primary antibody was labeled with Zenon Alexa Fluor® 488 
Mouse IgG1 (Invitrogen, Carlsbad, USA).  
4.2.3.2 Animals 
Eight cats, feline leukemia virus-, feline immunodeficiency virus-negative and strongly suspected of 
naturally occurring FIP by clinicians (based on cat profile, clinical signs and blood and/or exudate 
examination) were used in this study. As control animals, six healthy, conventionally housed, feline 
leukemia virus-, feline immunodeficiency virus and feline coronavirus-negative cats, that had to be 
euthanized for health-unrelated problems, were selected (Table 1). All owners gave prior informed 
consent. FIPV infection was confirmed by performing immunohistochemistry using a monoclonal 
antibody against the N-protein (10A12) in combination with IgG1-specific FITC (Invitrogen) on 
sections of lesions on internal organs (e.g. kidney, intestine). An appropriate isotype-matched antibody 
served as control (13D12) (Nauwynck and Pensaert, 1995). The presence of lesions was determined 
macroscopically (Table 1). 
Table 1: Overview of the Cats included in this study. The upper part shows the healthy animals (HC) while the lower part 
shows the FIP-diseased animals. N.A. = Not applicable, A. Effusion = Abdominal effusion present, Lesions: M = Mesentery, 
K = Kidney, S = Spleen, Li = Liver, I = Intestines, Lu = Lungs. 
Cat Age Gender Breed A. Effusion Lesions 
HC1 2 years ♂ European shorthair N.A. N.A. 
HC2 7 years ♀ Persian shorthair N.A. N.A. 
HC3 6 years ♂ European shorthair N.A. N.A. 
HC4 2 years ♂ European shorthair N.A. N.A. 
HC5 1 years ♀ European shorthair N.A. N.A. 
HC6 3 years ♂ European shorthair N.A. N.A. 
FIP1 1 years ♂ European shorthair + M K S 
FIP2 2 years ♂ Brittish shorthair + M K S 
FIP3 5 years ♂ European shorthair + M Li I 
FIP4 1 years ♀ European shorthair - K S Lu 
FIP5 4 years ♀ European shorthair + K Li 
FIP6 1 years ♂ Brittish shorthair + M I 
FIP7 2 years ♀ European shorthair + M K I 
FIP8 7 years ♂ European shorthair + M K 
4.2.3.3 Target cell line 
Crandell feline kidney cells (CRFK) were cultured in MEM medium (GlutaMAX) supplemented with 
5% fetal calf serum (FCS) (Greiner Bio-one, Kremsmuenster, Germany), 100 U ml-1 penicillin, 0.1 mg 
101 
Chapter 4 
ml-1 streptomycin, 0.1 mg ml-1 kanamycin and 2% lactalbumin (Invitrogen). To use CRFK as target 
cells, cells in suspension (1 x 106 ml-1) were stained with carboxyfluorescein succinimidyl ester 
(CFSE) for 10 minutes at 37°C. 
4.2.3.4 Cell isolation from blood and tissue with subsequent processing 
Traditionally, mononuclear cells from blood are isolated over Ficoll-Paque, which typically produces a 
variable yield. Additionally, blood analysis by clinical labs takes some time to be performed, which 
can have a deleterious effect on cell viability during transport and subsequently on cell frequencies and 
functions (Bull et al., 2007). That is why in these experiments, the absolute amount of cells was 
calculated with a combination of several methods. First, 10 ml of blood was taken from the vena 
jugularis in heparin (15 U ml-1) (Leo, Zaventem, Belgium). Then, a blood smear was prepared and 
subsequently stained with a diff-quick staining (Gomez-Ochoa et al., 2012). This staining provided the 
percentage of the lymphocyte population in in the total white blood cell population. This percentage 
was then applied to the total white blood cell count from a diagnostic analysis on 1 ml of whole blood. 
This gave accurate absolute lymphocyte counts. Finally, blood mononuclear cells were separated on 
Ficoll-Paque (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom). Staining of the 
(frozen) mononuclear cells (vide infra) then allowed identification and absolute quantification of all 
lymphocyte subsets. One cm2 of kidney cortex, containing lesion tissue if possible, and most of the 
mesentery was dissected from all cats and weighed afterwards. Cells in tissue were isolated by passing 
subsequently through tissue grinders (250 µM mesh) (Sigma-aldrich, St. Louis, Missouri, USA) and 
cell strainers (70 µM mesh) (Becton, Dickinson and Company, New Yersey, USA). After isolation, 
cells were counted, frozen (PTLPD81, Orthodyne, Alleur, Belgium) and stored at -196°C in liquid 
nitrogen. 
4.2.3.5 Quantification and phenotyping of natural killer cells 
Phenotyping of NK cells was performed as previously described (Vermeulen et al., 2012a). Briefly, a 
minimum of 1 x 106 isolated cells was stained at 4°C for the surface molecules CD8, CD11b, CD16, 
CD25, CD62L in combination with CD56 and CD3. Analysis was done on a FACScanto flow 
cytometer using FACSDiva software (BD Biosciences, Mountain View, California, USA).  
4.2.3.6 Quantification of Foxp3+ subsets 
Frozen isolated cells (1 x 106) were thawed and immediately stained for phenotypic analysis in RPMI 
supplemented with 1 mM ethylenediaminetetraacetic acid (EDTA). Cells were incubated for 20 min at 
4°C while gently shaking the cells, both with the primary and dye-conjugated secondary antibodies. 
Cells were washed with cold RPMI with EDTA and centrifuged at 300xg for 10 min at 4°C. After 
staining of surface molecules (CD3, CD4, CD8, CD21 and CD25) cells were fixed with the 
fixation/permeabilization kit optimized for staining of intracellular Foxp3. Cells were then stained 
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with anti-Foxp3 antibody, directly conjugated with AF647. Analysis was done on a FACScanto flow 
cytometer using FACSDiva software (BD Biosciences, Mountain View, California, USA).  
4.2.3.7 Natural killer cell purification 
As previously described, NK cells were identified through CD3 and CD56 staining followed by cell 
sorting on a FACS ARIAIII flow cytometer (BD Biosciences) (Vermeulen et al., 2012a). Typical NK 
(CD3-CD56+) cell counts were between 5 x 103 and 2 x 104 cells per ml blood or µg tissue, while 
NKT (CD3+CD56+) cell counts varied  between 5 x 102  and 2 x 103 cells per ml blood or µg tissue. 
Purity of the sorted cell populations was routinely >97%.  
4.2.3.8 NK functionality assay 
The functionality assay was performed as previously described, with minor modifications (Vermeulen 
et al., 2012a). Briefly, 5 x 104 target cells (CFSE-stained CRFK) were seeded in V-bottomed 96-well 
plates (Nunc, Langenselbold, Germany). Subsequently, target cells were cocultured for four hours 
with a varying amount of activated NK cells (activated with rHu IL-2 for 18 h (Invitrogen)). Evaluated 
effector/target cell ratios were: 0 - 1 - 5 - 10. The percentage of lysed cells was calculated as: 
4.2.3.9 In vitro restimulation assay to assess T cell proliferation 
An in vitro restimulation assay, optimized by Vermeulen et al. (2012b) (Chapter 3.1), was used to 
evaluate lymphocyte proliferation responses against both infectious and inactivated FECV and FIPV 
in three selected cats (FIP 1, 2 and 3), naturally infected with FIPV. Some modifications were made to 
make this analysis possible. The source for antigen presenting cells (to generate monocyte-derived 
dendritic cells) were isolated PBMC while the effector cells (lymphocytes) were isolated from the 
mesenteric lymph node. Due to the severe lymphopenia in blood and spleen, this approach was vital 
for a working setup. 
Briefly, mDCs were generated by incubating 2 x 105 ml-1 monocytes in complete RPMI 1640 medium 
(Invitrogen) containing 10 % FBS (Greiner Bio-one, Kremsmuenster, Germany), 100 U ml-1 penicillin, 
0.1 mg ml-1streptomycin, 0.1 mg ml-1 gentamycin, 1 mM sodium pyruvate and 1 % non-essential 
amino-acids (100x), supplemented with 10 ng ml-1 recombinant feline IL-4 and 50 ng ml-1 
recombinant feline granulocyte macrophage colony-stimulating factor (GM-CSF) (R|D systems, 
Minneaoplis, Minnesota, USA) during 7 days. For antigen presentation, mDCs were incubated for 1 
hour with infectious FECV or for 3 hours with equivalent UV-inactivated amounts FECV (180 mJ cm-
2). FECV that was used to stimulate the cells was the FECV UCD strain. Virus was first passaged two 
times on a newly developed colonocyte cell line (Chapter 4.1), in order to lose the detrimental effect 
from the fecal material in the original virus stock. Culture supernatant was then ultracentrifuged 
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(32.000 rpm, 2 h at 4°C) to obtain pure virus in wPBS. The pelleted virus was then subsequently 
quantified with RT-PCR. The amount of virus that was brought on mDCs was then adjusted to 1 x 1010 
FECV RNA copies/ml. The same strategy was followed to obtain pure FIPV, only starting from 
collected ascites from cat FIP1. This ascites was ultracentrifuged, quantified and brought onto the cells 
at the same concentration (1 x 1010 FIPV RNA copies/ml). After antigen pulsing, mDC’s were further 
incubated for 4 days at 37°C, 5 % CO2 in complete medium with 0.05 mM 2-mercaptoethanol (ME) 
(Invitrogen) together with 5 x 105 ml-1 homologous non-adherent cells (effector cells). Cells were then 
stained for proliferation with the FITC BrdU flow kit according to manufacturer’s instructions 
(Becton, Dickinson and Company, New Yersey, USA). Additionally, cells were stained with surface 
markers against CD3 and CD8 to identify the proliferating cell population. Analysis was done by flow 
cytometry (FACSCanto, Becton, Dickinson and Company). Data were analyzed using FACSDiva 
software. 
4.2.3.10 Statistical analysis 
Statistical analyses were performed with SPSS 20.0 (SPSS Inc., Chicago, IL, USA). For all data, 
differences between medians were assessed by Mann–Whitney U tests. Differences were considered 
significant when P≤0.05. 
4.2.3.11 Animal welfare 
This study was performed according to animal welfare guidelines. Under the application EC2012/043, 
this research was positively evaluated by the ethical committee of the Faculty of Veterinary Medicine, 
Ghent University 
4.2.4 Results 
4.2.4.1 Lymphocyte frequencies during FIPV infection 
In order to evaluate NK frequencies, cells extracted from blood, mesenteric lymph node, spleen, 
mesentery and kidney were stained with mAbs against CD56 and CD3. Fig 4.10-A shows the absolute 
numbers in each compartment in healthy and FIPV-infected cats. For blood, an average of 212±198 µl-
1 and 48±19 µl-1 NK cells was found in healthy and FIP cats respectively. Average NK cell counts in 1 
mg lymph node (LN), spleen, mesentery and kidney of healthy (H) and FIP (F) cats were 4631±2233 
mg-1 (H) | 790±504 mg-1 (F), 2748±2049 mg-1 (H) | 1047±1456 mg-1 (F), 12±11 mg-1 (H) | 29±33 mg-1 
(F) and 127±138 mg-1 (H) | 181±125 mg-1 (F), respectively. 
To quantify classical Tregs, cells were triple stained for CD4, CD25 and Foxp3. Treg staining 
(CD4+CD25+Foxp3+) (Fig 4.10-B) in the blood of healthy and FIP cats revealed an average of 50±38 
µl-1 and 3±2 µl-1 Tregs, respectively. In LN, spleen, mesentery and kidney, the average Treg counts for 
healthy and FIP cats were 2780±1804 mg-1 (H) | 140±154 mg-1 (F), 403±384 mg-1 (H) | 87±56 mg-1 
(F), 4±4 mg-1 (H) | 4±3 mg-1 (F) and 9±12 mg-1 (H) | 8±5 mg-1 (F), respectively. 
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Figure 4.10: Absolute number of NK cells (CD3-CD56+) and Tregs (CD4+CD25+Foxp3+) for healthy control cats and cats 
naturally infected with FIPV. Values are depicted as box-and-whisker plots where the whiskers refer to the minimum and 
maximum values (n=6 for healthy cats ; n=8 for FIPV cats). Comparison of numbers was done for healthy and FIPV-
infected cats in each compartment. Significant differences (P≤0.05) are indicated with an asterisk. 
Since general lymphopenia is a hallmark of FIPV infection, T and B cell counts were determined in 
blood and all tissues with CD3 and CD21 stainings (Fig 4.11). Results revealed significantly different 
T cell counts between healthy and FIP cats in blood 2206±1160 µl-1 (H) | 509±618 µl-1 (F), LN 
43859±22551 mg-1 (H) | 13371±15881 mg-1 (F) and spleen 17198±12956 mg-1 (H) | 3924±1704 mg-1 
(F), while significantly different B cell counts were only seen in blood 912±489 µl-1 (H) | 266±239 µl-1 
(F). 
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Figure 4.11: Absolute number of T cells (CD3+) and B cells (CD21+) for healthy control cats and cats naturally infected with 
FIPV. Values are depicted as box-and-whisker plots where the whiskers refer to the minimum and maximum values (n=6 
for healthy cats ; n=8 for FIPV cats). Comparison of numbers was done between healthy and FIPV-infected cats in each 
compartment. Significant differences (P≤0.05) are indicated with an asterisk. 
4.2.4.2 Assessment of NK and Treg lymphopenia 
To compare the degree of lymphopenia in the NK cell compartment to other lymphocyte populations, 
cell ratios were determined relatively to the amount of T and B cells (Fig 4.12). Results revealed 
significant differences only between ratios determined on cells isolated from the mesentery - NK/T 
0.276±0.071 (H) | 0.093±0.009 (F) and NK/B 0.510±0.240 (H) | 0.072±0.019 (F). 
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Figure 4.12: Cell ratio of NK cells (CD3-CD56+) relative to T cells (A) and B cells (B) for healthy control cats and cats 
naturally infected with FIPV. Values are depicted as box-and-whisker plots where the whiskers refer to the minimum and 
maximum values (n=6 for healthy animals and n=8 for FIPV-infected animals). Comparison of numbers was done for 
healthy and FIPV-infected cats in each compartment. The value right of the dotted line is plotted on the right Y-axis. 
Significant differences (P≤0.05) are indicated with an asterisk.   
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Similar to NK cells, Treg ratios were determined relatively to the total amount of T (CD3+, CD4+ and 
CD8+) and B cells (Fig 4.13). No significant differences could be seen in any of the compartments 
with the exception of the LN. Here, FIPV Treg ratios to all lymphocyte subsets were significantly 
lower when compared to healthy cats: Treg/CD3 0.059±0.039 (H) | 0.020±0.026 (F), Treg/CD4 
0.066±0.036 (H) | 0.032±0.048 (F), Treg/CD8 0.096±0.055 (H) | 0.030±0.033 (F) and Treg/CD21 
0.062±0.033 (H) | 0.019±0.020 (F). 
 
4.2.4.3 Other Foxp3+ regulatory subsets 
Several recent studies found important roles for other Foxp3 expressing lymphocytes in different 
immunological contexts. To examine the role of these subsets, Foxp3 expression was analyzed in 
CD4+CD25-, CD3+CD8+ and CD21+ cell populations (Fig 4.14). When the absolute numbers of 
Foxp3+ cells were compared between healthy and FIP cats, significantly lower CD4+CD25-Foxp3+ 
numbers could be seen in the blood 8.7±9.2 µl-1 (H) | 2.6±3.1 µl-1 (F) as well as in the LN 
compartment 1188.3±815.5 mg-1 (H) | 71.6±49.1 mg-1 (F) of FIP cats. The same compartments also 
had a significantly lower amount of CD3+CD8+Foxp3+ in FIP cats, in blood: 8.9±9.3 µl-1 (H) | 
2.5±3.1 µl-1 (F) and in LN: 170.1±200.9 mg-1 (H) | 9.6±7.2 mg-1 (F). Kidney tissue of FIPV-infected 
cats on the other hand, had significantly higher amounts of CD3+CD8+Foxp3+ cells in FIP cats 
1.1±0.5 mg-1 (H) | 9.1±10.3 mg-1 (F). 
Figure 4.13: Lymph node Treg cell 
ratio (CD4+CD25+Foxp3+) relative to 
CD3+ (T cells), CD4+, CD8+ and CD21+ 
cells (B cells) for healthy control cats 
and cats naturally infected with FIPV. 
Values are depicted as box-and-
whisker plots where the whiskers 
refer to the minimum and maximum 
values (n=6 for healthy animals and 
n=8 for FIPV-infected animals). 
Comparison of numbers was done for 
healthy and FIPV-infected cats in the 
lymph node. Significant differences 
(P≤0.05) are indicated with an 
asterisk. 
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Figure 4.14: Absolute quantification of several regulatory Foxp3+ subsets CD4+CD25-Foxp3+ (A), CD3+CD8+Foxp3+ (B) and 
CD21+Foxp3+. Values are depicted as box-and-whisker plots where the whiskers refer to the minimum and maximum 
values (n=6 for healthy cats ; n=8 for FIPV cats). Comparison of numbers was done for healthy and cats naturally infected 
with FIPV in each compartment. Significant differences (P≤0.05) are indicated with an asterisk. 
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4.2.4.4 Phenotypical analysis of NK cells 
Determining the cell phenotype can provide much information on the functional, migratory and/or 
activation status of a cell. NK surface phenotype was performed on cells extracted from blood, lymph 
node and spleen of healthy and FIPV-infected cats 
Figure 4.15: Comparison of the expression level of CD3 (A) on CD56+ cells and of 5 other markers: CD8 (B), CD11b (C), 
CD16 (D), CD25 (E) and CD62L (F) on NK cells (CD3-CD56+) from blood, mesenteric lymph node and spleen between 
healthy cats and naturally infected FIPV cats. Values are depicted as box-and-whisker plots where the whiskers refer to 
the minimum and maximum values (n=6 for healthy animals and n=8 for FIPV-infected animals). Significant differences 
(P≤0.05) are indicated with an asterisk. 
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When CD3 expression was compared between healthy and FIP cats, only CD56+ cells extracted from 
LN showed a significant difference 33.5±10.6% (H) | 19.7±9.4% (F) (Fig 4.14). No differences could 
be detected in CD8 cell surface expression. CD11b expression however was fourfold higher on blood . 
Cells from mesentery and kidney were too low in numbers to allow this analysis. Surface molecules 
that were co-evaluated on NK cells (CD56+CD3-) were CD8, CD11b, CD16, CD25 and CD62L (Fig 
4.15). NK cells from FIP cats 11.9±9.2% (H) | 44.4±25.3% (F). Staining for CD16 showed that a 
significantly higher number of NK cells isolated from blood and LN expressed this Fcγ receptor in FIP 
cats (blood 76±12% (H) | 90.9±9.5% (F) and LN 70.1±6.5% (H) | 80.5±8.2% (F)). The activation 
marker CD25 was also expressed on a higher proportion of NK cells isolated from blood in FIP 
compared to healthy cats: 43.1±18.8% (H) | 77.3±14.6% (F). Finally, the cell adhesion molecule 
CD62L (L-selectin) was expressed on three times more on blood- and LN-derived NK cells in FIP cats 
compared to healthy cats (blood  13.3±12.4% (H) | 39.9±17.5% (F) and LN 14.3±7.1% (H) | 
41.3±21.5% (F)). 
4.2.4.5 NK functionality 
Analysis revealed that LN-derived NK cells from FIP cats were significantly less functional than NK 
cells from control cats (Fig 4.16-A). In the LN, for an E:T ratio of 1, 5 and 10, the percentage of lysed 
cells was 24.3±5.6% (H) | 11.3±5.2% (F), 41.6±7.2% (H) | 25.1±9.0% (F) and 61.3±5.8% (H) | 
35.4±12.3% (F), respectively. In the spleen, no difference in NK cytotoxicity could be noted for E:T 
ratios 1 and 5 (Fig 4.16-B). Similar to NK cells, LN-derived NKT cells defined here as CD56+CD3+, 
isolated from healthy cats demonstrated a higher cytolytic activity (15.2±6.0%) than NKT cells from 
FIP cats (1.8±0.4%) at an E:T ratio of 1. Finally, NKT cells from spleen of both healthy and FIPV-
infected cats were uNable to lyse CRFK target cells. 
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4.2.4.6 Lymphocyte proliferation response upon in vitro restimulation with FECV and FIPV 
using mDC as APC 
In order to evaluate if the FIP cats can still mount a T cell-mediated immune response, proliferation of 
LN T cells in reaction to FIPV and FECV was assessed. Analysis revealed a strong significant signal 
in the CD8- T cell population when inactivated FIPV (11.9 ± 3.5 %) was presented to mDCs (mock 
control 4.5 ± 2.8 %) (Fig 4.17). Quantification of IFN-γ in culture supernatant revealed no detectable 
IFN-γ in any of the culture supernatant analyzed (results not shown). All cats showed similar patterns, 
so results are given as the mean of the three cats.  
 
 
Figure 4.17: Percentage proliferating T 
lymphocytes in response to both infectious and 
inactivated feline enteric coronavirus (FECV) 
and feline infectious peritonitis virus in FIP cats 
using monocyte derived dendritic cells as APC. 
Results are shown as mean ± SD (n=3). 
Significant differences between mock-treated 
and virus-treated conditions (p ≤ 0.05) are 
indicated with an asterix (*). 
 
Figure 4.16: Percentage of lysed target cells (CRFK) when 
co-cultured with different amounts of NK cells isolated 
from (A) LN and (B) spleen. Values are shown as mean 
±SEM and were compared between healthy and FIPV cats 
(n=3). Significant differences (P≤0.05) are indicated with an 
asterisk. 
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4.2.5 Discussion 
With the recent development of several cross-reactive or cat-specific monoclonal antibodies, more 
extensive analysis of specialized lymphocyte subsets, such as NK cells and Tregs has become possible 
(Lankford et al., 2008). Since these cells are involved in many virus-induced diseases and FIPV 
development is thought to be dependent on cell mediated immunity, this study aimed to investigate the 
role of these cells during a natural FIPV infection.  
First, absolute numbers of NK cells and Tregs were quantified in FIPV-infected cats and compared to 
healthy cats. This showed a drastic decrease in NK cell numbers for FIP cats in all immunologic 
compartments evaluated, with a five-, six- and three-fold reduction in blood, LN and spleen, 
respectively. For Tregs, a 17-fold, 20-fold and 4-fold reduction was noted in blood, LN and spleen, 
respectively. Remarkably, mesentery and kidney did not show any difference in NK cell or Treg 
numbers while these tissues are often involved in FIPV pathology with the formation of severe 
vasculitis and granulomas (Addie et al., 2009). 
NK cell lymphopenia is also seen during other viral infections, both human and feline. Explanations 
for this lymphopenia vary from virus-induced NK cell apoptosis to sequestration and altered 
trafficking of NK cells (Denney et al., 2010) (He et al., 2005; Mao et al., 2009; Howard et al., 2010). 
The Treg depletion that is seen during FIPV infection, somewhat contrasts other viral infections, 
which are nearly always associated with either an increase in Treg frequency or function (Keynan et 
al., 2008). One exception is HIV infection, which is characterized by decreased peripheral Treg 
numbers. However, the latter appears to result from Treg trafficking to lymph nodes and other places 
of viral replication (Andersson et al., 2005). More recent studies indicate that this Treg migration to 
sites of virus replication and lymphoid tissue is even vital for proper immune regulation (Belkaid and 
Tarbell, 2009; Campbell and Koch, 2011). In the current study, the opposite was noted, with extreme 
Treg depletion in all examined immunologic compartments. In addition, no evidence of elevated Treg 
numbers in inflamed tissue could be found. This depletion may likely contribute to the uncontrolled 
inflammatory responses that cause the typical immunopathology, which is lethal to a FIPV-infected 
cats. 
Besides regular Tregs (CD4+CD25+Foxp+), Foxp3+ regulatory cells also encompass CD4+CD25-, 
CD8+ and CD21+ regulatory cells (Morgan et al., 2005; Mizoguchi and Bhan, 2006; Noh et al., 2010). 
These cells have also been detected in cats (Lankford et al., 2008) and we verified the existence of 
these subsets in cats and detected a significant reduction of CD8+ Tregs and CD4+CD25- Tregs in 
both blood and LN  of FIPV-infected cats. Curiously, a significantly elevated number of CD8+ Tregs 
was noted in the kidney of FIPV-infected cats. This could imply an immunoevasive strategy of FIPV, 
by upregulating CD8+ Treg numbers and thus suppressing immunity at sites of infection. These cells, 
currently a hot topic in human immunology, seem to be implicated in tumor immunology and 
autoimmunity (Han et al., 2009; Leavy, 2010; Mauri and Bosma, 2012). 
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Lymphopenia is commonly present in FIP cats in both the T and B cell population in all 
immunological compartments (blood, LN and spleen) (Haagmans et al., 1996; Takano et al., 2007). 
This was verified in our setup through staining of CD21 and CD3 molecules. Indeed, severe 
lymphopenia was noticed in the T cell compartment with a four-, three- and four-fold reduction in 
numbers in blood, LN and spleen respectively. B cells however, were only significantly lowered in the 
blood with a three-fold reduction. These results are in agreement with those from Paltrinieri et al. 
(2003) who found a similar reduction in both the T and B cell compartment in blood from FIP cats. 
With regard to T cell functionality, suppression of proliferation to mitogens in FIP cats as well as 
inducement of proliferation to FIPV antigens in FIP-survivors has been frequently detected (Pedersen 
and Floyd, 1985; Stoddart et al., 1988a; Gerber et al., 1990; Knotek et al., 2000). To evaluate T cell 
functionality in this experiment, a recently developed technique was adapted to detect proliferation 
responses to inactivated and infectious coronaviruses in FIP cats (Vermeulen et al., 2012b). This 
revealed that inactivated FIPV can still induce proliferation in LN-derived T cells, which was not the 
case for infectious FIPV. These results indicate that T cells in FIP cats can still respond to FIPV 
antigens, but apparently infectious virus can suppress this response. Currently it is not clear how this is 
achieved by the virus. No reaction to FECV virus was detected. Possibly, the immune response was 
generated against mutated regions, which are involved in the pathotype switch from FECV to FIPV. 
Prominent candidates are the S and 3c proteins, both to which T cell responses have already been 
detected in FIP survivors (de Groot-Mijnes et al., 2005; Chang et al., 2012). 
To evaluate if NK cells and Tregs were more sensitive to lymphopenia than T or B cells, their 
depletion was determined relatively to T or B cells. Except for NK cells originating from the 
mesentery and Tregs originating from the LN, no significant differences could be observed. In the LN, 
Treg depletion was even more pronounced than in other lymphocyte populations, which may further 
influence immune responses since Treg homing to lymphoid tissue has been shown to be crucial for 
proper immune functioning (Zhang et al., 2009). This hypothesis may be relevant to the absence of T 
cell proliferation to infectious FIPV (vide supra). These results indicate that the T and B cell depletion, 
typical for FIP cats, is also present to a comparable extent in the NK cell and Treg compartment. This 
depletion might be the result of apoptosis, like was found for T and B cells. Roles for several 
apoptosis-inducing factors (TNF-α, TRAIL and Fas ligand) have already been proposed (Takano et al., 
2007), but need to be verified. 
In addition to cell frequency, cell phenotype also plays an important role in the functionality of a 
particular cell type (Morishima et al., 2006). Hence, the phenotype of NK cells originating from blood, 
LN and spleen were evaluated similar to Vermeulen et al. (2012) in healthy control and FIPV-infected 
cats. Due to low cell yield from the mesentery and kidney tissues, this analysis was not possible in 
these particular tissues.  
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A four-time increase in the percentage of blood-derived NK cells expressing CD11b might indicate 
that peripheral NK cells show a more mature phenotype in FIP cats, since CD11b expression is 
associated with maturation in both murine and human NK cells (Fu et al., 2011). In addition, FIPV NK 
cells could be more prone to migration to inflammatory sites or interaction with the complement 
system, since CD11b dimerizes with CD18 to form the adhesion molecule / complement receptor 
macrophage-1 antigen (Mac-1 or CR3) (Crozat et al., 2011). However, the latter seems unlikely since 
no significant higher amount of NK cells could be detected in FIPV-infected kidney or mesentery. 
Similar to CD11b, FIPV infection elevated the percentage CD16+ blood-derived NK cells. So at least 
in terms of CD16-expression, peripheral NK cells from FIP cats seem to be better equipped for 
ADCC. Although the relative increase was significant, the five-fold reduction in absolute NK cell 
numbers seen earlier, in addition to the absence of viral proteins in 50% of FIPV-infected cells and the 
rapid internalization of cell-surface bound antibodies in infected cells, somewhat lowers the impact of 
this finding (Cornelissen et al., 2007; Dewerchin et al., 2008). 
CD25 was also expressed on a higher percentage of blood-derived NK cells in FIP cats versus healthy 
cats. So even when NK cell numbers are significantly lower in FIP cats, their potential to proliferate 
appears to be much higher in comparison with normal healthy cats. This could indicate an attempt of 
the cat’s immune system to counteract the lymphopenia typical for FIPV disease. 
In addition to CD11b, CD16 and CD25, CD62L or L-selectin was also present on a higher percentage 
of blood-derived NK cells from FIP cats compared to healthy controls. The relative increase that was 
seen in our experiments could indicate that peripheral NK cells in FIP cats are more equipped to either 
migrate to the lymphoid tissues or the inflamed tissues that are ubiquitously present in an average 
FIPV diseased cat. However, NK cell enumeration did not reveal an increase in NK numbers in 
inflamed mesentery and kidney and even a major decrease in the LN. Another possibility might be that 
certain subsets (e.g. CD62L-) of NK cells are more sensitive to the FIPV induced lymphopenia, 
resulting in a relative increase in CD62L+ NK cell numbers. This is not necessarily a disadvantage for 
the FIPV diseased cats, since recent developments in human immunology indicate that CD62L could 
be used to define an intermediate state of NK cell maturation that performs both the cytotoxic as well 
as the cytokine producing functions, two functions that are normally divided between CD56dim and 
CD56bright NK subsets in blood (Juelke et al., 2010). This hypothesis however needs further 
examination with respect to feline NK cell maturation stages. 
In the LN of FIP cats, significantly more NK cells expressed CD16 and CD62L. This increase was 
comparable with that in the blood. Similar results were seen in activated, inflamed human LN where 
significant increases in CD16+ NK cell frequencies were noted in comparison to non-inflamed LN 
(Romagnani et al., 2007). The authors envisaged a system where, very early during an immune 
response, immature NK cells are recruited to LN from where they recirculate after maturation (e.g. 
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acquisition of CD16). Our findings (relative CD16+ NK cell increase in both blood and LN and a 
relative increase of CD62L+ LN NK cells ) agree with this hypothesis, giving the LN a central role in 
FIPV immunity. Lastly, FIPV LN also showed a significant decrease in relative NKT cell numbers 
(CD3+CD56+). This enigmatic subset often plays a crucial role in promoting and enhancing early 
innate and adaptive responses as has been shown for herpes simplex virus (Grubor-Bauk et al., 2008). 
Virus-induced loss of these cells could compromise the host’s capacity to control early virus infection 
and spread, resulting in higher viral loads as is the case for lymphocytic choriomeningitis virus 
(LCMV) and HIV (Tessmer et al., 2009).  
Unlike blood- and LN-derived NK cells, splenic NK cells did not show any differences in phenotype. 
Although the spleen has major roles in developing both innate and cellular immunity, it also differs 
quite a lot from other lymphoid tissues, especially with regard to cell migration. After all, in contrast 
to lymph nodes and Peyers patches, that mainly receive cells from the lymph fluid, the spleen monitors 
cells directly from the blood (Mebius and Kraal, 2005). This is also true for cat spleens, since they 
lack deep lymphatics (Blue and Weiss, 1981). 
To evaluate if the more activated NK phenotype in FIP cats leads to higher cytolytic capacities, a 
functional assay was performed on CRFK cells, similar to Vermeulen et al (2012). This test was only 
performed on NK (CD3-CD56+) cells from LN and spleen, since NK cell counts in blood from FIP 
cats were too low. NKT cells (CD3+CD56+) were also included in the functional assay, since these 
cells have recently been shown to possess NK-like cytotoxic abilities (Kuylenstierna et al., 2011). 
Results revealed NK and NKT cells isolated from LN in FIP cats to be significantly less cytotoxic 
while splenic NK and NKT cells showed no differences in cytotoxicity. This indicates that, even 
though NK cells from FIP cats show a more activated phenotype and relatively more CD16+ cells, 
they display a reduced capacity to lyse target cells in vitro, in comparison with NK cells from healthy 
cats. Normally, viruses induce a NK response that is characterized by a higher cytolytic capacity (e.g. 
Herpes simplex virus 1 (HSV-1)) (Long et al., 2010). Some viruses however, have evolved to induce 
lower functionality in NK cells (e.g. HIV and Hepatitis C virus (HCV)) (Meier et al., 2005). One 
explanation for the lower cytotoxicity could be a proportional dysregulation of functional subsets, 
similar to the dysregulation seen in HIV-patients where less CD16+ NK cells (the cytotoxic subset) 
are detected. However, the opposite was found during FIPV infection, i.e. higher amounts of CD16+ 
cells. Another possibility could be a lowered granulation, a prerequisite for inducing cytolysis. To test 
this hypothesis, several antibodies against CD107a were tested. Unfortunately, none of these showed 
cross reactivity with the cat system. Finally, differences in NK cell homeostasis between several 
subsets could be present, through for example different survival or generation rates, which could lead 
to a proportional dysregulation similar as proposed for HIV infection (Meier et al., 2005). Splenic NK 
cells did not reveal any differences in functionality between healthy and FIP cats. This could be the 
consequence of the different anatomy of the feline spleen, resulting in different trafficking patterns, 
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which could take the edge of any virus-induced alternations in frequency, phenotype or functionality 
(Blue and Weiss, 1981; Mebius and Kraal, 2005). Analysis of Treg functionality was not possible due 
to too low cell numbers in immunological compartments. 
The impact of the characteristics of individual FIP cats on the results is difficult to assess. Tissue from 
FIP-mesentery and -kidney without lesions showed comparable results to tissue with lesions, both with 
regard to cell frequency and functionality. Similarly, results from the FIP cat without effusion also 
showed no difference with the effusive FIP cats. This indicates that both cell frequency and function, 
are not associated with the disease pattern (effusive – non effusive) that follows infection nor in the 
disease severity (presence of lesions). Possibly, there are other cellular immunity associated factors 
such as cytokine production and cell-trafficking behavior, that determine which disease type follows 
infection with FIPV. In addition, the difference between effusive and dry FIP in practice is rather 
challenging with cats commonly possessing a mixture of the clinical signs typical for the wet or the 
dry form (Berg et al., 2005; Hartmann, 2005). The severity of the clinical signs, with regard to the 
magnitude of granulomas and the affected organs is also very diverse. To draw conclusions from 
immunity studies, with regard to the type of FIP, would demand careful selection of animals, with 
clinical signs belonging exclusively to the dry or wet type. 
Figure 4.18: Schematic overview of NK cell numbers, phenotype and function that are altered during an infection with 
FIPV. HEV = High endothelial venule. 
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In conclusion, FIPV infection is characterized by constitutive low amounts of NK cells in peripheral 
blood, mesenteric lymph nodes and spleen, while normal amounts of NK cells are found in infected 
tissue, despite the more migratory phenotype (i.e. higher expression of CD11b and CD62L). NK cells 
in FIP cats also showed a higher activation phenotype with higher expression of CD16 and CD25, but 
this did not translate in higher cytolytic activity, possibly due to virus-induced changes in NK cell 
biology or activation induced cell death (Fig 4.18). Similarly, Treg frequencies are significantly 
reduced in all immunological compartments, while no reduction in numbers could be detected in 
inflamed tissue. In the mesenteric lymph node, the relative reduction in Treg numbers was even 
greater than for T and B cells (Fig 4.19).  
Figure 4.19: Schematic overview of Foxp3+ regulatory cell numbers that are altered during an infection with FIPV. HEV = 
High endothelial venule. 
Additionally, CD8+ and CD4+CD25- Tregs were also found to be depleted in blood and LN from 
FIPV cats while elevated CD8+ Treg numbers were observed in inflamed kidneys. The role of these 
findings however needs additional research.  
4.2.6 Conclusion 
This study determined for the first time that FIPV-induced lymphocyte depletion, typical for T and B 
cells, also encompasses the NK and Treg lymphocyte compartments. T cells showed proliferation in 
response to inactivated but not to infectious FIPV. Additionally, despite their activated and migratory 
phenotype, NK cells were found to be less cytotoxic. These findings will translate in a reduced 
capacity of the innate (NK cells) and adaptive (T cells) immune response to battle virus infection and 
to aid ensuing immune responses and in a reduced capacity of the regulatory response (Tregs) to 
suppress the damaging inflammation that will lead to tissue damage. Further research, including more 
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extensive cytokine and receptor profiling, will propose candidates for treatments that improve NK cell, 
T cell and Treg function and survival in order to strengthen the cats’ immune response to FIPV 
infection 
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5 General discussion 
The group of feline coronaviruses typically consists of two pathotypes: feline enteric coronavirus 
(FECV) and feline infectious peritonitis virus (FIPV). Although they are genetically nearly identical, 
and FIPV most likely originates from FECV through mutation, their concomitant disease could not be 
more different. FECV causes a mild gastroenteritis while FIPV infection almost always results in a 
quick death with the formation of granulomas on several organs and the production of ascites in 
different body cavities (pericardial, abdominal and thoracic). Despite the statement that cellular 
immunity is crucial for the beneficial outcome of a FCoV infection nearly 30 years ago (Pedersen and 
Black, 1983), data on the cell-mediated immune response (CMI) is still scarce, both for FECV 
infections as well as FIPV infections.  
To allow analysis of both the innate and adaptive immunity during FCoV infections, some methods 
had to be optimized. First, an in vitro assay to study T cell proliferation in response to virus antigens 
was developed. Second, reference values for natural killer (NK) cell properties were determined in 
healthy uninfected cats. Subsequently, these methods and other others were used to characterize anti-
FCoV immunity in FECV- and FIPV-infected cats, with emphasis on T cells, regulatory T cells and 
NK cells. To this purpose three cats were inoculated with FECV UCD and followed during three 
months. Similarly, eight naturally FIPV-infected and six healthy, uninfected cats were euthanized and 
sampled. 
5.1 Development of a new assay to study lymphoproliferative responses to viral 
antigens 
In a first part of this research, focus was placed on determining cell-mediated immune responses 
against feline virus antigens. Proliferation and cytokine production were the two parameters chosen to 
verify the CMI response since these responses typically occur early in the response. As little to no data 
are available on any FCoV specific proliferative responses, efforts were made in the development of a 
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sensitive method that combined the detection of proliferation with identification of the responding cell 
type. The basic assay that was optimized accordingly was the 5-bromo-2’-deoxyuridine (BrdU) 
labeling, combining the sensitivity of radioactive thymidine labeling with the possibility of identifying 
proliferating lymphocytes through fluorescent labeling of surface markers. Another aspect that made 
the assay more simplified for practical use was the usage of N2-frozen cells. This allowed complete 
analysis of cells from one blood sample. 
Optimization was focused on several parameters. Firstly, several antigen presenting cells were 
compared in their capacity to induce proliferation. Monocyte-derived dendritic cells were found to 
generate the strongest lymphoproliferative responses. Second, because feline cells tend to be 
extremely sensitive to background proliferation, the origin, concentration and treatment of serum 
supplement is extremely important. Finally, other parameters such as BrdU concentration and 
incubation time and cell concentration were optimized to obtain strong proliferation signals while 
minimizing the background. 
When optimizing the assay, the lymphocyte proliferation response of vaccinated specific pathogen free 
cats was followed against three ubiquitously present, common feline viruses: feline calicivirus (FCV), 
felid herpesvirus-1 (FeHV-1) and feline panleukopenia virus (FPV). Results showed proliferation 
responses to all inactivated viruses in both the CD8- and CD8+ T cell population while only the CD8- 
T cell population responded to infectious calicivirus. These responses were verified through the 
detection of IFN-γ in the culture supernatant. The suppression of proliferation by infectious FeHV-1 
and FPV has been described in literature (Schultz et al., 1976; Montagnaro et al., 2009) and possibly is 
the result of induced apoptosis of infected cells (up to 80% of FeHV-1 infected cells were apoptotic) 
and/or down regulation of antigen presenting molecules such as MHC-I (Montagnaro et al., 2009). 
5.2 Characterization of natural killer cells in healthy cats 
In order to study natural killer cells in cats, reference values for healthy cats had to be determined. Due 
to the scarce information available on natural killer cell attributes in cats, focus was first placed on the 
determination of NK cell frequencies, their phenotype and their function in several immunological 
compartments and tissues. Absolute blood-derived NK cell numbers [227 NK cells µl-1 blood] 
revealed frequencies similar to, albeit a little lower than the numbers found in the blood from humans, 
monkeys and cattle (Alter et al., 2007; Ishizaki and Kariya, 2010). Likewise, relative numbers in 
blood, LN and spleen showed large similarities with their bovine, porcine and ovine counterparts 
(Boysen et al., 2008; Elhmouzi-Younes et al., 2010). Human blood and LN, and murine LN and 
spleen, however, showed different frequencies. Phenotypically, feline NK cells also showed some 
differences with other species. This was however to be expected because, with the exception of CD16, 
all markers are expressed differently in most species. Staining for CD8, CD11b and CD62L showed a 
low amount of cells positive for these markers (10-30%), while staining for CD25 and CD16 revealed 
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medium to high amounts of cells staining positive for these markers (43-82%). Confocal analysis of 
feline natural killer cells revealed CD16 – CD56 double positive cells with a large nucleus to 
cytoplasm ratio which are significantly bigger and more granulated than conventional T cells, a trait 
shared with many species. These findings acknowledge the generally accepted evolutionary 
conservation of NK cells. However it should be concluded that, despite large similarities cross-species, 
particularly with regard to cell frequencies and morphological appearance, caution is still advised 
when extrapolating results over species. Especially when predicting the expression of surface 
molecules such as CD8, CD11b and CD62L. 
To evaluate functionality, initially the K562 cell line was used. However no lysis could be detected 
with unpurified, purified or activated feline NK cells. This is somewhat unexpected since this cell line 
is used frequently in several species to assess NK functionality (Jondal and Pross, 1975; Evans and 
Jasofriedmann, 1993). Purified porcine NK cells did lyse the K562 cells efficiently, validating our 
setup. Literature on cell lines susceptible to feline NK cell-mediated lysis is very scarce and mostly 
contradicting with groups finding no NK activity or activity that is dependent on breed and 
immunological history (Hu et al., 1982; Mccarty and Grant, 1983; Tompkins et al., 1983; Kooistra and 
Splitter, 1985). In contrast to our study, one group did find NK cell mediated lysis of K562 cells 
(Zaccaro et al., 1995). Differences in detection (scatterplot and autofluorescence versus CFSE 
labeling) as well as used animals (SPF animals versus conventionally housed animals) might explain 
these discrepancies. Further testing revealed the Crandell feline kidney cells (CRFK) to be susceptible 
to NK cell mediated lysis with clear cell concentration-dependent cytotoxicity for cells extracted from 
all immunological compartments. The percentage of lysed cells was as high as 60% for a NK cell / 
CRFK ratio of 10:1. This cell line had been already used in a former study, however with very low 
percentages of lysed cells (~5%) (Zhao et al., 1995). These differences could be attributed to the use of 
other effector cells (lymphokine-activated killer cell), which makes comparison of effector:target 
ratios challenging. In addition, 51Cr labeling was used to detect lysis, which differs significantly from 
our fluorescent approach. 
Another interesting finding was the large amount of natural killer T (NKT) cells in immunological 
compartments, especially when compared with human and bovine blood and LN (Fehniger et al., 
2003; Lee et al., 2010). This enigmatic subset has characteristics of both T and NK cells, recognizes 
mainly (glyco)lipid antigens and recently got a lot of consideration as a possible therapeutic target. 
Especially in the context of intestinal immunity, these cells have acquired attention. Activation of 
NKT cells can be associated with oral tolerance to food antigens and commensal microorganisms 
while over activation can be linked to inflammatory bowel disease (IBD) (Zeissig et al., 2007). Also in 
cats and dogs, the innate immune system has been hypothesized to contribute to the development of 
IBD (Allenspach, 2011).  Possibly the large amount of NKT cells might predispose cats for attenuated 
immune responses to enterotropic viruses such FECV, which are resolved inefficiently when 
131 
Chapter 5 
 
compared to other virus infections in cats such as calicivirus or panleukopenia virus. Remarkably, 
results from this study indicated that NKT cells could also lyse CRFK cells. Although they have been 
reported to participate in direct lysis, their main function is thought to be immunoregulatory through 
the potent production of several cytokines such as TNF, IFN γ and IL-4 (Berzins et al., 2011). Further 
characterization of the mechanism of NK- and NKT-mediated lysis was however thwarted by the lack 
of cross reactive antibodies against cytotoxicity receptors (a rather extensive panel against e.g.  human 
nkp30, nkp46 and NKG2D, was tested for cross reactivity, without success). 
5.3 Immune responses during infection with feline coronaviruses 
It is generally accepted that the cell-mediated immune response is key to surviving FIP ever since 
Pedersen and colleagues first stated this about thirty years ago (Pedersen and Black, 1983). 
Nevertheless, few studies have attempted to further characterize and deepen the knowledge concerning 
arising cellular responses, especially since it is known that the humoral immunity does not offer 
protection from FIP development (Pedersen and Boyle, 1980; Weiss and Scott, 1981). Several studies 
highlighted the fact that FECVs and FIPVs are genetically very alike and that FIPVs do not spread 
from cat to cat but arise in each individual cat through mutation from FECVs (Hickman et al., 1995; 
Horzinek et al., 1995; Pedersen et al., 2009). Therefore, it is pertinent that immune responses to FECV 
infections are also characterized. After all, coronaviruses are particularly prone to mutation, so 
unchecked replication of FECV will favor high viral loads and thus lead to higher odds of a fatal 
mutation that will generate FIPV.  
Cellular immunity is typically divided into an innate and adaptive branch. Where in the adaptive part, 
the main players are CD4+ and CD8+ T lymphocytes, NK cells form the heart of the innate defenses. 
Additionally, regulatory cell types exist to exert control over all immune responses, both cellular and 
humoral. Regulatory T cells are most famous in this part, although it has been amply shown that 
certain NK cells and NKT cells can also perform regulatory roles. Most of these cell types have been 
shown to exert influence on each other; analysis of several types simultaneously may therefore allow 
better interpretation of results. 
In order to obtain data in both FECV- and FIPV-infected cats, two large experiments were set up. In 
the first experiment, three specific pathogen free cats were experimentally inoculated with the 
infectious field strain FECV-UCD. The animals were monitored daily and samples were taken at 
frequent, predetermined time points. For the second experiment, both healthy cats that had to be 
euthanized for diverse reasons and naturally FIPV-infected cats were euthanized and sampled over a 
two-year period. Several extensive stainings were performed on samples from different body 
compartments in order to obtain information on different immune cell types. 
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5.3.1 Viraemia 
During FECV-infection, virus was quantified by RT-PCR in oral swabs and feces on regular time 
points. Surprisingly, two fecal excretion patterns were detected. A normal excretion started 2-4 days 
after infection while a second secretion pattern seemed delayed for 2 weeks. It was deemed unlikely 
that this occurred because of a failed infection since virus could be amply detected for two days in the 
mouth and submandibular lymph nodes were clearly swollen 7 days p.i.. Further analysis showed the 
delayed excreted virus to be non-infectious on a new developed intestinal cell line, in contrast to the 
excreted virus from the two normally excreting cats. In order to verify FIPV-infection in suspected 
FIPV-infected cats, virus was detected through immunofluorescent staining of virus in FIPV-induced 
lesions on organs. 
In an attempt to explain the aberrant shedding patterns, an adapted infection model is proposed (Fig 
5.1). FECV infection would occur in three phases. In a first phase, virus infects permissive cells in the 
naso-oropharyngeal cavity (Fig 5.1-A), most likely macrophages (Mφ) or dendritic cells (DCs) which 
are among the first cells to encounter the virus. Monocytes-macrophages have been found to be 
susceptible to FECV infection, albeit at low levels without much cytopathic effect (Dewerchin et al., 
2005). Low level productive infection of these cells provides FECV with both an escape from immune 
responses and a means to spread throughout the host, much like what has been found for HIV and 
SARSV (Spiegel et al., 2006; Wu and KewalRamani, 2006). This hypothesis could explain the 
variable amount of virus detected in the oral cavity in this study (Fig 5.1-B) and why FECV-infected 
cells can be found throughout the body (Kipar et al., 2010). Through passage over DCs, the sugar coat 
enveloping FECV can be altered, which already has been suspected to be important in cell 
susceptibility to infection (Regan et al., 2010; Van Hamme et al., 2011). This would explain the 
inability of DC-adapted FECV virus to infect enterocytes. The typical fecal shedding pattern is here 
divided in phase II and III. Phase II represents infection of enterocytes as a consequence of gastro-
intestinal passage of orally administered virus. This infection leads to the high amounts of viral 
genomes on day 5 and is contained by the immune system 2-3 weeks after infection (Fig 5.1-B). The 
rest of the detected genomes later on, are the result of phase III of the infection. This phase is the 
outcome of virus dissemination by migrating infected cells (DCs). This model would be able to 
explain the aberrant shedding pattern of cat 2, which showed no phase II replication and only oral and 
enteric DC-associated replication. Possibly this was the result of gastric passage, which has a severe 
impact on FECV infectivity with a 2-3 log drop in infectivity in vitro after treatment at pH2 for 30’ at 
37°C (preliminary results). Another explanation might be a host associated (cat 2) mutation of the 
hitherto unknown receptor on enterocytes, similar to what has been described for HIV (Schneider-
Schaulies, 2000). Finally, a delayed migration of CD8+ Tregs (vide infra) might lead to a locally 
unsuppressed immune reaction in the gut, leading to clearance of enterocyte-associated virus. This 
model would also explain why no infectivity could be shown on enterocytes and why immune 
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responses are delayed, since it has been shown that coronavirus-infected DCs fail to induce key 
changes that are vital to the ensuing immune response, such as MHC I and II up regulation and  IFN-α 
production (Ziegler et al., 2005; Spiegel et al., 2006).  
 
Figure 5.1 Overview of an adapted hypothetical pathogenesis model of FECV. The model is characterized by three 
phases, separated in place by the sites sites of infection/virus production (A). Phase I takes place in the oral cavity and 
is the consequence of virus replication in permissive cells in the naso-oropharyngeal cavity. Passage of enterotropic 
virus (red) over these cells can lead to host cell adaption of the virus (blue). Phase II is the consequence of gastro-
intestinal passage of per-orally administered virus. Enterotropic virus here infects enterocytes. Phase III is the 
consequence of virus dissemination of the permissive cells in the naso-oropharyngeal cavity to the gut.  These three 
phases are also separated in time (B) (Phase I - day 1 to 21; Phase II -  day 3 to 28; Phase III – day 14 to ~). The red 
line in B represents infectious virus while the others represent viral RNA copies, representing each of the three 
phases. 
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5.3.2 Humoral immunity 
Despite high neutralizing antibody titers, the number of fecal virus genome copies remained high for 
several weeks, which indicates productive infection and virus replication (Fig 5.2). Several 
possibilities exist that allow the virus to elude antibodies (Fig 5.3). First, the formation of apoptotic 
bodies containing FECV particles could occur. These double membrane vesicles are taken up by 
macrophages-DCs, providing an antibody-unsensitive infection, similar to what has been found for 
porcine reproductive and respiratory syndrome virus (PRRSV) (Costers, 2008). Second, antibodies 
might even boost virus infection through antibody-dependent enhancement of infection (ADEI). This 
was also found during FIPV infection of FIPV immunized kittens (Weiss and Scott, 1981). A third 
possibility is the internalization of antibodies attached to virus proteins in the cell membrane, which 
allows evasion of the immune response that normally follows binding of antibodies (Dewerchin et al., 
2006). A final mechanism might be the direct cell-to-cell transfer of virus which has already been 
described for a neurotropic murine coronavirus (Nakagaki et al., 2005). Remarkably, when serum from 
naturally FIPV-infected cats was assayed in the FECV neutralizing assay, Nab levels were even higher 
than those from FECV cats (preliminary results). These findings indicate that the generated antibodies 
in both FECV and FIPV infected cats can neutralize FECV in vitro but that they do not protect cats 
from FECV infection, nor from FIPV infection, as was shown earlier (Pedersen and Boyle, 1980; 
Addie et al., 2003).  
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Figure 5.2: Virus quantification and immunity during an experimental FECV infection. Results are given for the cats 
with two shedding patterns, cat 1 and 3 on the left, cat 3 on the right. The upper panel represents a schematic 
overview of the amount of detected viral RNA genomes, divided in three phases according to the earlier mentioned 
adapted infection model. The red line shows the amount of infectious virus. The middle panel shows the fluctuations 
of several leukocytes relative to their pre-infection level, with emphasis placed on CD8+ regulatory T cells, 
represented by the blue line. The lower panel shows the amount of neutralizing antibodies. 
 
Figure 5.3: Schematic overview of mechanisms that allow FECV to circumvent the humoral immune response and 
allow persistent infection. Phagocytosis or macro pinocytosis of apoptotic bodies containing FECV particles (A). Fc-
mediated antibody dependent enhancement of infection (ADEI) (B). Internalization of FCoV-specific antibodies (C). 
Direct cell-to-cell transfer of virus particles (D). 
5.3.3 Cell-mediated immune responses 
5.3.3.1 T cell proliferation response to FECV and FIPV antigens 
The previously optimized proliferation assay (Chapter 3.1) was used to detect lymphoproliferative 
responses to FCoV. For this purpose, the assay had to be adjusted since no well-performing vaccine 
exists against either FECV or FIPV. Briefly, frozen PBMC, originating from blood taken from three 
cats, four weeks after an experimental FECV infection (Chapter 4.1), were seeded to generate the 
necessary mDC for antigen-presentation, the same frozen PBMC also served as a source for responder 
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cells. Virus-stimulant was infectious or inactivated FECV-UCD grown on a newly developed 
enterocyte cell line. For FIPV (Chapter 4.2), another strategy had to be devised since the severe 
lymphocyte depletion in the blood thwarted our intention to use PBMC as responder cells. To solve 
this issue, cells isolated from the mesenteric lymph node were used as responder cells while frozen 
PBMC generated the antigen presenting mDCs. Virus stimulant was infectious or inactivated FIPV, 
isolated from ascites of a naturally FIPV-infected cat. 
Results indicated that cats infected with FECV show lymphoproliferative responses to FECV antigens. 
Curiously, CD8- lymphocytes proliferate in response to infectious FECV but not to inactivated FECV. 
This contrasts with the results obtained with FCV, FeHV-1 and FPV, where all inactivated viruses 
elicited strong CD8- proliferation responses. However, all cats were vaccinated three times with a well 
performing attenuated vaccine, which provides a strong long lasting immune response (Kanellos et al., 
2008). In contrast, here an actual infection occurred, which may have additional immune evasive 
consequences (such as lymphocyte depletion) and which may not be as strong as repeated exposure to 
antigen. As a result, the immune system might require relatively more antigen to be stimulated again, 
explaining the need for infectious virus that can multiply and intensify the antigen load. Additionally, 
although it can be detected throughout the body, FECV infection is mainly constricted to the gut, 
which differs significantly in terms of immunity from systemic immunity (Kipar et al., 2010). These 
differences mainly lie in the migration of memory/effector cells to effector sites and in a self-limiting 
response protecting the gut inductive lymphoid tissue which can mask generated immunological 
memory (Brandtzaeg, 2007). Further, no proliferation could be detected with either inactivated or 
infectious FIPV. This indicates no cross immunogenicity (vide infra) and may partially explain why 
FECV recovered cats can still develop FIP (Kiss et al., 2004).  
In FIPV-infected cats, only inactivated FIPV can induce a proliferative response in LN-derived 
lymphocytes. The failure of infectious FIPV to do so indicates that this virus somehow suppresses 
lymphocyte proliferation. This might be the consequence of apoptosis-induction (Haagmans et al., 
1996; Takano et al., 2007). Another possibility would be sub-lethal infection of antigen-presenting 
cells which can lead to immunosuppressive consequences such as the down regulation of MHC 
complexes on the cell surface, like has been shown for SARS-CoV (Ziegler et al., 2005; Spiegel et al., 
2006). Further, there have been some publications on lymphocyte proliferation during FIPV infection. 
Some detected significant suppression of ConA-stimulated proliferation (Stoddart et al., 1988; Knotek 
et al., 2000) in PBMC from FIP cats. Others detected frequent proliferation in response to FIPV 
antigens in cats surviving a FIPV infection or vaccinated cats (Pedersen and Floyd, 1985; Stoddart et 
al., 1988; Gerber et al., 1990). However, large differences exist in experimental protocols (tritium 
detection, origin and treatment of responder cells), making comparison of results difficult. Similar to 
FECV-infected cats, no cross immunogenicity could be detected between the two coronaviruses, 
another confirmation that these viruses, albeit being almost identical, still evoke completely different 
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immune responses. It should be concluded that inactivated FIPV can induce a significant 
lymphoproliferative response in the CD8- T cell population of LN-derived cells (vide infra). This 
indicates that the cats’ immune system is still potent enough to mount an effective immune response, 
although it seems that infectious FIPV can suppress this response, possibly through the induction of 
apoptosis. 
Remarkably, IFN-γ could not be detected anywhere. This suggests that a Th2 response is initiated 
rather than a Th1 response. Further analysis of supernatant, detecting Th2 cytokines such as IL-4, IL5 
and IL-6 would further consolidate this hypothesis which is already strengthened by the fact that 
elevated IL-6 production in FIP cats has been described in FIPV-infected cats (Goitsuka et al., 1990; 
Gunn-Moore et al., 1998; Kipar et al., 2006). This would contrast the results from de Groot-mijnes et 
al. (2005), who readily detected Th1 directed CD4+ and CD8+ T cell responses to artificially 
expressed parts of the FIPV-proteome in FIPV-infected cats. Possibly, the addition of infectious or 
inactivated whole feline coronavirus can (re)direct the immune response to a Th2 response, which is 
arguably less effective against intracellular viral pathogens. This has been found for hepatitis B virus 
infections, where different peptides can generate either a Th1 or Th2 response (Huang et al., 2006). 
The latter resulted in a non-protective humoral response which was mainly directed on minimizing 
damaging immunopathology (Milich et al., 1997). A Th2 response is correlated with a strong humoral 
immunity, however feline coronaviruses seem to be especially equipped to evade humoral responses 
(Cornelissen et al., 2007; Dewerchin et al., 2008). 
All of the findings above are largely in line with the conclusions by de Groot-Mijnes et al. (2005) who 
detected CD4+ and CD8+ lymphocytes, albeit Th1 oriented, responding to retrovirally expressed FIPV 
antigens in FIPV-infected cats. They visualized the FIPV-driven lymphopenia that occurs very early 
during infection and the generating cellular immune response as two opposing forces. This finding 
also shows great similarity to infection with SARS-CoV. An adverse outcome during SARS-CoV 
infection is highly correlated with severe lymphopenia in all immunological compartments (Cui et al., 
2003; Wong et al., 2003). The results from this study verify the ability of the cat’s immune system to 
respond to the virus, although with different responder cells (lymph node lymphocytes vs splenocytes) 
that show a Th2 response rather than the earlier detected Th1 response. 
Another important finding is the absence of cross immunogenicity between FECV and FIPV in both 
FECV- and FIPV- infected cats. This might be partially explained by the proposed immunodominance 
of S-protein specific lymphocytes (de Groot-Mijnes et al., 2005). This dominance has been found for 
other RNA viruses (MHV & LCMV) and is often combined with T cell exhaustion, a virus-driven, 
antigen-load dependent functional impairment and/or physical deletion of virus specific T cells. 
Ultimately, these phenomena lead to an ineffective anti-viral T cell response (Bergmann et al., 1999; 
Wherry et al., 2003). Another explanation might be the difference in accessory proteins between FIPV 
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and FECV. Recent research indicates major differences between FECVs and FIPVs, particularly in the 
3c and 7b protein (Kennedy et al., 2008; Pedersen et al., 2009; Chang et al., 2010). The role of these 
proteins is still virtually unknown but it is not unlikely that they perform critical roles in shaping a 
developing immune response, as was discovered for SARS-CoV ORF3b and ORF6 (Frieman and 
Baric, 2008) and proposed for FCoV ORF7 (Dedeurwaerder et al., 2012). 
5.3.3.2 Changes in lymphocyte, monocyte and granulocytes numbers 
To further analyze and characterize the immune responses, several general cell types were quantified. 
During the FECV infection, no clear difference in cell numbers or function (with the exception of 
CD8+ Tregs, vide infra) could be detected between the cats with the different FECV shedding 
patterns, so most of the data on cell frequencies here is described as the mean of the three cats (Fig 
5.2). During FECV infection, T lymphocytes and B lymphocytes were quantified in the blood while 
during FIPV-infection, both T and B lymphocytes were quantified in the blood, mesenteric lymph 
node, spleen, mesentery and kidney. FECV infection was characterized by an initial rise of 
lymphocyte counts, followed by a gradual decrease that started to resolve at day 21 p.i. This drop 
could be the consequence of lymphocyte migration to places of infection (gut) and lymphoid tissue or 
the result of T cell exhaustion, although more research is needed to confirm this. One early report 
confirmed this trend in leukocyte counts (Pedersen et al., 1981) while more recent research indicated 
no differences in leukocyte numbers (Vogel et al., 2010). However, their results were mainly based on 
general haematological analysis, which probably is less accurate compared to our approach. This trend 
of low leukocyte numbers is in agreement with the general concept on infections and immunity that 
states that bacteria mainly induce higher leukocyte counts while viruses induce no changes in/or lower 
leukocyte numbers in peripheral blood (Peltola et al., 2006). In the peripheral blood of FIP cats, both T 
and B cells were depleted to a large extend. This is in agreement with many reports and this author 
believes that this lymphopenia is the main problem in the pathogenesis of FIPV (Haagmans et al., 
1996; Paltrinieri et al., 2003). The same conclusion was drawn by de Groot-mijnes et al. (2005), who 
found lymphocyte depletion to occur very early during FIPV-infection and concluded that the extent to 
which this occurred, determined the outcome of the infection (de Groot-Mijnes et al., 2005). 
Additional analysis of mesenteric lymph node and spleen also revealed large T cell depletion, adding 
to the findings of de Groot-mijnes et al. (2005) and bearing similarity to several other reports (Kipar et 
al., 1999; Paltrinieri et al., 1999). This depletion is probably the result of apoptosis-inducing molecules 
although no consensus could be reached (Haagmans et al., 1996; Takano et al., 2007). Our results add 
to this finding with no differences in both T and B cell counts at sites of infection, i.e. mesentery and 
kidney. These results confirm that migration has occurred to neither lymphoid tissue nor sites of 
infection. 
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5.3.3.3 The role of natural killer cells during infection with feline coronaviruses 
Further, this research focused on the role of natural killer (NK) cells during both FECV and FIPV 
infection. After all, they have been shown to be crucial in several virus infections, influencing both the 
innate as well as the adaptive immune reponse (Andoniou et al., 2006). Peripheral NK numbers were 
shown to be moderately reduced during FECV infection, already in the beginning of the response. 
Numbers started to rise again from 21 days p.i. (Fig 5.2). Remarkably, NK numbers were also 
negatively correlated with the amount of genomic virus copies in the feces . These results indicate that 
NK cells react to FECV infection, probably by migrating to sites of infection or lymphoid tissue where 
they can stimulate an arising immune response (Martin-Fontecha et al., 2004). FIPV-infection on the 
other hand, was characterized by drastic NK cell depletion in peripheral blood, LN and spleen while 
sites of infection showed neither increase nor decrease. This excludes cell migration as a cause for the 
depletion. FCoV also cannot directly infect lymphocytes, indicating that FIPV induces NK cell 
depletion indirectly. The degree of the depletion was similar to the one seen for T and B cells in all 
compartments, indicating that this could also be due to an apoptosis-induction like was proposed 
earlier (Haagmans et al., 1996). Such drastic NK depletion has also been noted for SARS-CoV 
infections and infections with feline immunodeficiency virus (FIV) (He et al., 2005; Howard et al., 
2010). NK depletion can result in a significant drop in IFN-γ production, a major player in anti-viral 
responses which will in turn lead to a less potent innate activity against acute infections (Denney et al., 
2010). This was supported by the lack of IFN-γ production during lymphocyte stimulation with FCoV 
antigens as was shown in Chapter 3.1. 
The phenotype of a particular cell is at least equally important as its frequency, as it determines the 
role and status of a cell (Morishima et al., 2006). During FECV infection, peripheral NK cells show a 
relative upregulation of the activation markers CD25 and the migration/adhesion markers CD11b and 
CD62L, which returned to pre-infection levels after 7 to 14 days. Additionally CD16, a marker for 
cytotoxicity, was expressed on more NK cells during the first week, which lasted until the end of the 
experiment. These results indicate that FECV-infection activates NK cells and subsequently induces 
migration of these cells to sites of infection/lymphoid as stated earlier. Very similar to FECV, FIPV 
infection is also associated with more activated/migrating NK cells, with more NK cells expressing 
CD11b, CD16, CD25 and CD62L (Fig 5.3). However, CD25 and CD62L were expressed much more 
on peripheral NK cells during FIPV infection, possibly the result of the more systemic nature of a 
FIPV-infection compared to the more gut-restricted infection of FECV and thus inducing a stronger 
response. Additionally, more LN-derived NK cells showed expression of CD16 and CD62L compared 
to LN-derived NK cells from healthy controls. The same upregulation was noted in inflamed human 
LNs, where the authors envisaged a system where immature NK cells are recruited to the LN early 
during the immune response where they mature and then subsequently recirculate (Romagnani et al., 
2007). These similarities would place the lymph node central in the developing immune response 
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against FIPV. Though LN-derived NK cells seemed more equipped for inducing lysis, as indicated by 
high amounts of CD16-expressing NK cells, they were significantly less toxic in a functionality assay 
on CRFK cells.  Possible explanations for this downregulation might be activation-induced cell death 
(Ida et al., 2003) and the downregulation of perforin as was found for HIV and FIV infections (Alter et 
al., 2006; Simoes et al., 2012). 
5.3.3.4 Implication of Foxp3+ regulatory cells  
Besides NK cells, this research also investigated the role of regulatory Foxp3+ cells during 
coronavirus infections. Next to classical Tregs (CD4+CD25+), other Foxp3+ expressing cells were 
also analyzed, i.e. CD4+CD25-, CD8+ and CD21+ cells. Results revealed an increase in classical Treg 
numbers during the first week after FECV infection followed by a transient depletion of Tregs that 
started to resolve three weeks p.i.. Interestingly, cat 2 with the aberrant shedding pattern showed a 
significant upregulation of peripheral CD8+ regulatory T cell numbers (CD8+ Tregs) during the first 
week. This regulatory subset has gained more importance during the last years, especially in gut 
immunology (Chaput et al., 2009). A possible hypothesis that explains the delayed shedding might be 
a slow/absent migration of the CD8+ Tregs to the gut, which could result in a vigorous immune 
response that leads in turn to a clearance/suppression of virus in the gut. Similarly, both HIV and SIV 
infections have been correlated with higher amounts of immunosuppressive CD8+ Tregs in the blood 
and colorectal mucosa respectively (Lim et al., 2007; Nigam et al., 2010). When Foxp3 regulatory 
cells were analyzed in FIPV cats, depletion could also be detected for almost all subsets in the blood 
and lymphoid compartments and to a larger extent then was noted for FECV infected cats. 
Additionally, no upregulation could be detected at sites of infection/inflammation, with the exception 
of the kidneys of FIPV-infected cats, where more CD8+ regulatory cells could be detected when 
compared to healthy cats. This might reflect an immune evasive method of FIPV to suppress local 
immunity to FIPV-infected cells. These findings contrast studies on regulatory T cell numbers during 
other viral infections, which are nearly always correlated with increases in numbers and/or function 
(Keynan et al., 2008). One exception is HIV, where a drastic depletion is noted in peripheral blood. 
However, this was found to be the result of Treg migration to sites of infection and lymphoid tissue 
(Anderson et al., 2006). This migration has been found to be vital for proper immune regulation 
(Belkaid and Tarbell, 2009; Campbell and Koch, 2011). This was not the case for FIP cats however, 
since extreme depletion could also be noted in lymphoid tissue and no significant increase of classical 
Tregs could be detected at sites of infection.  
To summarize, it seems that lymphocyte depletion in all lymphocyte compartments is the main factor 
in crippling a developing cell-mediated immune response. These findings add to earlier results that 
proposed the developing response and the FIPV-driven lymphopenia in activated lymphocytes as 
opposing forces (Haagmans et al., 1996). 
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5.4 Hypothetical model – T cell exhaustion lends a hand to virus-driven 
lymphopenia 
How does all this data fit into the pathogenesis of FECV and FIPV? The author would like to propose 
a role for the phenomenon T cell exhaustion. This model is described by the stepwise progressive loss 
of T cell numbers and functions following prolonged antigen stimulation, which can result in the 
subsequent physical deletion of pathogen-specific T cells (Wherry, 2011). Several facts point out that 
this phenomenon could also be present during FCoV infections. First, the pattern of declining T cell 
numbers during an experimental FECV infection, despite the high viral load (Fig 5.2), which is 
reminiscent of the pattern of the modeled T cell exhaustion response after a protracted infection (Yi et 
al., 2010). Second, despite the proliferative response, no significant IFN-γ could be detected in the cell 
culture supernatant. Third, the immunodominance of S-protein specific lymphocytes which was 
detected by de Groot-mijnes et al. (2005), indicate that some epitope specificities are more prone to 
exhaustion then others, a trait characteristic for the exhaustion model (Yi et al., 2010). And finally the 
initial upregulation of Tregs that was detected in our research combined with earlier reports on 
elevated IL-10 levels in FECV-infected cats (Kipar et al., 2006). After all, Tregs are defined as one of 
the three main regulatory pathways in T cell exhaustion (Wherry, 2011).  
T cell exhaustion during FECV infection could thus result in a biased T cell immunity (T cell 
immunity directed to certain epitopes only) which can eventually resolve virus infection several weeks 
after primary infection. This could hold consequences for FIPV development, a delayed, modified and 
tempered immunity during FECV infection would give rise to higher virus replication, which in turn 
elevates the chance of a fatal mutation that leads to FIPV. Whenever FIPV has arisen, the drastic FIP-
associated lymphopenia will then further diminish an already crippled T cell immunity (Fig 5.5). This 
will result in the complete demise of the cell mediated immunity, exemplified by the extreme 
depletion of NK cells, Tregs, T cells and B cells in peripheral blood, mesenteric lymph node and 
spleen and the functionally hampered NK cells and T cells.  
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Figure 5.5 Hypothetical model bridging FECV with FIPV infection with roles for T cell exhaustion and shedding 
patterns.   
As stated in Chapter one, there are several therapeutic approaches that aim to enhance or suppress 
specific parts of the adaptive immune response. However, it was concluded from this research that the 
main problem during feline coronavirus infections is actually the severe lymphopenia that is present in 
all lymphocyte subclasses. The focus should thus logically lie on suppressing the proposed T cell 
exhaustion and the FIPV-induced lymphopenia and thus provide the hosts’ immune system a chance to 
fully develop in order to fight of coronaviruses. Methods to counter or reverse exhaustion are currently 
under development in human and murine immunology. Focus here lies mainly on the administration of 
drugs that block central inhibitory receptors (such as program death-1 signaling) or certain cytokines 
(such as IL-10) (Wherry, 2011). Specifically for FECV, suppression of regulatory T cells in the 
beginning of infection could be a viable option to block subsequent exhaustion of T cells. Therapeutic 
avenues to block the FIPV-induced lymphopenia have already been partly explored by other groups, 
however with limited success. It was determined that TGF-β and TNF-α are important in the induced 
lymphopenia, however attempts to block this pathway were unsuccessful (Haagmans et al., 1996; 
Takano et al., 2007). Further characterization of the involved molecules and the involved pathways 
will be vital in order to devise a strategy to counter the lymphocyte depletion. This could include 
research to other molecules such as Fas and TNF-related apoptosis-inducing ligand (TRAIL) and 
further characterization of pathways downstream to TNF-α engagement to TNFRs such as NFκB, 
caspase-8 and -3 and Bid (Qidwai and Khan, 2011). If necessary, these treatments can be supported by 
therapeutics enhancing NK cell survival and activity such as for example the addition of cytokines (IL-
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2, IL-12, IL-15, IL-18 and IL-21) and the administration of drugs and antibodies (thalidomide, 
rituximab, etc..) (Zimmer, 2010). 
Main conclusions: 
• A BrdU assay was adapted, allowing the analysis of the T lymphocyte proliferative response to 
viral antigens. 
• Healthy NK cells show large similarities with other species, especially with regard to 
morphological appearance and numbers. For the phenotype however, species-specific flavors do 
prevail. 
• Feline NK cells cannot lyse the commonly used K562 cell line. Instead, the feline CRFK cell line 
can be used to assess NK mediated cytotoxicity. 
• Both FECV- and FIPV-infected cats can mount a proliferative response to FECV and FIPV 
antigens respectively, however both without significant IFN-γ production. 
• FECV infection of three cats showed one cat with an aberrant virus shedding state, which could not 
be explained by any of the assessed immune cell-mediated parameters, with the exception of CD8+ 
regulatory T cells. An alternative triphasic infection model is proposed, with first al oral phase 
infecting permissive cells in the oral cavity (DCs or Mφ?), second an intestinal phase with first 
infection of enterocytes which slowly gets followed up by a phase of infection of DC-macrophage 
cell types in the gut. 
• FECV infection is characterized by an initial increase of T cells (3 days p.i.), B cells (3 days p.i.) 
and Tregs (7 days p.i.), followed by a gradual decrease that started to resolve 21 days p.i.  
• During FECV infection, NK cells immediately started to decline in numbers. NK phenotype was 
transiently activated (CD16 and CD25) and migration-capable (CD11b and CD62L). 
• FIPV-infected cats showed extreme depletion of T cells, B cells (only in blood), NK cells and 
Tregs in peripheral blood, LN and spleen. However no depletion could be noted in FIPV-infected 
tissues. Non-classical Foxp3 regulatory cells (CD3+CD8+ and CD4+CD25-) were also found to be 
depleted from FIP blood and LN. Peculiarly, Foxp3+CD3+CD8+ regulatory cells were upregulated 
at the kidney site of infection  
• During FIPV infection, the same molecules (CD11b, CD16, CD25 and CD62L) were upregulated 
on peripheral NK cells as with FECV infection, albeit at higher levels for CD25 and CD62L. More 
FIP LN-derived NK cells showed expression of CD16 and CD62L and Tregs were found here to be 
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even more drastically reduced when compared to T or B cells. However, despite their more 
activated phenotype, LN-derived NK cells lysed significantly less CRFK cells. 
Fundamental research like described in this thesis is important to obtain more extensive knowledge on 
the way virus and immune system respond to each other. This will eventually lead to the development 
of therapies that can enhance / suppress certain affected parts of the cell-mediated immunity in order 
to allow containment and resolution of feline coronavirus infections. Although the amount of used 
animals is small, the main power of this study lies in its in vivo relevance. Confirmation of these 
results in more animals and extension of the knowledge on certain feline immune parameters would 
however provide more information on how breed/immune status affect immunity and to what degree 
this corresponds to human/murine immunology.  
Future goals and open questions 
Some future goals deserving priority are the further characterization of the FIPV-induced 
lymphopenia. Hereby, focus should lie on the possible involvement of molecules other than TNF-α 
and TGF-β. Additionally, emphasis should be placed on determining what viral factor (accessory 
proteins) influences this lymphopenia. Depending on the findings, an approach can be devised in order 
to counter  the lymphocyte depletion. 
Another factor that deserves attention are the Tregs. More extensive research on functionality and 
cytokine response can further determine in what way these cells are influenced by FCoVs and how this 
can be countered. Special emphasis here should be placed on the CD8+ Tregs. These cells were shown 
to be upregulated in the FECV-infected cat that displayed a delayed fecal shedding and were also 
shown to be downregulated in FIPV-infected cats.  
Finally, more general immunotyping and development of antibodies targeting several markers, e.g. 
PD-1, CD127, CD160, CD244…, can describe and confirm the hypothesized T cell exhaustion model 
for coronavirus infections. This in turn, can lead to the development of therapeutic avenues targeting 
one or more molecules specifically. 
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6.1 Summary 
Two coronaviruses are described in cats. Feline enteric coronavirus (FECV) and feline infectious 
peritonitis (FIPV). FECV, ubiquitously present throughout the felid population worldwide, causes at 
most a transient gastroenteritis and is more likely to be even unapparent. Infection with FIPV on the 
other hand, usually results in death. Current hypothesis states that FIPV arises from FECV through 
mutation. Up to this moment, most infection studies focused on humoral immunity, which has been 
described to be unprotective. The strength of the cell-mediated immunity (CMI) is thought to be the 
decisive factor in FIPV pathogenesis but still surprisingly little is known about CMI during FIPV 
infections. Since FIPV arises from FECV through mutation it would be important to characterize CMI 
responses in both FECV and FIPV infections, which forms the central aim of this thesis. To this end, 
focus was placed on the roles of T lymphocytes, natural killer cells and regulatory T cells, which form 
the hearts of the adaptive, innate and regulatory immune responses respectively. 
Chapter 1 gives an overview on the literature on taxonomy, genome, proteins, replication cycle, 
pathogenesis and immunity during feline coronavirus infections. The immunity part also elaborates on 
literature regarding regulatory T cells and natural killer cells. 
In chapter 2, the main aims of this dissertation are formulated. 
Chapter 3 bundles the optimization of techniques that allow study of CMI responses in coronavirus- 
infected cats. In chapter 3.1, a method was selected to study CMI responses in cats. For this purpose, 
the 5-bromo-2’-deoxyuridine (BrdU) labeling method was selected because of its sensitivity and the 
possibility of further characterization of proliferating cells. The assay was optimized by selecting the 
best batch and concentration of fetal bovine serum, β-mercaptoethanol concentration, cell density, 
BrdU incubation time and antigen presenting cell type. Cats were vaccinated with the attenuated 
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Nobivac vaccine Tricat and the peripheral blood lymphocyte proliferation responses were quantified 
upon in vitro restimulation with inactivated and infectious feline panleukopenia virus (FPV), feline 
calicivirus (FCV) and felid herpesvirus 1 (FeHV-1). Proliferation signals were detected with 
inactivated FeHV-1 in the CD8+ but not in the CD8- T lymphocyte population, with inactivated FCV 
and FPV in both CD8- and CD8+ T lymphocyte populations. Restimulation with infectious FCV caused 
significant proliferation in the CD8- T lymphocyte population only while infectious FPV and FeHV-1 
seemed to suppress lymphocyte proliferation in both T cell populations. Additional IFN-γ 
quantification in the culture supernatant revealed a large correlation between the proliferation signals 
and IFN-γ production, indicating that BrdU labeling is a very reliable technique to assess and 
characterize feline lymphoproliferative responses to viral antigens in vitro. In chapter 3.2, CMI 
reference values for healthy cats were determined, to allow comparison with coronavirus-infected cats. 
More specifically, focus was placed on the quantification and phenotyping of NK cells in several 
compartments of healthy cats in addition to the assessement of their functional properties. The results 
indicated that NK numbers, both absolute and relative, and phenotype mostly correspond with those 
found in bovine, ovine, human and murine immunology. However, there were also distinct 
differences, especially with regard to the expression of the integrin CD11b and the selectin CD62L 
(between 10 and 30% of feline NK cells stain positive for these markers) and the relative frequencies 
in lymph nodes (6.7%), which stand central in NK cell development. Caution should be taken when 
extrapolating findings on NK cell properties over species, notwithstanding the generally accepted 
evolutionary conservation of NK cells and their subtypes. It was also shown that K562 cells, the 
‘golden’ target cell line for NK functionality tests did not work for feline cells. The feline kidney cell 
line CRFK proved to be very responsive to NK- and NKT- mediated lysis and therefore, represents an 
ideal alternative target. These results provided good references for NK cell numbers, both absolute and 
relative, phenotype and function in several anatomical compartments of healthy cats and for cat-
specific cytotoxic assays involving both NK and NKT cells. 
In chapter 4, the earlier described techniques and reference values were then used to analyze CMI 
responses in coronavirus-infected cats. Therefore two large experiments were devised. In the first 
experiment (Chapter 4.1), three SPF cats were experimentally inoculated with the infectious field 
strain FECV-UCD. The animals were monitored daily and samples were taken at frequent, 
predetermined time points. For the second experiment (Chapter 4.2), both healthy cats that had to be 
euthanized for diverse reasons and naturally FIPV-infected cats were sampled and euthanized over a 
two-year period. Several extensive stainings and functionality assays were performed on samples from 
different body compartments in order to obtain information on different immune cell types.  
More specifically during FECV (Chapter 4.1), both the humoral and cell-mediated immune response 
was investigated. Virus was quantified, both by real time RT-PCR and virus titration, in feces and oral 
fluids during the entire infection course of three cats, experimentally infected with the field strain 
154 
 
Summary - Samenvatting 
FECV UCD. Simultaneously, both neutralizing antibodies and different subsets of leukocytes were 
quantified in blood. In addition, the phenotype of natural killer (NK) cells was evaluated and the cell-
mediated immunity was evaluated through the detection of proliferating T cells in response to viral 
antigens. After inoculation, FECV was shed in the naso-oropharyngeal cavity infrequently during the 
first three weeks, with the highest amounts during the first 2 days after inoculation. FECV was 
detected in the feces from 2 days post inoculation (p.i.) in cats 1 and 3 and remained detectable for 2 
months p.i. while cat 2 started secreting virus in feces starting from 14 days p.i. and continued 
shedding until the end of the experiment. Infectious virus was detected from 4 days till 28 days p.i., in 
feces from cats 1 and 3 but not from cat 2 by titration on feline enterocyte cultures. The virus titers 
were 107-108 times lower than the virus RNA levels. Neutralizing antibodies (Nabs) were detected 
from 9 days p.i. for the 2 cats that showed early fecal secretion. The cat with delayed fecal secretion 
also showed a delayed generation of Nabs, which started at 14 days p.i.. High Nab levels in all cats did 
not eliminate viral infection. An FECV infection resulted in a progressing reduction of all 
lymphocytes, albeit with different starting points for each subset, which started to resolve at 21 days 
p.i.. Blood NK cells showed an activated status (elevated CD16 and CD25 expression) which was 
more prone to migrate (elevated CD11b and CD62L). No differences could be seen in leukocyte 
numbers that could explain the difference in shedding patterns, with the exception of CD8+ regulatory 
T cells (Tregs), who were shown to be considerably increased in the blood of the delayed shedder. 
This relatively unknown subset has been frequently associated with gut immunity as they suppress 
immune responses during gut parasite infections and rectal retrovirus infections. Proliferation assays 
verified that cats mounted a cell-mediated response to FECV antigens, probably Th2 oriented. In 
conclusion, this research provides more in depth knowledge on the complex interaction of the feline 
immune system and a FECV infection.  
In order to integrate all clinical, virological and immunological data, an adapted infection model is 
proposed. This model addresses several peculiarities such as the different shedding patterns and 
delayed immunity and tries to clarify the role of immunity during infection. According to this model, 
FECV infection would occur in three phases. In a first phase, virus infects permissive cells in the naso-
oropharyngeal cavity; most likely cells of the monocytic cell line, which are among the first cells to 
encounter the virus and which are readily found in several tissues of the feline naso-oropharyngeal 
cavity. Monocytic cells have been found to be susceptible to FECV infection, albeit at low levels 
without much cytopathic effect. Infection of these cells provides FECV with both an escape from 
immune responses and a means to spread throughout the host. This hypothesis could explain the 
variable amount of virus detected in the naso-oropharyngeal cavity in this study and why FECV-
infected cells can be found throughout the body. The typical fecal shedding pattern is divided in phase 
II and III. Phase II represents infection of enterocytes as a consequence of gastro-intestinal passage of 
orally administered virus. This infection leads to high amounts of viral RNA copies detected on day 5 
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and is contained by the immune system 2-3 weeks after infection. The rest of the detected genomes 
later on, are the result of phase III of the infection. This phase is the outcome of virus dissemination 
from the naso-oropharyngeal cavity by migrating infected permissive cells (monocytic cell line). 
Dissemination can occur via blood and/or lymph fluid. 
A strong CMI is thought to be indispensable for protection against infection with FIPV in cats. So in 
Chapter 4.2, the role of NK cells, T lymphocytes and Tregs, central players in the innate, adaptive 
and regulatory immunity respectively, was examined during natural FIPV infection. When quantified, 
NK cells, T cells and Tregs were drastically depleted from the peripheral blood, mesenteric lymph 
node (LN) and spleen in FIP cats. In contrast, mesentery and kidney from FIP cats did not show any 
difference when compared to healthy non-infected control animals. In addition, other regulatory 
lymphocytes (CD4+CD25-Foxp3+ and CD3+CD8+Foxp3+) were found to be depleted from blood 
and LN as well. Phenotypic analysis of blood-derived NK cells in FIP cats revealed an upregulation of 
activation markers (CD16 and CD25) and migration markers (CD11b and CD62L) while LN-derived 
NK cells showed upregulation of only CD16 and CD62L. LN-derived NK cells from FIPV-infected 
cats were also significantly less cytotoxic when compared with healthy cats. Although T cells were 
depleted from blood and lymphoid tissue, they still proliferated when stimulated with inactived FIPV 
but not with infectious FIPV. This study reveals for the first time that FIPV infection is associated 
with severe suppression of NK cells, T cells and Tregs, which is reflected by cell depletion and 
lowered cell functionality (NK and T cells). This will un-doubtfully lead to a reduced capacity of the 
innate adaptive immune system (NK cells and T cells) to battle FIPV infection and a decreased 
capacity (Tregs) to suppress the immunopathology typical for FIP. However, these results will also 
open possibilities for new therapies targeting specifically NK cells, T cells and Tregs to enhance their 
numbers and/or functionality during FIPV infection. 
As a general conclusion, based on the results of chapter 4.1 and 4.2, the authors would like to propose 
a hypothetical model bridging FECV and FIPV infection. In this model, a prominent role is played by 
the phenomenon T cell exhaustion, which is described by the stepwise progressive loss of T cell 
numbers and functions following prolonged antigen stimulation, which can result in the subsequent 
physical deletion of pathogen-specific T cells. Several facts point out that this phenomenon could also 
be present during FCoV infections. First, the pattern of declining T cell numbers during an 
experimental FECV infection, despite the high viral load. Second, despite the proliferative response, 
no significant IFN-γ could be detected in the cell culture supernatant. Third, the immunodominance of 
S-protein specific lymphocytes which was detected by de Groot-mijnes et al. (2005), indicate that 
some epitope specificities are more prone to exhaustion then others, a trait characteristic for the 
exhaustion model. And finally the initial upregulation of Tregs that was detected in our research 
combined with earlier reports on elevated IL-10 levels in FECV-infected cats. Tregs are defined as one 
of the three main regulatory pathways in T cell exhaustion. T cell exhaustion during FECV infection 
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could thus result in a biased T cell immunity (T cell immunity directed to certain epitopes only) which 
can eventually resolve virus infection several weeks after primary infection. This could hold 
consequences for FIPV development. A delayed, modified and tempered immunity during FECV 
infection would give rise to higher virus replication, which in turn elevates the chance of a fatal 
mutation that leads to FIPV. Whenever FIPV has arisen, the drastic FIP-associated lymphopenia will 
then further diminish an already crippled T cell immunity. This will result in the complete demise of 
the cell mediated immunity, exemplified by the extreme depletion of NK cells, Tregs, T cells and B 
cells in peripheral blood, mesenteric lymph node and spleen and the functionally hampered NK cells 
and T cells (Fig 6.1). 
 
Figure 6.1: Hypothetical model bridging FECV with FIPV infection with roles for T cell exhaustion and shedding 
patterns. 
The main conclusions from this dissertation are: 
• A BrdU assay was adapted, allowing the analysis of the T lymphocyte proliferative response 
to viral antigens.  
• Healthy NK cells show large similarities with other species, especially with regard to 
morphological appearance and numbers. For the phenotype however, species-specific flavors 
do prevail.  
• Feline NK cells cannot lyse the commonly used K562 cell line. Instead, the feline CRFK cell 
line can be used to assess NK mediated cytotoxicity.  
• Both FECV- and FIPV-infected cats can mount a proliferative response to FECV and FIPV 
antigens respectively, however both without significant IFN-γ production.  
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• FECV infection of three cats showed one cat with an aberrant virus shedding state, which 
could not be explained by any of the assessed immune cell-mediated parameters, with the 
exception of CD8+ regulatory T cells. An alternative triphasic infection model is proposed, 
with first al oral phase infecting permissive cells in the oral cavity (monocytic cells?), second 
an intestinal phase with first infection of enterocytes which slowly gets followed up by a phase 
of infection of DC-macrophage cell types in the gut.  
• FECV infection is characterized by an initial increase of T cells (3 days p.i.), B cells (3 days 
p.i.) and Tregs (7 days p.i.), followed by a gradual decrease that started to resolve 21 days p.i. 
• During FECV infection, NK cells immediately started to decline in numbers. NK phenotype 
was transiently activated (CD16 and CD25) and migration-capable (CD11b and CD62L).  
• FIPV-infected cats showed extreme depletion of T cells, B cells (only in blood), NK cells and 
Tregs in peripheral blood, LN and spleen. However no depletion could be noted in FIPV-
infected tissues. Non-classical Foxp3 regulatory cells (CD3+CD8+ and CD4+CD25-) were 
also found to be depleted from FIP blood and LN. Peculiarly, Foxp3+CD3+CD8+ regulatory 
cells were upregulated at the kidney site of infection  
• During FIPV infection, the same molecules (CD11b, CD16, CD25 and CD62L) were 
upregulated on peripheral NK cells as with FECV infection, albeit at higher levels for CD25 
and CD62L. More FIP LN-derived NK cells showed expression of CD16 and CD62L and 
Tregs were found here to be even more drastically reduced when compared to T or B cells. 
Despite their more activated phenotype, LN-derived NK cells lysed significantly less CRFK 
cells.  
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6.2 Samenvatting 
In de kat zijn er twee coronavirussen beschreven. Felien enterisch coronavirus (FECV) en feliene 
infectieuze peritonitis virus (FIPV). FECV, wereldwijd verspreid in alle katachtigen, veroorzaakt 
hoogstens een voorbijgaande gastroenteritis en gaat meestal ongemerkt voorbij. Infectie met FIPV aan 
de andere kant leidt meestal tot de dood. De huidige hypothese stelt dat FIPV uit FECV ontstaat door 
mutatie. Tot op heden concentreren de meeste infectiestudies zich op de humorale immuniteit, die 
echter beschreven staat als onbeschermend. De sterkte van de cel-gemedieerde immuniteit (CMI) 
wordt verondersteld als de beslissende factor in FIPV pathogenese. Verrassend genoeg is net over 
deze CMI gedurende FIPV infecties weinig geweten. Aangezien FIPV uit FECV onstaat door mutatie, 
is het belangrijk om voor deze beide virussen de CMI te karakteriseren. De focus werd daarom 
geplaatst op NK cellen, T lymfocyten en regulatorische T cellen, die elk cruciaal zijn in respectievelijk 
de adaptieve, aangeboren en regulatorische immuunresponsen.  
Hoofdstuk 1 geeft de literatuur weer inzake de taxonomie, de genomische informatie, de proteïnen, de 
replicatiecyclus, de pathogenese en de immuniteit tijdens infecties met feliene coronavirusen. Het deel 
over de immuniteit geeft ook meer uitgebreide literatuur weer over regulatorische T cellen (Tregs) en 
natural killer (NK) cellen. 
In hoofdstuk 2 worden de hoofddoelstellingen van deze thesis geformuleerd. 
Hoofdstuk 3 bundelt de optimalisering van technieken die de studie van CMI responsen in 
coronavirus-geïnfecteerde katten toelaat. Meer specifiek, in hoofdstuk 3.1 werd een methode 
geoptimaliseerd om CMI reponsen in katten te bestuderen. Hiervoor werd de 5-bromo-2’-deoxyuridine 
(BrdU) labeling method geselecteerd, aangezien deze gevoelige methode de mogelijkheid biedt om 
prolifererende cellen verder te karakteriseren. De assay werd geoptimaliseerd door de beste batch en 
concentratie van fetaal bovien serum, de beste β-mercaptoethanol concentratie, de beste cel densiteit, 
de beste BrdU incubatietijd en het beste antigeen-presenterende cel type te selecteren. De katten 
werden gevaccineerd met het geattenueerde Nobivac vaccin Tricat en de prolifererende responsen van 
perifere bloed lymfocyten als respons op geïnactiveerd en infectieus felien panleukopenie (FPV), 
felien calicivirus (FCV) en felien herpesvirus 1 (FeHV-1), werden gekwantificeerd. Proliferatie 
signalen als respons op geinactiveerd FeHV-1 werden gedetecteerd in de CD8+ maar niet in de CD8- 
T cel populatie. Wanneer geïnactiveerd FCV en FPV werd aangeboden, werden er proliferatie signalen 
gezien in zowel de CD8+ als de CD8- T cel populatie. Stimulatie met infectieus FCV gaf significante 
proliferatie in enkel de CD8- T cel populatie terwijl infectieus FPV en FEHV-1 de lymfocyt 
proliferatie zelfs leek te onderdrukken in beide populaties. Aanvullende kwantificatie van IFN-γ 
toonde een grote correlatie aan tussen de proliferatie signalen en de IFN-γ productie. Dit toont aan dat 
BrdU labeling een betrouwbare techniek vormt om de lymfoproliferatieve responsen op virale 
antigenen in vitro te evalueren en te karakteriseren. In hoofdstuk 3.2 werden CMI referentiewaarden 
opgesteld voor gezonde katten, om zo een vergelijking met coronavirus-geïnfecteerde katten toe te 
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laten in een later stadium. Focus werd geplaatst op de kwantificatie en fenotypering van NK cellen in 
diverse compartimenten van gezonde katten en aanvullend werden hun functionele eigenschappen 
geëvalueerd. De resultaten toonden aan dat NK aantallen, zowel absoluut als relatief, en het fenotype 
veelal overeenstemmen met waarden uit boviene, oviene, humane en muriene immunologie. Hoewel, 
er werden ook duidelijke verschillen waargenomen, vooral met betrekking tot de expressie van het 
integrine CD11b, het selectine CD62L (tussen 10 en 30% van de de feliene NK cellen brengen deze 
merkers tot expressie) en de relatieve frequenties in lymfe knopen (6.7%), dewelke centraal staan in de 
NK cell ontwikkeling. Voorzichtigheid wordt aangeraden wanneer NK cell eigenschappen worden 
geëxtrapoleerd tussen diersoorten, niettegenstaande de algemeen aanvaarde evolutionaire conservatie 
van NK cellen en hun subtypes. Ook werd aangetoond dat de K562 cellen, de ‘gouden’ doelwit cellijn 
voor NK functionaliteitstesten, niet werkten voor feliene cellen. De feliene cellijn CRFK daarentegen 
was wel erg gevoelig voor NK- en NKT-gemedieerde lyse. Deze cellijn vormt aldus een ideaal 
alternatief voor de K562 cellen. Deze resultaten voorzagen goede referentiewaarden voor NK cel 
aantallen, zowel absoluut als relatief, fenotype en functie in diverse anatomische compartimenten van 
gezonde katten en voor kat-specifieke cytotoxiciteitsassays voor zowel NK en NKT cellen.  
In hoofdstuk 4 worden de eerder beschreven technieken en referentiewaarden gebruikt om CMI 
responsen te analyseren in coronavirus-geïnfecteerde katten. Daarvoor werden twee uitgebreide 
experimenten opgesteld. In het eerste experiment (Hoofdstuk 4.1) werden drie SPF (specifiek 
pathogeen vrije) katten experimenteel geïnoculeerd met de infectieuze veld stam FECV UCD. De 
dieren werden dagelijks opgevolgd en stalen werden genomen op voorafbepaalde tijdstippen. Voor het 
tweede experiment (Hoofdstuk 4.2), werden er stalen genomen van zowel geëuthanaseerde gezonde 
(niet-geïnfecteerde) katten als van katten die natuurlijk geïnfecteerd waren met FIPV. Vervolgens 
werden diverse kleuringen en functionaliteitsassays uitgevoerd op de diverse stalen van verschillende 
weefsels om zo informatie te verkrijgen over een aantal immuuncel types. 
Meer specifiek gedurende FECV infectie (Hoofdstuk 4.1), werden zowel de humorale als de cel-
gemedieerde immuunresponsen onderzocht. Virus werd gekwantificeerd, zowel met real-time RT-
PCR als met virus titratie, in de feces en orale vloeistoffen gedurende het gehele infectieverloop van 
drie katten, experimenteel geïnfecteerd met FECV UCD. Gelijktijdig werden zowel neutraliserende 
antilichamen als verschillende lymfocyt subsets gekwantifeerd in het bloed. Additioneel werd het 
fenotype van NK cellen geëvalueerd en werd de adaptieve cel-gemedieerde immuniteit geanalyseerd 
met behulp van de detectie van proliferende T cellen na stimulatie met virale antigenen. Na inoculatie 
werd FECV infrequent uitgescheiden in de naso-orofaryngeale holte gedurende de eerste drie weken 
met de hoogste hoeveelheden tijden de eerste twee dagen na inoculatie. FECV werd vanaf dag 2 na 
inoculatie gedetecteerd in de feces in kat 1 en 3 en bleef detecteerbaar gedurende 2 maanden na 
inoculatie. In Kat 2 werd fecale virussecretie gedecteerd vanaf 14 dagen na inoculatie en dit hield aan 
tot het einde van het experiment. Infectieus virus werd gedetecteerd in de feces van kat 1 en 3 
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startende vanaf dag 4 na inoculatie tot dag 28 na inoculatie. Bij kat 2 werd echter nooit infectieus virus 
gedetecteerd. De virustiters waren 107-108 maal lager dan de virale RNA niveaus. Neutralizerende 
antilichamen (Nabs) werden gedetecteerd vanaf 9 dagen na inoculatie voor de twee katten die vroege 
fecale uitscheiding hadden. De kat met de vertraagde fecale uitscheiding had ook een vertraagde 
opkomst van Nabs, dewelke startte 14 dagen na inoculatie. De hoge Nab niveaus in alle katten 
resulteerde niet in eliminatie van virus infectie. FECV infectie leidde tot een geleidelijke afname van 
alle lymfocyt aantallen, weliswaar met verschillende startpunten voor elke subset, die vanaf 21 dagen 
na inoculatie begon te verdwijnen. Bloed NK cellen vertoonden een geactiveerde status (verhoogde 
CD16 en CD25 expressie) dewelke meer geschikt was voor migratie (verhoogde CD11b en CD62L 
expressie). Met uitzondering van CD8+ regulatorische T cellen werden er geen verschillen in lymfocyt 
aantallen waargenomen die de verschillende uitscheidingspatronen kunnen verklaren. CD8+ Tregs, die 
aanzienlijk verhoogd waren in het bloed van kat 3, vormen een relatief ongekende subset die vaak 
geassocieerd worden met intestinale immuniteit waar ze immuunresponsen kunnen onderdrukken, 
zoals aangetoond met intestinale parasitaire en rectale retrovirale infecties. Proliferatie assays 
verifieerden dat katten een cel-gemedieerde respons kunnen genereren, waarschijnlijk Th2 
geörienteerd,  als antwoord op FECV antigenen. Er kan besloten worden dat deze resultaten meer 
uitgebreide kennis aanbrengen over de respons van het feliene immuun systeem tijdens een infectie 
met FECV. 
Om al de klinische, virologische en immunologische data te kunnen integreren, werd een aangepast 
infectiemodel voorgesteld. Dit model adresseert verschillende merkwaardigheden zoals de 
verschillende uitscheidingspatronen en de vertraagde immuniteit en tracht de rol van de immuniteit te 
verklaren gedurende infectie. Volgens dit model, treedt FECV infectie op in drie fasen. In een eerste 
fase infecteert het virus gevoelige cellen in de naso-orofaryngeale holte, waarschijnlijk cellen van 
monocyt-oorsprong, dewelke één van de eerste cellen zijn die virus detecteren en frequent worden 
terug gevonden in weefsels van de naso-orofaryngeale holte. Monocytaire cellen werden gevoelig 
gevonden voor FECV infectie, weliswaar aan lage niveaus zonder veel cytopathogeen effect. Infectie 
van deze cellen zou FECV zowel een ontsnappingsmiddel aan de immuniteit bieden als een 
transportmiddel voor verspreiding doorheen de hele gastheer. Deze hypothese zou de variërende 
hoeveelheid virus in de naso-orofaryngeale holte kunnen verklaren alsook een verklaring bieden 
waarom FECV ook systemisch kan teruggevonden worden in het lichaam. Het typisch fecaal 
uitscheidingspatroon is onderverdeeld in fase 2 en 3. Fase 2 vertegenwoordigt enterocyt-infectie als 
gevolg van gastro-intestinale passage van oraal toegediend virus. Deze infectie leidt tot de hoge 
hoeveelheid aan viraal RNA dat gedecteerd wordt op dag 5 na inoculatie en wordt onderdrukt door het 
immuunsysteem 2-3 weken na infectie. De rest van het getecteerd viraal RNA dat later wordt 
gedecteerd is het gevolg van fase III van de infectie. Deze fase is het resultaat van virus verspreiding 
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van de naso-orofaryngeale holte met behulp van migrerende geïnfecteerde gevoelige cellen 
(monocytaire cellen). Migratie kan door bloed en/of lymfe geschieden. 
Een sterke cel-gemedieerde immuniteit (CMI) wordt verondersteld onmisbaar te zijn voor 
bescherming tegen infectie met FIPV in katten. Daarom werd in hoofdstuk 4.2 de rol van NK cellen, 
T cellen en Tregs, centrale spelers in de aangeboren, adaptieve en regulatorische immuniteit 
respectievelijk, onderzocht gedurende een natuurlijke FIPV infectie. Kwantificatie toonde aan dat NK 
cellen, T cellen en Tregs allen drastisch gedepleteerd waren van het perifeer bloed, de mesenterische 
lymfe knoop en de milt in FIP katten. Dit in tegenstelling tot het mesenterium en nieren van FIP 
katten, die geen verschil toonden met gezonde ongeïnfecteerde katten. Overigens waren ook andere 
regulatorische lymfocytsubsets (CD4+CD25-Foxp3+ en CD3+CD8+Foxp3) gedepleteerd in het bloed 
en de mesenterische lymfe knoop (LN). Fenotypische analyse van bloed NK cellen in FIP katten 
toonde een opregulatie aan van activatie merkers (CD16 en CD25) en migratie merkers (CD11b en 
CD62L) terwij LNl NK cellen enkel opregulatie vertoonden van CD16 en CD62. LN-afgeleide NK 
cellen waren ook significant minder cytotoxisch vergeleken met  LN NK cellen van gezonde katten. 
Alhoewel T cellen gedepleteerd waren van bloed en lymfoïde weefsels, prolifereerden ze nog steeds 
wanneer ze gestimuleerd werden met geïnactiveerd FIPV maar niet met met infectieus FIPV. Deze 
studie toonde voor de eerste maal aan dat FIPV infectie geassocieerd is met ernstige onderdrukking 
van NK cellen en Tregs, aangetoond door cel depletie en de verlaagde functionaliteit (enkel NK 
cellen). Dit zal ongetwijfeld leiden tot een verlaagde capaciteit van de aangeboren en adaptieve 
immuniteit om een FIPV infectie te bestrijden en een verlaagde capaciteit van de regulerende 
immuniteit om de FIPV-typische immunopathologie te onderdrukken. Overigens kunnen deze 
bevindingen ook mogelijkheden openen voor nieuwe therapieën die specifiek NK cellen en Tregs 
beïnvloeden om hun aantallen/functionaliteit te vergroten gedurende FIPV infectie. 
Als algemeen besluit, gebaseerd op de resultaten van hoofdstuk 4.1 en 4.2, zouden de autheurs graag 
een hypothetisch model voorstellen dat de FECV infectie linkt met de FIPV infectie. In dit model 
wordt een belangrijke rol gespeeld door het fenomeen T cel uitputting, een verschijnsel dat 
gekenmerkt wordt door het progressieve verlies van T cel aantallen en functies als gevolg van een 
langdurige blootstelling aan antigenen, wat zelfs kan resulteren in de fysische deletie van pathogeen 
specifieke T cellen. Er zijn verschillende feiten die erop wijzen dat dit fenomeen ook kan aanwezig 
zijn gedurende FCoV infecties. Ten eerste, het patroon van afnemende T cel aantallen tijdens een 
experimentele FECV infectie, desondanks de hoge virale druk. Ten tweede, ondanks de proliferatieve 
respons, kon er geen IFN-γ getecteerd worden in het cel cultuur supernatans. Ten derde, de 
immunodominantie van S-proteïne specifieke lymfocyten, gedetecteerd door de Groot-mijnes et al. 
(2005), tonen aan dat sommige epitoop specieke lymfocyten meer gevoelig zijn voor uitputting dan 
andere, een typisch kenmerk voor het T cel uitputtingsmodel. Tenslotte, de initiële gedetecteerde 
opregulatie van Tregs gecombineerd met eerder beschreven verhoogde IL-10 niveaus in FECV-
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geïnfecteerde katten. Tregs vormen dan ook een van de drie hoofdregulatie pathways in het T cel 
uitputtingsmodel. Dit fenomeen kan dus resulteren in een éénzijdige immuniteit (gericht tegen 
bepaalde epitopen enkel) die uiteindelijk, eventueel virus infectie kan overwinnen, verschillende 
weken na de primaire infectie. Dit houdt gevolgen in voor FIPV ontwikkeling. Een vertraagde, 
aangepaste en getemperde immuniteit tijdens infectie met FECV kan aanleiding geven tot hogere virus 
replicaties, wat op zijn beurt dan weer de kans verhoogt op een fatale mutatie die leidt tot FIPV. Eens 
FIPV onstaan is, kan de FIPV-geassocieerde lymfopenie op zijn beurt, de reeds verzwakte T cel 
immuniteit nog verder ondermijnen. Dit zal resulteren in de complete ondergang van de cel-
gemedieerde immuniteit, zoals aangetoond door de extreme depletie van NK cellen, Tregs  T cellen in 
het bloed, de LN en de milt en door de aangetaste functionaliteit van NK en T cellen (Fig 6.1) 
 
Figure 6.1 : Hypotetisch model dat de brug legt tussen FECV en FIPV infectie, met rollen voor T cell uitputting en 
uitscheidingspatronen. 
De hoofdbesluiten van deze verhandeling zijn: 
• Een BrdU assay werd aangepast om de lymfoproliferatie te kunnen detecteren als reactie op 
blootstelling aan virale antigenen.  
• NK cellen van gezonde kitten, vertonen grote gelijkenissen met andere diersoorten. Vooral 
met betrekking to aantallen en morfologisch uiterlijk. Wat betreft het fenotype echter, zijn er 
diersoort-specifieke kenmerken.  
• Feliene NK cellen kunnen de algemeen gebruikte K562 cellen niet lyseren. De feliene cellijn 
CRFK kan dienen als alternatief om NK gemedieerde cytotoxiciteit te evalueren. 
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• Zowel FECV- als FIPV geïnfecteerde katten kunnen een proliferatieve response genereren 
tegen respectievelijk FECV en FIPV antigenen. Tijdens beide responsen wordt er evenwel 
geen IFN-γ geproduceerd. 
• Tijdens de infectie van 3 katten met FECV werd in één van de katten een afwijkend 
uitscheidingspatroon gedetecteerd. Dit kon niet verklaard worden door één van de 
geanalyseerde immuun parameters, met de uitzondering van CD8+ regulatorische T cellen. 
Een alternatief 3-fase infectie model werd voorgesteld, met eerst een orale fase waarin 
gevoelige cellen in de naso-oropharyngeale holte (mogelijks monocytaire cellen) worden 
geïnfecteerd. Dit wordt gevolgd door een intestinale fase met eerst infectie van enterocyten 
(fase 2), die opgevolgd wordt door een derde fase met infectie van andere gevoelige cellen 
(monocytaire cellen?) in het intestinale systeem. 
• FECV infectie wordt gekenmerkt door een initiële stijging van T cellen (3 dagen na 
inoculatie), B cellen (3 dagen na inoculatie) en Tregs (7 dagen na inoculatie). Dit wordt 
gevolgd door een graduele daling die eindigt 21 dagen na inoculatie. 
• Tijdens een FECV infectie dalen NK cel aantallen onmiddelijk. Het NK fenotype was tijdelijk 
geactiveerd (verhoogde CD16 en CD25 expressie) en capabel voor migratie (verhoogde 
CD11b en CD62L expressie). 
• FIPV-geïnfecteerde katten vertoonden extreme depletie van T cellen, B cellen (alleen in het 
bloed), NK cellen en Tregs in het perifeer blood, LN en milt. In FIPV-geïnfecteerd weefsel 
daarentegen kon geen depletie worden vastgesteld. Niet-klassieke Foxp3 regulatorische cellen 
(CD3+CD8+ en CD4+CD25-) waren ook gedepleteerd in bloed en LN van FIP katten. 
Eigenaardig genoeg werden hogere aantallen Foxp3+CD3+CD8+ regulatorische cellen 
gevonden in FIPV-geïnfecteerde nieren. 
• Tijdens FIPV infectie werden dezelfde molecules (CD11b, CD16, CD25 en CD62L) 
geopreguleerd op perifere NK cellen als bij een FECV infectie, maar wel tot hogere niveause 
voor CD25 en CD62L. Vergeleken met gezonde katten, toonden de FIP LN-afgeleide NK 
cellen een verhoogde expressie van CD16 en CD62L. Daarenboven was de depletie voor 
Tregs in de LN nog ernstiger dan voor T of B cellen. Ondanks hun meer geactiveerd fenotype, 
lyseerden LN-afgeleide NK cellen significant minder target cellen dan gezonde 
ongeïnfecteerde katten. 
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